activity_id,assay_chembl_id,assay_description,canonical_smiles,data_validity_comment,data_validity_description,document_chembl_id,document_journal,document_year,molecule_chembl_id,molecule_pref_name,parent_molecule_chembl_id,pchembl_value,record_id,relation,src_id,standard_flag,standard_relation,standard_text_value,standard_type,standard_units,standard_value,target_chembl_id,target_organism,target_pref_name,target_tax_id,type,units,uo_units,value,activity_label
301072,CHEMBL698532,PGI-2 agonistic activity by measuring inhibition of 4 uM ADP-induced human platelet aggregation,O=C(O)COc1cccc2c1CCC(Cn1cc(C(c3ccccc3)c3cccnc3)cn1)C2,,,CHEMBL1150504,Bioorg Med Chem Lett,1995,CHEMBL11779,,CHEMBL11779,6.82,10069,=,1,1,=,,IC50,nM,150.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.15,1
321299,CHEMBL699152,In vitro inhibition of ADP-induced human platelet aggregation.,O=C(NC[C@H](NS(=O)(=O)Cc1ccccc1)C(=O)O)c1ccc2c(c1)C(=O)N(CCC1CCNCC1)C2,,,CHEMBL1129711,Bioorg Med Chem Lett,1996,CHEMBL85064,,CHEMBL85064,8.4,151571,=,1,1,=,,IC50,nM,4.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,4.0,0
371813,CHEMBL700565,Compound was evaluated for GROalpha-mediated calcium mobilization in human polymorphonuclear neutrophils(PMNs),N#Cc1ccc(NC(=O)Nc2ccccc2Br)c(O)c1Cl,,,CHEMBL1149089,J Med Chem,2004,CHEMBL27446,,CHEMBL27446,8.59,36909,=,1,1,=,,IC50,nM,2.6,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,2.6,0
398348,CHEMBL699491,In vitro inhibition of collagen-induced platelet aggregation in human platelet rich plasma,COc1ccc(-c2nc(CCO)sc2-c2ccc(OC)cc2)cc1,,,CHEMBL1121768,J Med Chem,1981,CHEMBL35637,,CHEMBL35637,,58384,=,1,1,=,,IC50,ug.mL-1,0.00032,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,ng ml-1,UO_0000274,0.32,0
268967,CHEMBL698532,PGI-2 agonistic activity by measuring inhibition of 4 uM ADP-induced human platelet aggregation,CCC/C(CC1CCc2c(cccc2OCC(=O)O)C1)=N\OC(c1ccccc1)c1ccccc1,,,CHEMBL1150504,Bioorg Med Chem Lett,1995,CHEMBL268477,AP-227,CHEMBL268477,6.82,10072,=,1,1,=,,IC50,nM,150.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.15,1
292343,CHEMBL698689,In vitro inhibition of histamine release from human basophils,c1cc(Nc2nccc(-c3ccncc3)n2)cc(OCCn2ccnc2)c1,,,CHEMBL1126800,J Med Chem,1993,CHEMBL329204,,CHEMBL329204,6.7,168310,=,1,1,=,,IC50,nM,200.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.2,1
168479,CHEMBL872816,Inhibition of growth of human mammary carcinoma (MCF-7) cell line.,COc1ccc(NS(=O)(=O)c2c(F)c(F)c(F)c(F)c2F)cc1NC(=O)[C@H](C)NC(C)=O,,,CHEMBL1134655,J Med Chem,2001,CHEMBL120186,,CHEMBL120186,8.0,227928,=,1,1,=,,IC50,nM,10.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,10.0,0
99899,CHEMBL699503,Inhibitory activity against PAF-induced aggregation of human platelets suspended in plasma,CCCOc1c(OC)cc([C@@H]2CC[C@@H](c3cc(OC)c(OC)c(OC)c3)O2)cc1S(=O)(=O)CCO,,,CHEMBL1126126,J Med Chem,1992,CHEMBL299944,,CHEMBL299944,7.26,221179,=,1,1,=,,IC50,nM,55.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,55.0,1
397182,CHEMBL699491,In vitro inhibition of collagen-induced platelet aggregation in human platelet rich plasma,COc1ccc(-c2nc(C)sc2-c2ccc(OC)cc2)cc1,,,CHEMBL1121768,J Med Chem,1981,CHEMBL37381,,CHEMBL37381,,58393,=,1,1,=,,IC50,ug.mL-1,0.00032,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,ng ml-1,UO_0000274,0.32,0
452952,CHEMBL701319,Inhibition of leukotriene B4 production in human whole blood,c1ccc(Cc2ccc(OCCN3CCCCC3)cc2)cc1,,,CHEMBL1134981,Bioorg Med Chem Lett,2002,CHEMBL112522,,CHEMBL112522,6.77,215630,=,1,1,=,,IC50,nM,170.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.17,1
243851,CHEMBL767837,Concentration of test compound required to inhibit 50% LTB4-induced calcium mobilization in intact human PMNs,COc1ccc(CCCCCCCCOc2ccc(CSCc3ccc(C(=O)O)cc3)nc2/C=C/C(=O)O)cc1,,,CHEMBL1127355,J Med Chem,1994,CHEMBL325637,,CHEMBL325637,6.76,212918,=,1,1,=,,IC50,nM,175.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,175.0,1
558421,CHEMBL698304,Tested for inhibition of platelet aggregation induced by arachidonic acid (AAIPA) in human platelet rich plasma,O=C(O)CCCc1ccccc1Cc1ccccc1-c1nc(C(=O)NCCCCC2CCCCC2)co1,,,CHEMBL1152043,Bioorg Med Chem Lett,1992,CHEMBL355420,,CHEMBL355420,7.24,343139,=,1,1,=,,IC50,nM,58.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,I50,uM,UO_0000065,0.058,1
317871,CHEMBL843256,Inhibition of U 46619-induced Aggregation of human Washed platelets,O=C(O)CC[C@H](CCCCNS(=O)(=O)c1ccc(Cl)cc1)CCOc1cccnc1,,,CHEMBL1127028,J Med Chem,1993,CHEMBL68058,,CHEMBL68058,8.0,114049,=,1,1,=,,IC50,nM,10.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,10.0,0
583920,CHEMBL878710,Tested for Concentration required for the inhibition of ADP-induced aggregation of human platelets,CC#CCC(C)[C@H](O)/C=C/[C@H]1[C@H](O)CC2Oc3c(CCCC(=O)[O-])cccc3[C@@H]21.[Na+],,,CHEMBL1132727,Bioorg Med Chem Lett,2000,CHEMBL94694,,CHEMBL1205415,8.37,174246,=,1,1,=,,IC50,nM,4.3,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,4.3,0
44392,CHEMBL763979,Inhibition of human platelet aggregation induced by ADP after 3 min incubation with platelet rich plasma,Cl.Oc1nc2cc3cc(OCCCc4nnnn4C4CCN(CC5CCCC5)CC4)ccc3[nH]c-2n1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1126868,J Med Chem,1993,CHEMBL1203027,,CHEMBL113055,,208546,=,1,1,=,,IC50,nM,0.009,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,0.009,0
589100,CHEMBL759885,"Inhibitory activity against platelet aggregation, induced by arachidonic acid in human platelet rich plasma",CSc1ccc(CCCCNC(=O)c2coc(C3C4CCC(O4)C3Cc3ccccc3CCC(=O)O)n2)cc1,,,CHEMBL1126688,J Med Chem,1993,CHEMBL287068,,CHEMBL287068,8.22,47558,=,1,1,=,,IC50,nM,6.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,I50,nM,UO_0000065,6.0,0
48036,CHEMBL763979,Inhibition of human platelet aggregation induced by ADP after 3 min incubation with platelet rich plasma,Cl.O=S(=O)(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)N1CCN(CC2CCCCC2)CC1,,,CHEMBL1126868,J Med Chem,1993,CHEMBL1203069,,CHEMBL111700,9.96,208585,=,1,1,=,,IC50,nM,0.11,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,0.11,0
123280,CHEMBL699805,Compound was tested in vitro inhibitory activity against human neutrophil CD11b/CD18. ,CCc1cc(C(C)=O)c(O)cc1OCCCOc1ccc2c(=O)c3cc(C(=O)O)ccc3oc2c1CCC(=O)O,,,CHEMBL1129361,J Med Chem,1996,CHEMBL88337,,CHEMBL88337,7.33,162545,=,1,1,=,,IC50,nM,47.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,47.0,1
559910,CHEMBL759885,"Inhibitory activity against platelet aggregation, induced by arachidonic acid in human platelet rich plasma",O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCc2ccccc2)co1,,,CHEMBL1126688,J Med Chem,1993,CHEMBL410732,,CHEMBL410732,8.05,47532,=,1,1,=,,IC50,nM,9.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,I50,nM,UO_0000065,9.0,0
37215,CHEMBL763979,Inhibition of human platelet aggregation induced by ADP after 3 min incubation with platelet rich plasma,Cl.O=C(NCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)N1CCN(CCC2CCCCC2)CC1,,,CHEMBL1126868,J Med Chem,1993,CHEMBL1203052,,CHEMBL110806,10.14,208519,=,1,1,=,,IC50,nM,0.072,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,0.072,0
386571,CHEMBL761638,In vitro inhibition of collagen-induced platelet aggregation in human platelet-rich plasma (PRP),COc1ccc(-c2csnn2)cc1,,,CHEMBL1122973,J Med Chem,1985,CHEMBL139589,,CHEMBL139589,,267956,=,1,1,=,,IC50,ug.mL-1,3.2,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,ug ml-1,UO_0000274,3.2,0
421105,CHEMBL699491,In vitro inhibition of collagen-induced platelet aggregation in human platelet rich plasma,CC(C(=O)O)c1ccc(-c2ccccc2)c(F)c1,,,CHEMBL1121768,J Med Chem,1981,CHEMBL563,FLURBIPROFEN,CHEMBL563,,58388,=,1,1,=,,IC50,ug.mL-1,0.32,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,ug ml-1,UO_0000274,0.32,0
85270,CHEMBL699531,Concentration required for 50% inhibition of platelet aggregation of human gel-filtered platelets(GFP) in platelet aggregation assay,C=CCCS(=O)(=O)N[C@@H](CNC(=O)c1cc2n(n1)CCN(CCC1CCNCC1)C2=O)C(=O)O,,,CHEMBL1130456,Bioorg Med Chem Lett,1997,CHEMBL36961,,CHEMBL36961,7.96,60927,=,1,1,=,,IC50,nM,11.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,11.0,0
210685,CHEMBL842872,Compound was tested for its in vitro activity in the inhibition of platelet aggregation using human platelet rich plasma,CCCCOC(=O)N[C@@H](CNC(=O)C[C@@H]1C[C@H](c2ccc(C(=N)N)cc2)N(C)O1)C(=O)O.Cl,,,CHEMBL1131698,Bioorg Med Chem Lett,1999,CHEMBL545572,,CHEMBL1194066,6.79,302041,=,1,1,=,,IC50,nM,164.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.164,1
272477,CHEMBL881157,"Inhibitory activity against U-46,619-induced aggregation of washed human platelets.",Cl.O=C(O)CCCCCC(CNS(=O)(=O)c1ccccc1)c1cccnc1,,,CHEMBL1126260,J Med Chem,1992,CHEMBL557427,,CHEMBL1196572,8.4,263742,=,1,1,=,,IC50,nM,4.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.004,0
638015,CHEMBL767676,Test inhibition of LTB4 production in human peripheral blood polymorphonuclear leukocytes (HPMN),COC1(c2cccc(COc3ccc4c(-c5ccccc5)c5c(cc4c3)C(=O)OC5)c2)CCOCC1,,,CHEMBL1129067,J Med Chem,1996,CHEMBL129292,,CHEMBL129292,8.82,245859,=,1,1,=,,IC50,nM,1.5,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,1.5,0
144342,CHEMBL698042,Compound was tested in vitro for inhibitory activity in LTB4 induced Ca mobilization.,O=C(O)/C=C/c1nc(CSc2c(Cl)cccc2Cl)ccc1OCCc1ccccc1,,,CHEMBL1129361,J Med Chem,1996,CHEMBL90214,TICOLUBANT,CHEMBL90214,8.18,162540,=,1,1,=,,IC50,nM,6.6,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,6.6,0
585339,CHEMBL759885,"Inhibitory activity against platelet aggregation, induced by arachidonic acid in human platelet rich plasma",O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)Nc2ccccc2)co1,,,CHEMBL1126688,J Med Chem,1993,CHEMBL280605,,CHEMBL280605,7.92,47517,=,1,1,=,,IC50,nM,12.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,I50,nM,UO_0000065,12.0,0
46782,CHEMBL763559,Concentration required for maximal in vitro inhibition of aggregation of human platelet rich plasma (hPRP),Cc1noc(C)c1S(=O)(=O)N[C@@H](CNC(=O)C[C@H]1CC(c2ccc(C(=N)NCc3cccc(F)c3)cc2)=NO1)C(=O)O,,,CHEMBL1133917,Bioorg Med Chem Lett,2001,CHEMBL303420,,CHEMBL303420,7.26,123893,=,1,1,=,,IC50,nM,55.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.055,1
164275,CHEMBL694769,Tested in vitro for the inhibition of ADP-induced aggregation of human blood platelets,CC(C)CC(=O)N[C@@H](CCCNC(=O)Cc1ccc(C(=N)N)cc1)CC(=O)O,,,CHEMBL1129882,Bioorg Med Chem Lett,1997,CHEMBL162505,,CHEMBL162505,7.0,319866,=,1,1,=,,IC50,nM,100.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,100.0,1
32398,CHEMBL764816,Inhibitory activity of Ca-ionophore-A23187-induced Leukotriene B4 (LTB4) release in human polymorphonuclear leukocytes,CCOC(=O)C(Cc1ccccc1)Nc1nc2cc(CC)ccc2s1,,,CHEMBL1127687,J Med Chem,1994,CHEMBL354415,,CHEMBL354415,7.92,341178,=,1,1,=,,IC50,nM,12.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.012,0
42017,CHEMBL763979,Inhibition of human platelet aggregation induced by ADP after 3 min incubation with platelet rich plasma,Cl.O=C(NCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)N1CCN(c2ccccn2)CC1,,,CHEMBL1126868,J Med Chem,1993,CHEMBL1203066,,CHEMBL419572,9.16,208576,=,1,1,=,,IC50,nM,0.69,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,0.69,0
42019,CHEMBL763979,Inhibition of human platelet aggregation induced by ADP after 3 min incubation with platelet rich plasma,Cl.O=S(=O)(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCN(Cc2cccc(C(F)(F)F)c2)CC1,,,CHEMBL1126868,J Med Chem,1993,CHEMBL1203029,,CHEMBL321707,10.42,208541,=,1,1,=,,IC50,nM,0.038,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,0.038,0
98334,CHEMBL699531,Concentration required for 50% inhibition of platelet aggregation of human gel-filtered platelets(GFP) in platelet aggregation assay,O=C(N[C@@H](CNC(=O)c1cc2n(n1)CCN(CCC1CCNCC1)C2=O)C(=O)O)OCc1ccccc1,,,CHEMBL1130456,Bioorg Med Chem Lett,1997,CHEMBL286172,,CHEMBL286172,8.3,60930,=,1,1,=,,IC50,nM,5.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,5.0,0
297667,CHEMBL873090,Inhibition of growth of human keratinocytes,C=C1/C(=C\C=C2/CCC[C@]3(C)C([C@@H](C)COc4ccc(C(C)(C)O)cc4)CC[C@@H]23)C[C@@H](O)C[C@@H]1O,,,CHEMBL1134331,J Med Chem,2001,CHEMBL318267,,CHEMBL318267,9.96,187296,=,1,1,=,,IC50,nM,0.11,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,0.11,0
235675,CHEMBL873083,Inhibitory concentration against U 46619 induced aggregation of human washed platelets(WP),O=C(O)CCCCCc1cnccc1CCNS(=O)(=O)c1ccc(Cl)cc1,,,CHEMBL1150530,Bioorg Med Chem Lett,1992,CHEMBL298009,,CHEMBL298009,6.71,68650,=,1,1,=,,IC50,nM,195.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.195,1
228100,CHEMBL695988,Antiproliferative activity was evaluated by the 72 hr MTT cell viability assay using human colon carcinoma cells (GC3).,COc1ccc(C[C@H]2NC(=O)/C=C/C[C@@H]([C@H](C)[C@H]3O[C@@H]3c3ccccc3)OC(=O)[C@H](CC(C)C)OC(=O)C(C)(C)CNC2=O)cc1Cl,,,CHEMBL1131700,Bioorg Med Chem Lett,1999,CHEMBL316640,CRYPTOPHYCIN 52,CHEMBL316640,9.7,320870,=,1,1,=,,IC50,nM,0.2,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,0.2,0
612122,CHEMBL702141,Inhibition of human vascular smooth muscle proliferation was determined,O=C(NCc1ccccc1)N[C@@H](CCC(=O)N1CCN(c2cccc(NC3=NCCCN3)c2)CC1)C(=O)O,,,CHEMBL1146737,Bioorg Med Chem Lett,2004,CHEMBL315956,,CHEMBL315956,,155710,>,1,1,>,,IC50,nM,10.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,10.0,0
608835,CHEMBL824150,Compound was tested in vitro for inhibitory activity against human FKBP,CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3C[C@@H](O)[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC,,,CHEMBL1130792,Bioorg Med Chem Lett,1998,CHEMBL172542,,CHEMBL172542,8.92,342763,=,1,1,=,,IC50,nM,1.21,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,1.21,0
141920,CHEMBL765890,Concentration of peptide resulting in 50% inhibition of C5a (100 nM) causing the release of MPO from polymorphonuclear leukocytes,NC(N)=NCC[C@H]1NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](CC2CCCCC2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](NC(=O)[C@@H](N)Cc2ccccc2)CCNC1=O,,,CHEMBL1132227,J Med Chem,1999,CHEMBL433838,,CHEMBL433838,6.7,103084,=,1,1,=,,IC50,nM,199.53,CHEMBL372,Homo sapiens,Homo sapiens,9606,-Log IC50,,UO_0000065,6.7,1
551432,CHEMBL702585,In vitro inhibitory activity against superoxide production from human neutrophils stimulated with f-MLP,CCOc1ccc(-c2nc(-c3cccc(C(=O)O)n3)cs2)cc1OCC,,,CHEMBL1128742,J Med Chem,1995,CHEMBL332750,TETOMILAST,CHEMBL332750,7.16,226487,=,1,1,=,,IC50,nM,70.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.07,1
585332,CHEMBL759885,"Inhibitory activity against platelet aggregation, induced by arachidonic acid in human platelet rich plasma",NC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1,,,CHEMBL1126688,J Med Chem,1993,CHEMBL31087,,CHEMBL31087,7.36,47516,=,1,1,=,,IC50,nM,44.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,I50,nM,UO_0000065,44.0,1
561973,CHEMBL759885,"Inhibitory activity against platelet aggregation, induced by arachidonic acid in human platelet rich plasma",O=C(O)c1cccc(CCC2C3CCC(O3)C2c2nc(C(=O)NCCCCC3CCCCC3)co2)c1,,,CHEMBL1126688,J Med Chem,1993,CHEMBL286708,,CHEMBL286708,6.96,47553,=,1,1,=,,IC50,nM,110.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,I50,nM,UO_0000065,110.0,1
579411,CHEMBL763989,The compound was tested for their ability to inhibit ADP-stimulated platelet aggregation in human platelet rich plasma,Cc1cccc(S(=O)(=O)N[C@@H](CNC(=O)Cc2cc(-c3ccc(C(=N)N)cc3)no2)C(=O)O)c1.O=C(O)C(F)(F)F,,,CHEMBL1132701,J Med Chem,1999,CHEMBL428535,,CHEMBL1185697,7.16,21801,=,1,1,=,,IC50,nM,69.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.069,1
566932,CHEMBL763989,The compound was tested for their ability to inhibit ADP-stimulated platelet aggregation in human platelet rich plasma,N=C(N)c1ccc(C2=NO[C@@H](CC(=O)NC[C@H](NS(=O)(=O)c3ccccc3C(F)(F)F)C(=O)O)C2)cc1.O=C(O)C(F)(F)F,,,CHEMBL1132701,J Med Chem,1999,CHEMBL18165,,CHEMBL1178266,7.05,21835,=,1,1,=,,IC50,nM,89.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.089,1
36021,CHEMBL763979,Inhibition of human platelet aggregation induced by ADP after 3 min incubation with platelet rich plasma,Cl.O=C(NCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)N1CCN(Cc2ccc(F)cc2)CC1,,,CHEMBL1126868,J Med Chem,1993,CHEMBL1203057,,CHEMBL113360,9.46,208526,=,1,1,=,,IC50,nM,0.35,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,0.35,0
297665,CHEMBL873090,Inhibition of growth of human keratinocytes,C=C1/C(=C\C=C2/CCC[C@]3(C)C([C@@H](C)CSc4ccc(C(C)(C)O)cc4)CC[C@@H]23)C[C@@H](O)C[C@@H]1O,,,CHEMBL1134331,J Med Chem,2001,CHEMBL318617,,CHEMBL318617,9.55,187291,=,1,1,=,,IC50,nM,0.28,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,0.28,0
535950,CHEMBL878324,Leukotriene synthesis inhibition activity in the Human PMN assay,CC(C)(C)Sc1c(CC(C)(C)C(=O)O)n(Cc2ccc(Cl)cc2)c2ccc(OCc3ccc4ccccc4n3)cc12,,,CHEMBL1126364,Bioorg Med Chem Lett,1992,CHEMBL16596,QUIFLAPON,CHEMBL16596,8.52,45168,=,1,1,=,,IC50,nM,3.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,3.0,0
490994,CHEMBL879053,In vitro cytotoxicity expressed as conc. that inhibits 50% of KB (human) cell proliferation,CO[C@H]1Nc2cc3c(cc2C(=O)N2C=C(/C=C/C(=O)N(C)C)C[C@@H]12)OCO3,,,CHEMBL1134670,J Med Chem,2001,CHEMBL125393,,CHEMBL125393,8.3,235315,=,1,1,=,,IC50,nM,5.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,5.0,0
497188,CHEMBL768070,In vitro inhibition of human Platelet-rich plasma (PRP) aggregation induced by 5 uM ADP,N=C(N)c1ccc(NC(=O)c2ccc3c(c2)CC(CC(=O)O)CC3)cc1,,,CHEMBL1131137,J Med Chem,1998,CHEMBL423326,,CHEMBL423326,7.34,250124,=,1,1,=,,IC50,nM,46.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,46.0,1
58221,CHEMBL764816,Inhibitory activity of Ca-ionophore-A23187-induced Leukotriene B4 (LTB4) release in human polymorphonuclear leukocytes,CC(C)c1ccc2oc(NC(CN3CCOCC3)c3ccccc3)nc2c1,,,CHEMBL1127687,J Med Chem,1994,CHEMBL171863,,CHEMBL171863,7.28,341212,=,1,1,=,,IC50,nM,52.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.052,1
301384,CHEMBL698689,In vitro inhibition of histamine release from human basophils,Cl.Cl.O.c1ccc(-c2ccnc(Nc3cccc(-n4ccnc4)c3)n2)nc1,,,CHEMBL1126800,J Med Chem,1993,CHEMBL2092907,,CHEMBL89928,6.7,168412,=,1,1,=,,IC50,nM,200.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.2,1
476493,CHEMBL879053,In vitro cytotoxicity expressed as conc. that inhibits 50% of KB (human) cell proliferation,CN(C)C(=O)/C=C/C1=CN2C(=O)c3cc4c(cc3NC(S(=O)(=O)[O-])[C@@H]2C1)OCO4.[Na+],,,CHEMBL1134670,J Med Chem,2001,CHEMBL124477,SODIUM BISULFITE ADDUCT,CHEMBL1205635,7.3,235314,=,1,1,=,,IC50,nM,50.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,50.0,1
345039,CHEMBL701315,Inhibition of interleukin-2 (IL-2) synthesis in human whole blood stimulated by PMA/ionomycin.,O=C(Nc1ccc(-n2nc(C(F)(F)F)cc2OC(F)F)cc1)c1ccncc1F,,,CHEMBL1133605,J Med Chem,2000,CHEMBL103517,,CHEMBL103517,6.74,188110,=,1,1,=,,IC50,nM,182.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,182.0,1
303303,CHEMBL697913,Inhibition of ADP-induced platelet aggregation,CN(C(=O)CCCOc1ccc2c(c1)CN1CC(=O)NC1=N2)C1CCCCC1,,,CHEMBL1123669,J Med Chem,1987,CHEMBL69139,LIXAZINONE,CHEMBL69139,6.96,191872,=,1,1,=,,IC50,nM,110.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.11,1
68601,CHEMBL763979,Inhibition of human platelet aggregation induced by ADP after 3 min incubation with platelet rich plasma,Cl.O=S(=O)(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCN(CC2CCCCC2)CC1,,,CHEMBL1126868,J Med Chem,1993,CHEMBL1203024,,CHEMBL110959,10.52,208539,=,1,1,=,,IC50,nM,0.03,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,0.03,0
621549,CHEMBL842220,Inhibition of TNF-alpha synthesis in human monocytes,COc1ccc2c(Cc3c(Cl)cncc3Cl)nnc(-c3ccccc3)c2c1,,,CHEMBL1134046,Bioorg Med Chem Lett,2001,CHEMBL310387,,CHEMBL310387,7.34,232432,=,1,1,=,,IC50,nM,46.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,46.0,1
293369,CHEMBL696392,Inhibition of ADP-induced platelet aggregation in human gel-filtered platelets,O=C(NC[C@H](NS(=O)(=O)c1cccnc1)C(=O)O)c1cc2cc(OCC3CCNCC3)ccc2[nH]1,,,CHEMBL1151560,Bioorg Med Chem Lett,1997,CHEMBL92091,,CHEMBL92091,7.92,174755,=,1,1,=,,IC50,nM,12.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,12.0,0
372017,CHEMBL702327,Compound was evaluated for inhibiting production of LTB4 in calcium Ionophore (A23187) activated human whole blood.,CC(C#Cc1ccc(Oc2ccc(F)cc2)o1)N(O)C(N)=O,,,CHEMBL1131622,J Med Chem,1998,CHEMBL59598,,CHEMBL59598,7.0,103430,=,1,1,=,,IC50,nM,100.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.1,1
358256,CHEMBL761638,In vitro inhibition of collagen-induced platelet aggregation in human platelet-rich plasma (PRP),c1ccc(-c2nnsc2-c2ccccc2)cc1,,,CHEMBL1122973,J Med Chem,1985,CHEMBL442964,,CHEMBL442964,,267955,=,1,1,=,,IC50,ug.mL-1,3.2,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,ug ml-1,UO_0000274,3.2,0
579158,CHEMBL759885,"Inhibitory activity against platelet aggregation, induced by arachidonic acid in human platelet rich plasma",O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCc2ccc(O)cc2)co1,,,CHEMBL1126688,J Med Chem,1993,CHEMBL29429,,CHEMBL29429,7.92,47527,=,1,1,=,,IC50,nM,12.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,I50,nM,UO_0000065,12.0,0
331811,CHEMBL843255,Inhibition of U 46619-induced Aggregation of Human Washed Platelets,O=C(O)CC[C@H](CCCCNS(=O)(=O)c1ccc(Cl)cc1)CCCc1cccnc1,,,CHEMBL1127028,J Med Chem,1993,CHEMBL64005,,CHEMBL64005,7.96,114048,=,1,1,=,,IC50,nM,11.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,11.0,0
284878,CHEMBL696392,Inhibition of ADP-induced platelet aggregation in human gel-filtered platelets,O=C(NC[C@H](NS(=O)(=O)c1ccccc1)C(=O)O)c1cc2cc(OCC3CCNCC3)ccc2[nH]1,,,CHEMBL1151560,Bioorg Med Chem Lett,1997,CHEMBL96097,,CHEMBL96097,7.89,174751,=,1,1,=,,IC50,nM,13.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,13.0,0
291597,CHEMBL881157,"Inhibitory activity against U-46,619-induced aggregation of washed human platelets.",Cl.O=C(O)CCCCCCC(CNS(=O)(=O)c1ccc(Cl)cc1)c1cccnc1,,,CHEMBL1126260,J Med Chem,1992,CHEMBL544150,,CHEMBL1192844,8.0,263746,=,1,1,=,,IC50,nM,10.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.01,0
504483,CHEMBL768070,In vitro inhibition of human Platelet-rich plasma (PRP) aggregation induced by 5 uM ADP,N=C(N)c1ccc(C(=O)Nc2ccc3c(c2)CC(CC(=O)O)CC3)cc1,,,CHEMBL1131137,J Med Chem,1998,CHEMBL131823,,CHEMBL131823,7.24,250099,=,1,1,=,,IC50,nM,57.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,57.0,1
479024,CHEMBL879053,In vitro cytotoxicity expressed as conc. that inhibits 50% of KB (human) cell proliferation,CO[C@H]1Nc2ccccc2C(=O)N2C=C(/C=C/C(=O)N(C)C)C[C@@H]12,,,CHEMBL1134670,J Med Chem,2001,CHEMBL340393,,CHEMBL340393,7.07,235311,=,1,1,=,,IC50,nM,86.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,86.0,1
600410,CHEMBL842220,Inhibition of TNF-alpha synthesis in human monocytes,COc1ccc2c(Cc3c(Cl)cncc3Cl)nnc(Oc3ccccc3)c2c1,,,CHEMBL1134046,Bioorg Med Chem Lett,2001,CHEMBL312322,,CHEMBL312322,6.78,232416,=,1,1,=,,IC50,nM,166.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,166.0,1
352500,CHEMBL761638,In vitro inhibition of collagen-induced platelet aggregation in human platelet-rich plasma (PRP),c1ccc(-c2cnns2)cc1,,,CHEMBL1122973,J Med Chem,1985,CHEMBL445639,,CHEMBL445639,,267949,=,1,1,=,,IC50,ug.mL-1,3.2,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,ug ml-1,UO_0000274,3.2,0
51890,CHEMBL763559,Concentration required for maximal in vitro inhibition of aggregation of human platelet rich plasma (hPRP),CCCCOC(=O)N[C@@H](CNC(=O)C[C@H]1CC(c2ccc(C(=N)NCC)cc2)=NO1)C(=O)O,,,CHEMBL1133917,Bioorg Med Chem Lett,2001,CHEMBL70890,,CHEMBL70890,7.09,123890,=,1,1,=,,IC50,nM,82.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.082,1
400969,CHEMBL699491,In vitro inhibition of collagen-induced platelet aggregation in human platelet rich plasma,COC(=O)C(C)(C)c1nc(-c2ccc(OC)cc2)c(-c2ccc(OC)cc2)s1,,,CHEMBL1121768,J Med Chem,1981,CHEMBL435574,,CHEMBL435574,,58381,=,1,1,=,,IC50,ug.mL-1,0.0032,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,ng ml-1,UO_0000274,3.2,0
145356,CHEMBL872816,Inhibition of growth of human mammary carcinoma (MCF-7) cell line.,COc1ccc(NS(=O)(=O)c2c(F)c(F)c(F)c(F)c2F)cc1N,,,CHEMBL1134655,J Med Chem,2001,CHEMBL118433,,CHEMBL118433,8.0,227922,=,1,1,=,,IC50,nM,10.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,10.0,0
51920,CHEMBL763979,Inhibition of human platelet aggregation induced by ADP after 3 min incubation with platelet rich plasma,Cl.O=C(NCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)N1CCN(N2CCC(Cc3ccccc3)CC2)CC1,,,CHEMBL1126868,J Med Chem,1993,CHEMBL1203061,,CHEMBL322062,9.8,208531,=,1,1,=,,IC50,nM,0.16,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,0.16,0
33539,CHEMBL763979,Inhibition of human platelet aggregation induced by ADP after 3 min incubation with platelet rich plasma,CC(C)CN1CCC(S(=O)(=O)CCCOc2ccc3[nH]c4nc(O)nc-4cc3c2)CC1.Cl,,,CHEMBL1126868,J Med Chem,1993,CHEMBL1203087,,CHEMBL111687,10.57,208568,=,1,1,=,,IC50,nM,0.027,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,0.027,0
138205,CHEMBL702523,Anti-platelet activity was measured by studying their antagonist effects on human platelets aggregated with collagen,O=C(O)CCn1c2c(c3ccccc31)C[C@H](NS(=O)(=O)c1ccc(F)cc1)CC2,,,CHEMBL1136030,Bioorg Med Chem Lett,2002,CHEMBL361812,RAMATROBAN,CHEMBL361812,7.3,150727,=,1,1,=,,IC50,nM,50.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.05,1
610993,CHEMBL702141,Inhibition of human vascular smooth muscle proliferation was determined,CC(C)COC(=O)N[C@@H](CCC(=O)N1CCN(c2cccc(NC3=NCC(C)(C)CN3)c2)CC1)C(=O)O,,,CHEMBL1146737,Bioorg Med Chem Lett,2004,CHEMBL431208,,CHEMBL431208,8.47,155715,=,1,1,=,,IC50,nM,3.4,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,3.4,0
639277,CHEMBL767676,Test inhibition of LTB4 production in human peripheral blood polymorphonuclear leukocytes (HPMN),O=C1OCc2c1cc1cc(OCc3cccc(C4(O)CC5COC(C4)O5)c3)ccc1c2-c1ccccc1,,,CHEMBL1129067,J Med Chem,1996,CHEMBL129253,,CHEMBL129253,8.22,245893,=,1,1,=,,IC50,nM,6.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,6.0,0
330904,CHEMBL764818,Inhibitory activity against production of leukotriene B4 in isolated human polymorphonuclear leukocytes,OCc1ccccc1CCCc1cc2c(cc1O)CCO2,,,CHEMBL1124721,J Med Chem,1990,CHEMBL170484,,CHEMBL170484,6.72,340572,=,1,1,=,,IC50,nM,190.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,190.0,1
553964,CHEMBL763989,The compound was tested for their ability to inhibit ADP-stimulated platelet aggregation in human platelet rich plasma,CC(C)NS(=O)(=O)N[C@@H](CNC(=O)CC1CC(c2ccc(C(=N)N)cc2)=NO1)C(=O)O.O=C(O)C(F)(F)F,,,CHEMBL1132701,J Med Chem,1999,CHEMBL273556,,CHEMBL1182941,7.29,21813,=,1,1,=,,IC50,nM,51.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.051,1
633888,CHEMBL697933,Inhibition of platelet aggregation,Br.CC(OC(=O)CN1Cc2cc(OCCCC(=O)N(C)C3CCCCC3)ccc2N=C1N)c1ccccc1,,,CHEMBL1124005,J Med Chem,1988,CHEMBL308196,,CHEMBL1183626,6.82,119237,=,1,1,=,,IC50,nM,150.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.15,1
604096,CHEMBL700861,Ability to block GRO-alpha driven human neutrophil chemotaxis,CCN(CC)CCCCNc1nc2cc(Cl)c(Cl)cc2nc1-c1ccc(-c2cccs2)s1,,,CHEMBL1133879,Bioorg Med Chem Lett,2001,CHEMBL39740,,CHEMBL39740,6.77,101434,=,1,1,=,,IC50,nM,170.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,170.0,1
121690,CHEMBL733698,Inhibition of LPS-stimulated TNF-alpha production in monocyte cells,O=C1NCc2c(-c3ccc(F)cc3F)cc(N3CCNCC3)cc2N1c1c(Cl)cccc1Cl,,,CHEMBL1136271,Bioorg Med Chem Lett,2003,CHEMBL94417,,CHEMBL94417,8.11,174909,=,1,1,=,,IC50,nM,7.8,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,7.8,0
616440,CHEMBL761738,In vitro for its inhibitory activity against platelet aggregation induced by ADP,NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CO)NC(=O)c1ccccc1N=C(N)N)C(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CO)NC(=O)c1ccccc1N=C(N)N,,,CHEMBL1151085,Bioorg Med Chem Lett,1995,CHEMBL3037892,,CHEMBL3037892,7.06,100712,=,1,1,=,,IC50,nM,87.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.087,1
60737,CHEMBL763559,Concentration required for maximal in vitro inhibition of aggregation of human platelet rich plasma (hPRP),N/C(=N/Cc1ccccc1)c1ccc(C2=NOC(CC(=O)NCCC(=O)O)C2)cc1,,,CHEMBL1133917,Bioorg Med Chem Lett,2001,CHEMBL70577,,CHEMBL70577,6.7,123886,=,1,1,=,,IC50,nM,200.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.2,1
570558,CHEMBL878710,Tested for Concentration required for the inhibition of ADP-induced aggregation of human platelets,O=C(O)COc1cccc2c1CCC(Cn1cc(C(c3ccccc3)c3ccccc3)cn1)=C2,,,CHEMBL1132727,Bioorg Med Chem Lett,2000,CHEMBL430154,,CHEMBL430154,7.39,174249,=,1,1,=,,IC50,nM,41.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.041,1
570605,CHEMBL759885,"Inhibitory activity against platelet aggregation, induced by arachidonic acid in human platelet rich plasma",CC(C)NC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1,,,CHEMBL1126688,J Med Chem,1993,CHEMBL29947,,CHEMBL29947,8.15,47525,=,1,1,=,,IC50,nM,7.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,I50,nM,UO_0000065,7.0,0
616104,CHEMBL702141,Inhibition of human vascular smooth muscle proliferation was determined,O=C(O)[C@H](CCC(=O)N1CCN(c2cccc(NC3=NCCCN3)c2)CC1)NS(=O)(=O)c1ccccc1,,,CHEMBL1146737,Bioorg Med Chem Lett,2004,CHEMBL86321,,CHEMBL86321,,155714,>,1,1,>,,IC50,nM,10.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,10.0,0
457207,CHEMBL771475,Antiviral activity against human respiratory syncytial virus (RSV),NC(=O)CCN(CCC(N)=O)S(=O)(=O)c1cccc(Nc2nc(Nc3cccc(S(=O)(=O)N(CCC(N)=O)CCC(N)=O)c3)nc(Nc3ccc(/C=C/c4ccc(Nc5nc(Nc6cccc(S(=O)(=O)N(CCC(N)=O)CCC(N)=O)c6)nc(Nc6cccc(S(=O)(=O)N(CCC(N)=O)CCC(N)=O)c6)n5)cc4S(=O)(=O)O)c(S(=O)(=O)O)c3)n2)c1,,,CHEMBL1149193,J Med Chem,2004,CHEMBL415008,,CHEMBL415008,6.82,35811,=,1,1,=,,IC50,nM,150.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.15,1
79896,CHEMBL699531,Concentration required for 50% inhibition of platelet aggregation of human gel-filtered platelets(GFP) in platelet aggregation assay,C#C[C@H](CC(=O)O)NC(=O)c1cc2n(n1)CCN(CCC1CCNCC1)C2=O,,,CHEMBL1130456,Bioorg Med Chem Lett,1997,CHEMBL418424,,CHEMBL418424,6.92,60931,=,1,1,=,,IC50,nM,120.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,120.0,1
590353,CHEMBL759885,"Inhibitory activity against platelet aggregation, induced by arachidonic acid in human platelet rich plasma",COc1ccc(NC(=O)c2coc(C3C4CCC(O4)C3Cc3ccccc3CCC(=O)O)n2)cc1,,,CHEMBL1126688,J Med Chem,1993,CHEMBL282845,,CHEMBL282845,8.22,47533,=,1,1,=,,IC50,nM,6.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,I50,nM,UO_0000065,6.0,0
360975,CHEMBL841401,Inhibitory activity against LPS-stimulated IL-1 beta release from human monocytes,COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CCc5c(cc(OC(C)=O)c(OC(C)=O)c5C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1,,,CHEMBL1130726,Bioorg Med Chem Lett,1998,CHEMBL292578,PRISTIMEROL DIACETATE,CHEMBL292578,7.1,230945,=,1,1,=,,IC50,nM,80.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,80.0,1
32380,CHEMBL763979,Inhibition of human platelet aggregation induced by ADP after 3 min incubation with platelet rich plasma,CCC(CC)CN1CCN(S(=O)(=O)CCCOc2ccc3[nH]c4nc(O)nc-4cc3c2)CC1.Cl,,,CHEMBL1126868,J Med Chem,1993,CHEMBL1203068,,CHEMBL111704,9.8,208583,=,1,1,=,,IC50,nM,0.16,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,0.16,0
43193,CHEMBL763979,Inhibition of human platelet aggregation induced by ADP after 3 min incubation with platelet rich plasma,CCCC(CCC)CN1CCC(S(=O)(=O)CCCOc2ccc3[nH]c4nc(O)nc-4cc3c2)CC1.Cl,,,CHEMBL1126868,J Med Chem,1993,CHEMBL1203081,,CHEMBL323743,9.64,208565,=,1,1,=,,IC50,nM,0.23,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,0.23,0
471423,CHEMBL841662,Inhibition of TNF alpha synthesis in human monocytes,COc1ccc(C(=O)Nc2c(Cl)cncc2Cl)cc1OC1CCCC1,,,CHEMBL1132750,Bioorg Med Chem Lett,2000,CHEMBL42126,PICLAMILAST,CHEMBL42126,8.89,127286,=,1,1,=,,IC50,nM,1.3,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,1.3,0
607759,CHEMBL702325,In vitro inhibition of TNF-alpha production was determined by using LPS-stimulated human whole blood assay (WBA),Cc1cc(COc2ccc(NC(=O)[C@H]3NCCC[C@@H]3C(=O)NO)cc2)c2ccccc2n1,,,CHEMBL1144985,Bioorg Med Chem Lett,2003,CHEMBL341380,,CHEMBL341380,6.92,261486,=,1,1,=,,IC50,nM,120.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.12,1
597430,CHEMBL702141,Inhibition of human vascular smooth muscle proliferation was determined,O=C(N[C@@H](CCC(=O)N1CCN(c2cccc(NC3=NCC(O)CN3)c2)CC1)C(=O)O)OCc1ccccc1,,,CHEMBL1146737,Bioorg Med Chem Lett,2004,CHEMBL87688,,CHEMBL87688,8.46,155719,=,1,1,=,,IC50,nM,3.5,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,3.5,0
106520,CHEMBL701928,Inhibition of LPS-stimulated TNF-alpha production in human whole blood,O=C1NCc2c(-c3ccc(F)cc3Cl)cc(C3CCN(C4CCC4)CC3)cc2N1c1c(Cl)cccc1Cl,,,CHEMBL1136271,Bioorg Med Chem Lett,2003,CHEMBL419140,,CHEMBL419140,7.91,174913,=,1,1,=,,IC50,nM,12.2,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,12.2,0
390774,CHEMBL699491,In vitro inhibition of collagen-induced platelet aggregation in human platelet rich plasma,FC(F)(F)c1nc(-c2ccccc2)c(-c2ccccc2)s1,,,CHEMBL1121768,J Med Chem,1981,CHEMBL37302,,CHEMBL37302,,58386,=,1,1,=,,IC50,ug.mL-1,0.32,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,ug ml-1,UO_0000274,0.32,0
62186,CHEMBL764816,Inhibitory activity of Ca-ionophore-A23187-induced Leukotriene B4 (LTB4) release in human polymorphonuclear leukocytes,CCOC(=O)[C@H](Cc1ccccc1)Nc1nc2ccccc2o1,,,CHEMBL1127687,J Med Chem,1994,CHEMBL2110338,,CHEMBL2110338,6.82,341183,=,1,1,=,,IC50,nM,150.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.15,1
179467,CHEMBL872816,Inhibition of growth of human mammary carcinoma (MCF-7) cell line.,COc1ccc(NS(=O)(=O)c2c(F)c(F)c(F)c(F)c2F)cc1NC(=O)CNC(C)=O,,,CHEMBL1134655,J Med Chem,2001,CHEMBL332838,,CHEMBL332838,8.11,227927,=,1,1,=,,IC50,nM,7.7,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,7.7,0
42043,CHEMBL764816,Inhibitory activity of Ca-ionophore-A23187-induced Leukotriene B4 (LTB4) release in human polymorphonuclear leukocytes,Clc1ccc2oc(NC(CN3CCSCC3)c3ccccc3)nc2c1,,,CHEMBL1127687,J Med Chem,1994,CHEMBL173238,,CHEMBL173238,7.32,341227,=,1,1,=,,IC50,nM,48.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.048,1
627438,CHEMBL702141,Inhibition of human vascular smooth muscle proliferation was determined,CCOC(=O)N[C@@H](CCC(=O)N1CCN(c2cccc(NC3=NCCCN3)c2)CC1)C(=O)O,,,CHEMBL1146737,Bioorg Med Chem Lett,2004,CHEMBL84911,,CHEMBL84911,8.68,155721,=,1,1,=,,IC50,nM,2.1,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,2.1,0
63470,CHEMBL764816,Inhibitory activity of Ca-ionophore-A23187-induced Leukotriene B4 (LTB4) release in human polymorphonuclear leukocytes,Cc1ccc2oc(NC(CC3CCCCC3)c3ccccn3)nc2c1,,,CHEMBL1127687,J Med Chem,1994,CHEMBL368307,,CHEMBL368307,8.4,341240,=,1,1,=,,IC50,nM,4.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.004,0
391883,CHEMBL760709,Ability to block Glycoprotein IIb-IIIa was measured by inhibiting ADP induced human platelet aggregation (5 uM),N=C(N)c1ccc(NC(=O)c2ccc3c(c2)CCN(CC(=O)O)C3=O)cc1,,,CHEMBL1130079,J Med Chem,1997,CHEMBL292795,,CHEMBL292795,7.05,114224,=,1,1,=,,IC50,nM,90.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.09,1
508704,CHEMBL700876,The compound was tested for the inhibition of platelet aggregation,O=C(NC[C@H](NS(=O)(=O)c1cccs1)C(=O)O)c1cc2sc(CCC3CCNCC3)cc2s1,,,CHEMBL1151496,Bioorg Med Chem Lett,1997,CHEMBL78517,,CHEMBL78517,7.89,335398,=,1,1,=,,IC50,nM,13.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,13.0,0
66151,CHEMBL764816,Inhibitory activity of Ca-ionophore-A23187-induced Leukotriene B4 (LTB4) release in human polymorphonuclear leukocytes,Clc1ccccc1C(CC1CCCCC1)Nc1nc2ccccc2o1,,,CHEMBL1127687,J Med Chem,1994,CHEMBL173903,,CHEMBL173903,7.1,341200,=,1,1,=,,IC50,nM,80.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.08,1
67308,CHEMBL763979,Inhibition of human platelet aggregation induced by ADP after 3 min incubation with platelet rich plasma,Cl.O=S(=O)(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCN(CCC2CCCCC2)CC1,,,CHEMBL1126868,J Med Chem,1993,CHEMBL1203044,,CHEMBL326644,10.32,208537,=,1,1,=,,IC50,nM,0.048,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,0.048,0
51918,CHEMBL763979,Inhibition of human platelet aggregation induced by ADP after 3 min incubation with platelet rich plasma,Cl.O=S(=O)(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCN(CCc2ccccc2)CC1,,,CHEMBL1126868,J Med Chem,1993,CHEMBL1203028,,CHEMBL108553,9.89,208540,=,1,1,=,,IC50,nM,0.13,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,0.13,0
273070,CHEMBL698689,In vitro inhibition of histamine release from human basophils,NS(=O)(=O)c1ccc(Nc2nccc(-c3cccnc3)n2)cc1,,,CHEMBL1126800,J Med Chem,1993,CHEMBL433151,,CHEMBL433151,6.7,168295,=,1,1,=,,IC50,nM,200.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.2,1
464579,CHEMBL701319,Inhibition of leukotriene B4 production in human whole blood,CN(CCCOc1ccc(Cc2ccccc2)cc1)CCC(=O)O,,,CHEMBL1134981,Bioorg Med Chem Lett,2002,CHEMBL112671,,CHEMBL112671,7.31,215636,=,1,1,=,,IC50,nM,49.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.049,1
317209,CHEMBL768604,In vitro inhibition of U 46619 induced aggregation of washed platelets,Cc1ccc(S(=O)(=O)NCCCCC(CCCc2cccnc2)CCC(=O)O)cc1,,,CHEMBL1126283,J Med Chem,1992,CHEMBL435590,,CHEMBL435590,7.24,264748,=,1,1,=,,IC50,nM,58.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.058,1
614802,CHEMBL729970,Inhibition of VEGF-stimulated migration of human microvascular endothelial cells,CC(=O)N[C@H](CCCCN)C(=O)Nc1ccc(C(=O)N[C@@H](CC(=O)O)C(=O)O)cc1,,,CHEMBL1146719,Bioorg Med Chem Lett,2004,CHEMBL176441,,CHEMBL176441,11.0,346357,=,1,1,=,,IC50,nM,0.01,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,0.01,0
594823,CHEMBL729970,Inhibition of VEGF-stimulated migration of human microvascular endothelial cells,NCCCCCC(=O)Nc1ccc(C(=O)O)c(-c2ccc(O)cc2)c1,,,CHEMBL1146719,Bioorg Med Chem Lett,2004,CHEMBL173266,,CHEMBL173266,10.22,346356,=,1,1,=,,IC50,nM,0.06,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,0.06,0
359102,CHEMBL700565,Compound was evaluated for GROalpha-mediated calcium mobilization in human polymorphonuclear neutrophils(PMNs),N#Cc1ccc(NC(=O)Nc2ccccc2Br)c(O)c1,,,CHEMBL1149089,J Med Chem,2004,CHEMBL27863,,CHEMBL27863,7.28,36910,=,1,1,=,,IC50,nM,53.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,53.0,1
74646,CHEMBL700456,Inhibition of human platelet (isolated from PRP) aggregation,CC1(c2ccc(C(=N)N)cc2)NC(=O)N(CC(=O)NC(CC(=O)O)c2ccccc2)C1=O,,,CHEMBL1134795,J Med Chem,2001,CHEMBL16759,,CHEMBL16759,6.7,20050,=,1,1,=,,IC50,nM,200.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.2,1
38451,CHEMBL763979,Inhibition of human platelet aggregation induced by ADP after 3 min incubation with platelet rich plasma,Cl.O=S(=O)(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCN(CC2CCCCO2)CC1,,,CHEMBL1126868,J Med Chem,1993,CHEMBL1203021,,CHEMBL321475,10.47,208532,=,1,1,=,,IC50,nM,0.034,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,0.034,0
451448,CHEMBL702719,Compound was tested for inhibition of ADP induced platelet aggregation by using human platelet rich plasma(PRP) assay,CCCCOC(=O)N[C@@H](CNC(=O)c1cc(OCc2ccc(C(=N)N)cc2)no1)C(=O)O.O=C(O)C(F)(F)F,,,CHEMBL1130705,Bioorg Med Chem Lett,1998,CHEMBL117343,,CHEMBL1180224,7.22,222446,=,1,1,=,,IC50,nM,60.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,60.0,1
54418,CHEMBL763559,Concentration required for maximal in vitro inhibition of aggregation of human platelet rich plasma (hPRP),N=C(N)c1ccc(C2=NO[C@@H](CC(=O)NCCC(=O)O)C2)cc1,,,CHEMBL1133917,Bioorg Med Chem Lett,2001,CHEMBL129766,,CHEMBL129766,7.22,123880,=,1,1,=,,IC50,nM,60.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.06,1
167332,CHEMBL702317,Ability to inhibit lipopolysaccharide (LPS) induced PGE-2 production was determined by human whole blood assay.,CS(=O)(=O)c1ccc(-n2cc(C(F)(F)F)nc2-c2cccnc2)cc1,,,CHEMBL1133620,J Med Chem,2000,CHEMBL325755,,CHEMBL325755,6.7,203200,=,1,1,=,,IC50,nM,200.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.2,1
289660,CHEMBL696392,Inhibition of ADP-induced platelet aggregation in human gel-filtered platelets,O=C(NC[C@H](NS(=O)(=O)c1ccccc1)C(=O)O)c1cc2cc(OCCn3ccnc3)ccc2[nH]1,,,CHEMBL1151560,Bioorg Med Chem Lett,1997,CHEMBL330154,,CHEMBL330154,7.35,174761,=,1,1,=,,IC50,nM,45.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,45.0,1
230704,CHEMBL841666,Inhibition of alpha-CD3 mAb induced IL-2 production in human whole blood,COc1cc(-c2nn([C@H]3CC[C@H](N4CCN(C)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)c1ccccc1,,,CHEMBL1135159,Bioorg Med Chem Lett,2002,CHEMBL297363,,CHEMBL297363,7.3,75946,=,1,1,=,,IC50,nM,50.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.05,1
520176,CHEMBL759889,Compound was tested for its inhibitory activity against platelet aggregation induced by collagen in human platelet-rich plasma,N#Cc1c(-c2ccccc2)no[n+]1[O-],,,CHEMBL1127832,J Med Chem,1994,CHEMBL336467,FUROXAN,CHEMBL336467,6.7,265981,=,1,1,=,,IC50,nM,199.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,M,UO_0000065,1.99e-07,1
567922,CHEMBL759885,"Inhibitory activity against platelet aggregation, induced by arachidonic acid in human platelet rich plasma",O=C(O)CCCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCC2CCCCC2)co1,,,CHEMBL1126688,J Med Chem,1993,CHEMBL31154,,CHEMBL31154,8.22,47545,=,1,1,=,,IC50,nM,6.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,I50,nM,UO_0000065,6.0,0
580379,CHEMBL759883,"Inhibitory activity against platelet aggregation, induced by arachidonic acid in human platelet rich plasma",CCCCCCCCCCNC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1,,,CHEMBL1126688,J Med Chem,1993,CHEMBL418585,,CHEMBL418585,9.0,47515,=,1,1,=,,IC50,nM,1.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,I 50,nM,UO_0000065,1.0,0
303665,CHEMBL698689,In vitro inhibition of histamine release from human basophils,c1cc(Nc2nccc(-c3cccs3)n2)cc(OCCn2ccnc2)c1,,,CHEMBL1126800,J Med Chem,1993,CHEMBL94006,,CHEMBL94006,7.0,168438,=,1,1,=,,IC50,nM,100.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.1,1
132269,CHEMBL698052,Compound was tested in vitro inhibitory activity against LBT4 induced chemotaxis of human neutrophil,O=C(O)C1(c2ccc3c(c2)OC[C@H](Cc2ccc(-c4ccccc4)cc2)[C@H]3O)CCCC1,,,CHEMBL1129361,J Med Chem,1996,CHEMBL51770,,CHEMBL51770,8.3,162526,=,1,1,=,,IC50,nM,5.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,5.0,0
489514,CHEMBL696990,In vitro ability to inhibit the aggregation of ADP-stimulated human platelets,CCCCS(=O)(=O)N[C@@H](CNC(=O)C1CCC2(CC1)CCN(c1ccncc1)CC2)C(=O)O,,,CHEMBL1134062,Bioorg Med Chem Lett,2001,CHEMBL24397,,CHEMBL24397,6.75,33881,=,1,1,=,,IC50,nM,179.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.179,1
54497,CHEMBL763559,Concentration required for maximal in vitro inhibition of aggregation of human platelet rich plasma (hPRP),CCCCOC(=O)N[C@@H](CNC(=O)C[C@H]1CC(c2ccc(C(=N)N)cc2)=NO1)C(=O)OC,,,CHEMBL1133917,Bioorg Med Chem Lett,2001,CHEMBL18301,ROXIFIBAN,CHEMBL18301,7.3,123891,=,1,1,=,,IC50,nM,50.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.05,1
63471,CHEMBL764816,Inhibitory activity of Ca-ionophore-A23187-induced Leukotriene B4 (LTB4) release in human polymorphonuclear leukocytes,CN(C)C(=O)c1ccc2oc(NC(CC3CCCCC3)c3ccccc3)nc2c1,,,CHEMBL1127687,J Med Chem,1994,CHEMBL171336,,CHEMBL171336,6.77,341209,=,1,1,=,,IC50,nM,170.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.17,1
59416,CHEMBL764816,Inhibitory activity of Ca-ionophore-A23187-induced Leukotriene B4 (LTB4) release in human polymorphonuclear leukocytes,Cc1ccc2oc(N[C@@H](CC3CCCCC3)c3ccccn3)nc2c1,,,CHEMBL1127687,J Med Chem,1994,CHEMBL2104845,ONTAZOLAST,CHEMBL2104845,9.0,341239,=,1,1,=,,IC50,nM,1.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.001,0
152631,CHEMBL872816,Inhibition of growth of human mammary carcinoma (MCF-7) cell line.,COc1ccc(NS(=O)(=O)c2c(F)c(F)c(F)c(F)c2F)cc1NC(=O)[C@@H](NC(C)=O)[C@@H](C)O,,,CHEMBL1134655,J Med Chem,2001,CHEMBL121130,,CHEMBL121130,8.13,227930,=,1,1,=,,IC50,nM,7.4,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,7.4,0
435708,CHEMBL873078,Efficacy of compound in cell migration of primary human Smooth Muscle Cells (SMC) was determined,O=C(CNC(=O)c1cnc(NC(=O)NCc2ccccc2)o1)NC[C@H](NC(=O)OCc1ccccc1)C(=O)O,,,CHEMBL1135113,Bioorg Med Chem Lett,2002,CHEMBL29146,,CHEMBL29146,9.3,43643,=,1,1,=,,IC50,nM,0.5,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,0.5,0
448899,CHEMBL696537,The compound was tested for inhibition of blood platelet aggregation induced by ADP,CC#CCC(C)[C@H](O)/C=C/[C@H]1[C@H](O)C[C@]2(C#CCCCO)C/C(=C\CCCC(=O)O)C[C@H]12,,,CHEMBL1126418,Bioorg Med Chem Lett,1992,CHEMBL341706,,CHEMBL341706,8.0,267001,=,1,1,=,,IC50,nM,10.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,M,UO_0000065,1e-08,0
499957,CHEMBL700876,The compound was tested for the inhibition of platelet aggregation,O=C(NC[C@H](NS(=O)(=O)c1ccccc1)C(=O)O)c1cc2sc(CCC3CCNCC3)cc2s1,,,CHEMBL1151496,Bioorg Med Chem Lett,1997,CHEMBL78570,,CHEMBL78570,8.1,335393,=,1,1,=,,IC50,nM,8.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,8.0,0
97288,CHEMBL842875,Inhibition of ADP-induced aggregation of human platelet rich plasma,Cc1ccc(S(=O)(=O)N[C@H]2CC/C(=N\OCc3ccc(C(F)(F)F)cc3)[C@@H]2C/C=C\CCCC(=O)O)cc1,,,CHEMBL1128160,Bioorg Med Chem Lett,1995,CHEMBL20218,,CHEMBL20218,6.75,25188,=,1,1,=,,IC50,nM,180.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.18,1
484439,CHEMBL768070,In vitro inhibition of human Platelet-rich plasma (PRP) aggregation induced by 5 uM ADP,CCC/N=C(\N)c1ccc(C(=O)Nc2ccc3c(c2)CC(CC(=O)O)CC3)cc1,,,CHEMBL1131137,J Med Chem,1998,CHEMBL130405,,CHEMBL130405,7.17,250109,=,1,1,=,,IC50,nM,68.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,68.0,1
622405,CHEMBL702141,Inhibition of human vascular smooth muscle proliferation was determined,O=C(N[C@@H](CCC(=O)N1CCN(c2cccc(NC3=NCC(F)CN3)c2)CC1)C(=O)O)OCc1ccccc1,,,CHEMBL1146737,Bioorg Med Chem Lett,2004,CHEMBL84578,,CHEMBL84578,9.59,155722,=,1,1,=,,IC50,nM,0.26,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,0.26,0
54523,CHEMBL764816,Inhibitory activity of Ca-ionophore-A23187-induced Leukotriene B4 (LTB4) release in human polymorphonuclear leukocytes,c1ccc(CC(Nc2nc3ccccc3s2)c2ccccc2)cc1,,,CHEMBL1127687,J Med Chem,1994,CHEMBL367099,,CHEMBL367099,6.77,341193,=,1,1,=,,IC50,nM,170.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.17,1
613780,CHEMBL702325,In vitro inhibition of TNF-alpha production was determined by using LPS-stimulated human whole blood assay (WBA),Cc1cc(COc2ccc(NC(=O)[C@H]3CCN(C(=O)c4ccco4)C[C@@H]3C(=O)NO)cc2)c2ccccc2n1,,,CHEMBL1144985,Bioorg Med Chem Lett,2003,CHEMBL343548,,CHEMBL343548,6.77,261472,=,1,1,=,,IC50,nM,170.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.17,1
60840,CHEMBL763979,Inhibition of human platelet aggregation induced by ADP after 3 min incubation with platelet rich plasma,Cl.O=C(NCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)N1CCN(CC2CCCC2)CC1,,,CHEMBL1126868,J Med Chem,1993,CHEMBL1203020,,CHEMBL110162,10.03,208534,=,1,1,=,,IC50,nM,0.094,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,0.094,0
38478,CHEMBL764816,Inhibitory activity of Ca-ionophore-A23187-induced Leukotriene B4 (LTB4) release in human polymorphonuclear leukocytes,COc1ccc(CC(Nc2nc3cc([N+](=O)[O-])ccc3o2)c2ccccn2)cc1,,,CHEMBL1127687,J Med Chem,1994,CHEMBL442978,,CHEMBL442978,7.85,341216,=,1,1,=,,IC50,nM,14.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.014,0
81091,CHEMBL842875,Inhibition of ADP-induced aggregation of human platelet rich plasma,O=C(O)CCC/C=C\C[C@H]1/C(=N/OCc2ccc(C(F)(F)F)cc2)CC[C@@H]1NS(=O)(=O)c1ccc(Cl)cc1,,,CHEMBL1128160,Bioorg Med Chem Lett,1995,CHEMBL283374,,CHEMBL283374,6.7,25200,=,1,1,=,,IC50,nM,200.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.2,1
435608,CHEMBL702718,Compound was tested for inhibition of ADP induced platelet aggregation by using human platelet rich plasma (PRP) assay,CCCCOC(=O)N[C@@H](CNC(=O)c1cc(OCC2CCN(C(=N)N)CC2)no1)C(=O)OC.O=C(O)C(F)(F)F,,,CHEMBL1130705,Bioorg Med Chem Lett,1998,CHEMBL115532,,CHEMBL1180161,6.7,222445,=,1,1,=,,IC50,nM,200.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,200.0,1
130746,CHEMBL701928,Inhibition of LPS-stimulated TNF-alpha production in human whole blood,O=C1NCc2c(-c3ccc(F)cc3Cl)cc(C3CCN(CC4CC4)CC3)cc2N1c1c(Cl)cccc1Cl,,,CHEMBL1136271,Bioorg Med Chem Lett,2003,CHEMBL419134,,CHEMBL419134,8.12,174915,=,1,1,=,,IC50,nM,7.6,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,7.6,0
517669,CHEMBL702585,In vitro inhibitory activity against superoxide production from human neutrophils stimulated with f-MLP,CCOc1ccc(-c2nc(-c3ccc4c(c3)CCC(=O)N4)cs2)cc1OCC,,,CHEMBL1128742,J Med Chem,1995,CHEMBL120374,,CHEMBL120374,7.1,226481,=,1,1,=,,IC50,nM,80.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.08,1
36011,CHEMBL763979,Inhibition of human platelet aggregation induced by ADP after 3 min incubation with platelet rich plasma,Cl.Oc1nc2cc3cc(OCCCc4nnnn4C4CCN(Cc5ccccc5)CC4)ccc3[nH]c-2n1,,,CHEMBL1126868,J Med Chem,1993,CHEMBL1203031,,CHEMBL111317,10.41,208553,=,1,1,=,,IC50,nM,0.039,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,0.039,0
180383,CHEMBL811521,Concentration required to reduce the proliferation of PHA stimulated human peripheral blood T lymphocytes,C=Cc1cn(COCCO)c(=O)[nH]c1=O,,,CHEMBL1133838,Bioorg Med Chem Lett,2001,CHEMBL97886,,CHEMBL97886,,184061,>,1,1,>,,IC50,ug.mL-1,50.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,ug ml-1,UO_0000274,50.0,1
601161,CHEMBL729970,Inhibition of VEGF-stimulated migration of human microvascular endothelial cells,CC(=O)NCCCC[C@@H](NC(C)=O)C(=O)Nc1ccc(C(=O)N[C@@H](CC(=O)O)C(=O)O)cc1,,,CHEMBL1146719,Bioorg Med Chem Lett,2004,CHEMBL263988,,CHEMBL263988,,346353,>,1,1,>,,IC50,nM,100.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,100.0,1
442437,CHEMBL701319,Inhibition of leukotriene B4 production in human whole blood,COC(=O)C1CC2CC1CN2CCOc1ccc(Cc2ccccc2)cc1,,,CHEMBL1134981,Bioorg Med Chem Lett,2002,CHEMBL114591,,CHEMBL114591,6.7,215618,=,1,1,=,,IC50,nM,200.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.2,1
574492,CHEMBL763989,The compound was tested for their ability to inhibit ADP-stimulated platelet aggregation in human platelet rich plasma,N=C(N)c1ccc(C2=NOC(CC(=O)NC[C@H](NS(=O)(=O)c3cccc(Br)c3)C(=O)O)C2)cc1.O=C(O)C(F)(F)F,,,CHEMBL1132701,J Med Chem,1999,CHEMBL18229,,CHEMBL1178269,7.22,21828,=,1,1,=,,IC50,nM,60.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.06,1
593945,CHEMBL761738,In vitro for its inhibitory activity against platelet aggregation induced by ADP,N=C(N)Nc1ccc(C(=O)NCCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](Cc2ccc(O)cc2)C(=O)O)cc1,,,CHEMBL1151085,Bioorg Med Chem Lett,1995,CHEMBL58654,,CHEMBL58654,6.72,100719,=,1,1,=,,IC50,nM,190.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.19,1
376728,CHEMBL698305,"Compound was evaluated for anti-platelet activity by measuring its inhibitory effect on human platelet rich plasma (PRP) aggregated with U-46,619.",O=C(O)CC/C=C\C[C@@H]1CO[C@H](c2ccccc2Cl)O[C@@H]1c1ccccc1O,,,CHEMBL1151592,Bioorg Med Chem Lett,1996,CHEMBL30024,,CHEMBL30024,7.89,223235,=,1,1,=,,IC50,nM,13.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.013,0
333806,CHEMBL768604,In vitro inhibition of U 46619 induced aggregation of washed platelets,O=C(O)/C=C/C(CCCCNS(=O)(=O)c1ccc(Cl)cc1)CCCc1cccnc1,,,CHEMBL1126283,J Med Chem,1992,CHEMBL134686,,CHEMBL134686,7.16,264763,=,1,1,=,,IC50,nM,70.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.07,1
538871,CHEMBL702585,In vitro inhibitory activity against superoxide production from human neutrophils stimulated with f-MLP,CCOc1cc(-c2nc(-c3ccc4c(c3)CCC(=O)N4)cs2)ccc1OC,,,CHEMBL1128742,J Med Chem,1995,CHEMBL334190,,CHEMBL334190,7.05,226496,=,1,1,=,,IC50,nM,90.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.09,1
224215,CHEMBL695988,Antiproliferative activity was evaluated by the 72 hr MTT cell viability assay using human colon carcinoma cells (GC3).,COc1ccc(C[C@H]2NC(=O)/C=C/C[C@@H]([C@H](C)[C@H]3O[C@@H]3c3ccccc3)OC(=O)[C@H](CC(C)C)NC(=O)C[C@@H](C)NC2=O)cc1Cl,,,CHEMBL1131700,Bioorg Med Chem Lett,1999,CHEMBL162213,,CHEMBL162213,10.22,320865,=,1,1,=,,IC50,nM,0.06,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,0.06,0
69955,CHEMBL763979,Inhibition of human platelet aggregation induced by ADP after 3 min incubation with platelet rich plasma,Cl.Oc1nc2cc3cc(OCCCc4nnnn4C4CCN(CCc5ccccc5)CC4)ccc3[nH]c-2n1,,,CHEMBL1126868,J Med Chem,1993,CHEMBL1203051,,CHEMBL109971,10.08,208549,=,1,1,=,,IC50,nM,0.083,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,0.083,0
621119,CHEMBL702141,Inhibition of human vascular smooth muscle proliferation was determined,O=C(Cc1ccccc1)N[C@@H](CCC(=O)N1CCN(c2cccc(NC3=NCCCN3)c2)CC1)C(=O)O,,,CHEMBL1146737,Bioorg Med Chem Lett,2004,CHEMBL85196,,CHEMBL85196,,155712,>,1,1,>,,IC50,nM,10.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,10.0,0
299316,CHEMBL881157,"Inhibitory activity against U-46,619-induced aggregation of washed human platelets.",Cc1ccc(S(=O)(=O)NCC(CCCCCC(=O)O)c2cccnc2)cc1.Cl,,,CHEMBL1126260,J Med Chem,1992,CHEMBL553822,,CHEMBL1195086,6.7,263752,=,1,1,=,,IC50,nM,200.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.2,1
559907,CHEMBL759885,"Inhibitory activity against platelet aggregation, induced by arachidonic acid in human platelet rich plasma",O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)Nc2ccc(Cl)cc2)co1,,,CHEMBL1126688,J Med Chem,1993,CHEMBL30312,,CHEMBL30312,8.22,47534,=,1,1,=,,IC50,nM,6.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,I50,nM,UO_0000065,6.0,0
569293,CHEMBL759885,"Inhibitory activity against platelet aggregation, induced by arachidonic acid in human platelet rich plasma",O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCc2ccc(Cl)cc2)co1,,,CHEMBL1126688,J Med Chem,1993,CHEMBL278159,,CHEMBL278159,8.4,47531,=,1,1,=,,IC50,nM,4.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,I50,nM,UO_0000065,4.0,0
506880,CHEMBL768070,In vitro inhibition of human Platelet-rich plasma (PRP) aggregation induced by 5 uM ADP,CN(C(=O)c1ccc(C(=N)N)cc1)c1ccc2c(c1)CC(CC(=O)O)CC2,,,CHEMBL1131137,J Med Chem,1998,CHEMBL335445,,CHEMBL335445,6.7,250100,=,1,1,=,,IC50,nM,200.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,200.0,1
393300,CHEMBL699491,In vitro inhibition of collagen-induced platelet aggregation in human platelet rich plasma,COc1ccc(-c2nc(CC(N)=O)sc2-c2ccc(OC)cc2)cc1,,,CHEMBL1121768,J Med Chem,1981,CHEMBL288265,,CHEMBL288265,,58382,=,1,1,=,,IC50,ug.mL-1,0.0032,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,ng ml-1,UO_0000274,3.2,0
63462,CHEMBL763979,Inhibition of human platelet aggregation induced by ADP after 3 min incubation with platelet rich plasma,Cl.O=S(=O)(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)N1CCN(c2nc3ccccc3o2)CC1,,,CHEMBL1126868,J Med Chem,1993,CHEMBL1203073,,CHEMBL109541,8.62,208582,=,1,1,=,,IC50,nM,2.41,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,2.41,0
483665,CHEMBL700876,The compound was tested for the inhibition of platelet aggregation,CCCCS(=O)(=O)N[C@@H](CNC(=O)c1cc2sc(CCC3CCNCC3)cc2s1)C(=O)O,,,CHEMBL1151496,Bioorg Med Chem Lett,1997,CHEMBL312113,,CHEMBL312113,8.0,335399,=,1,1,=,,IC50,nM,10.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,10.0,0
343018,CHEMBL699152,In vitro inhibition of ADP-induced human platelet aggregation.,O=C(NC[C@H](NS(=O)(=O)c1ccccc1)C(=O)O)c1ccc2c(c1)C(=O)N(CCC1CCNCC1)C2,,,CHEMBL1129711,Bioorg Med Chem Lett,1996,CHEMBL298589,,CHEMBL298589,8.1,151574,=,1,1,=,,IC50,nM,8.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,8.0,0
95333,CHEMBL697995,Inhibitory concentration against liposaccharide induced IL1-beta production in human peripheral monocytes,CC[C@@H](C)/C=C(\C)C[C@@H](C)C[C@@H](C)/C=C/C=C/C=C/C(=O)N[C@H](CO)C[C@@]1(O)C(=O)C=C[C@@H]2O[C@@H]21,,,CHEMBL1134756,Bioorg Med Chem Lett,2001,CHEMBL418376,SCYPHOSTATIN,CHEMBL418376,7.0,32449,=,1,1,=,,IC50,nM,100.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.1,1
495596,CHEMBL699612,Tested for the ability to inhibit Leukotriene B4 (LTB4) induced chemotaxis. Test compound added to upper and lower wells.,CCCc1c(OCCCOc2ccc(-c3cscn3)c(OC)c2CC2CC2)ccc2c1OC(CCC(=O)O)CC2,,,CHEMBL1128264,J Med Chem,1995,CHEMBL172168,,CHEMBL172168,7.31,335059,=,1,1,=,,IC50,nM,49.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,49.0,1
586270,CHEMBL698309,Inhibitory activity against ADP-mediated human platelet aggregation in human platelet rich plasma,O=C(O)COc1ccc(C(=O)CNC(=O)c2cc3c(s2)CCNC3)cc1OCC(=O)O,,,CHEMBL1128920,Bioorg Med Chem Lett,1996,CHEMBL315036,,CHEMBL315036,6.8,159247,=,1,1,=,,IC50,nM,160.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.16,1
60738,CHEMBL763559,Concentration required for maximal in vitro inhibition of aggregation of human platelet rich plasma (hPRP),N/C(=N/Cc1cccc(F)c1)c1ccc(C2=NOC(CC(=O)NCCC(=O)O)C2)cc1,,,CHEMBL1133917,Bioorg Med Chem Lett,2001,CHEMBL70993,,CHEMBL70993,7.92,123887,=,1,1,=,,IC50,nM,12.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.012,0
572087,CHEMBL763989,The compound was tested for their ability to inhibit ADP-stimulated platelet aggregation in human platelet rich plasma,N=C(N)c1ccc(C2=NOC(CC(=O)NC[C@H](NS(=O)(=O)c3ccc(Br)cc3)C(=O)O)C2)cc1.O=C(O)C(F)(F)F,,,CHEMBL1132701,J Med Chem,1999,CHEMBL18391,,CHEMBL1178273,7.29,21805,=,1,1,=,,IC50,nM,51.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.051,1
440955,CHEMBL701319,Inhibition of leukotriene B4 production in human whole blood,COC(=O)CC1CC2CC1CN2CCOc1ccc(Cc2ccccc2)cc1,,,CHEMBL1134981,Bioorg Med Chem Lett,2002,CHEMBL116174,,CHEMBL116174,6.96,215610,=,1,1,=,,IC50,nM,110.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.11,1
320301,CHEMBL843256,Inhibition of U 46619-induced Aggregation of human Washed platelets,O=C(O)CC[C@@H](CCCCNS(=O)(=O)c1ccc(Cl)cc1)CCOc1cccnc1,,,CHEMBL1127028,J Med Chem,1993,CHEMBL302970,,CHEMBL302970,8.05,114052,=,1,1,=,,IC50,nM,9.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,9.0,0
373860,CHEMBL761638,In vitro inhibition of collagen-induced platelet aggregation in human platelet-rich plasma (PRP),c1ccc(-c2csnn2)cc1,,,CHEMBL1122973,J Med Chem,1985,CHEMBL341811,,CHEMBL341811,,267954,=,1,1,=,,IC50,ug.mL-1,3.2,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,ug ml-1,UO_0000274,3.2,0
42041,CHEMBL764816,Inhibitory activity of Ca-ionophore-A23187-induced Leukotriene B4 (LTB4) release in human polymorphonuclear leukocytes,c1ccc(CC(Nc2nc3ccccc3o2)c2ccccc2)cc1,,,CHEMBL1127687,J Med Chem,1994,CHEMBL367098,,CHEMBL367098,7.29,341192,=,1,1,=,,IC50,nM,51.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.051,1
586522,CHEMBL759885,"Inhibitory activity against platelet aggregation, induced by arachidonic acid in human platelet rich plasma",O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCc2ccc(Cl)cc2)co1,,,CHEMBL1126688,J Med Chem,1993,CHEMBL30615,,CHEMBL30615,8.4,47528,=,1,1,=,,IC50,nM,4.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,I50,nM,UO_0000065,4.0,0
407768,CHEMBL699491,In vitro inhibition of collagen-induced platelet aggregation in human platelet rich plasma,COc1ccc(-c2nc(C(C)(C)CO)sc2-c2ccc(OC)cc2)cc1,,,CHEMBL1121768,J Med Chem,1981,CHEMBL289713,,CHEMBL289713,,58385,=,1,1,=,,IC50,ug.mL-1,0.0032,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,ng ml-1,UO_0000274,3.2,0
299866,CHEMBL696392,Inhibition of ADP-induced platelet aggregation in human gel-filtered platelets,O=C(NC[C@H](NS(=O)(=O)c1ccccc1)C(=O)O)c1cc2cc(OCCC3CCNCC3)ccc2[nH]1,,,CHEMBL1151560,Bioorg Med Chem Lett,1997,CHEMBL57040,,CHEMBL57040,8.1,174767,=,1,1,=,,IC50,nM,8.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,8.0,0
541029,CHEMBL699166,"Tested for concentration required for antagonism of U-46,619-Induced Human Platelet Aggregation",O=C(O)CCC/C=C\C[C@H]1CCC[C@@H]1NS(=O)(=O)c1ccccc1,,,CHEMBL1125980,Bioorg Med Chem Lett,1991,CHEMBL300681,,CHEMBL300681,6.82,84485,=,1,1,=,,IC50,nM,150.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,150.0,1
265017,CHEMBL702047,In vitro inhibition of arachidonic acid induced platelet aggregation of human platelet-rich plasma,CCCCCCOCC1C2CCC(O2)C1CCCCCCC(=O)O,,,CHEMBL1123449,J Med Chem,1986,CHEMBL78290,,CHEMBL78290,6.7,136715,=,1,1,=,,IC50,nM,200.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,I50,uM,UO_0000065,0.2,1
579410,CHEMBL763989,The compound was tested for their ability to inhibit ADP-stimulated platelet aggregation in human platelet rich plasma,N=C(N)c1ccc(C2=NOC(CC(=O)NC[C@H](NS(=O)(=O)c3ccc(C(F)(F)F)cc3)C(=O)O)C2)cc1.O=C(O)C(F)(F)F,,,CHEMBL1132701,J Med Chem,1999,CHEMBL267579,,CHEMBL1182806,6.77,21807,=,1,1,=,,IC50,nM,170.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.17,1
455920,CHEMBL697158,In vitro inhibitory potency against human gel filtered platelet (GFP) aggregation,O=C(O)C[C@H](NC(=O)[C@@H]1CCCN(C(=O)CCC2CCNCC2)C1)c1ccc(-c2ccsc2)nc1,,,CHEMBL1132284,J Med Chem,1999,CHEMBL347296,,CHEMBL347296,6.7,292242,=,1,1,=,,IC50,nM,200.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.2,1
307227,CHEMBL699152,In vitro inhibition of ADP-induced human platelet aggregation.,CCCCS(=O)(=O)N[C@@H](CNC(=O)c1ccc2c(c1)C(=O)N(CCC1CCNCC1)C2)C(=O)O,,,CHEMBL1129711,Bioorg Med Chem Lett,1996,CHEMBL315065,,CHEMBL315065,7.85,151582,=,1,1,=,,IC50,nM,14.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,14.0,0
233275,CHEMBL841666,Inhibition of alpha-CD3 mAb induced IL-2 production in human whole blood,COc1cc(-c2nn([C@H]3CC[C@H](N4CCN(C)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)OCc1ccccc1,,,CHEMBL1135159,Bioorg Med Chem Lett,2002,CHEMBL47787,,CHEMBL47787,8.7,75951,=,1,1,=,,IC50,nM,2.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.002,0
448902,CHEMBL696537,The compound was tested for inhibition of blood platelet aggregation induced by ADP,CC#CCC(C)[C@H](O)/C=C/[C@H]1[C@H](O)C[C@]2(C#CCCCI)C/C(=C\CCCC(=O)O)C[C@H]12,,,CHEMBL1126418,Bioorg Med Chem Lett,1992,CHEMBL344390,,CHEMBL344390,8.3,267006,=,1,1,=,,IC50,nM,5.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,M,UO_0000065,5e-09,0
479811,CHEMBL700867,Inhibition of phorbol 12-myristate-13-acetate induced release of superoxide in human neutrophils,CC(C)(C)C(=O)OCn1nnc(-c2cccc(O)c2C(=O)c2c(O)cc(C(=O)O[C@@H]3CCC[C@H]3NC(=O)c3ccc(O)cc3)cc2O)n1,,,CHEMBL1128793,Bioorg Med Chem Lett,1995,CHEMBL300658,,CHEMBL300658,6.82,90770,=,1,1,=,,IC50,nM,150.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.15,1
348264,CHEMBL761638,In vitro inhibition of collagen-induced platelet aggregation in human platelet-rich plasma (PRP),COc1ccc(-c2snnc2-c2ccccc2)cc1,,,CHEMBL1122973,J Med Chem,1985,CHEMBL141366,,CHEMBL141366,,267944,=,1,1,=,,IC50,ug.mL-1,0.003,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,ng ml-1,UO_0000274,3.0,0
243719,CHEMBL695988,Antiproliferative activity was evaluated by the 72 hr MTT cell viability assay using human colon carcinoma cells (GC3).,COc1ccc(C[C@H]2NC(=O)/C=C/C[C@@H]([C@H](C)[C@H]3O[C@@H]3c3ccccc3)OC(=O)[C@H](CC(C)C)OC(=O)C[C@@H](C)NC2=O)cc1Cl,,,CHEMBL1131700,Bioorg Med Chem Lett,1999,CHEMBL350017,,CHEMBL350017,10.52,320864,=,1,1,=,,IC50,nM,0.03,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,0.03,0
229467,CHEMBL763982,Inhibitory activity against aggregation of human platelets,CC1(c2ccc(C(=N)N)cc2)NC(=O)N(CC(=O)NC(CC(=O)O)c2cccnc2)C1=O,,,CHEMBL1129321,J Med Chem,1996,CHEMBL302502,,CHEMBL302502,7.0,116217,=,1,1,=,,IC50,nM,100.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.1,1
304214,CHEMBL881157,"Inhibitory activity against U-46,619-induced aggregation of washed human platelets.",Cl.O=C(O)CCCCCC(CNS(=O)(=O)c1ccc(-c2cccc3ccccc23)cc1)c1cccnc1,,,CHEMBL1126260,J Med Chem,1992,CHEMBL555812,,CHEMBL1196045,7.1,263750,=,1,1,=,,IC50,nM,80.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.08,1
243889,CHEMBL699168,Inhibition of 10 uM ADP induced aggregation in human gel filtered platelets in the presence fibrinogen and aspirin.,N=C(N)c1ccc(N2CCN([C@H]3CC[C@](O)(CC(=O)O)CC3)CC2)cc1,,,CHEMBL1127402,J Med Chem,1994,CHEMBL126818,,CHEMBL126818,7.14,242184,=,1,1,=,,IC50,nM,72.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,72.0,1
439930,CHEMBL697158,In vitro inhibitory potency against human gel filtered platelet (GFP) aggregation,O=C(O)C[C@H](C#Cc1ccccc1)NC(=O)[C@@H]1CCCN(C(=O)CCC2CCNCC2)C1,,,CHEMBL1132284,J Med Chem,1999,CHEMBL151808,,CHEMBL151808,7.1,292274,=,1,1,=,,IC50,nM,80.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.08,1
547721,CHEMBL697915,"Compound was tested for inhibition of U-46,619 induced aggregation of human platelets",O=C(O)CCc1c(-c2ccccc2)ccc2c1CCC(NS(=O)(=O)c1ccc(Cl)cc1)C2,,,CHEMBL1130822,Bioorg Med Chem Lett,1998,CHEMBL448096,,CHEMBL448096,6.92,43500,=,1,1,=,,IC50,nM,120.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.12,1
414134,CHEMBL768073,Inhibition of 10 uM ADP induced platelet aggregation in human platelet rich citreated plasma (PRP),COc1ccc(C[C@H]2NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H]3CCCN3C(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(C)=O)C(C)(C)SSC[C@@H](C(N)=O)NC(=O)[C@H](CCCN=C(N)N)NC2=O)cc1,,,CHEMBL1127482,J Med Chem,1994,CHEMBL2371547,,CHEMBL2371547,6.77,327403,=,1,1,=,,IC50,nM,170.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.17,1
376061,CHEMBL873457,Inhibition of ADP-induced human platelet rich plasma aggregation,CC(=O)Oc1ccccc1C(=O)OCc1no[n+]([O-])c1C(N)=O,,,CHEMBL1145772,J Med Chem,2003,CHEMBL165496,,CHEMBL165496,10.52,322550,=,1,1,=,,IC50,nM,0.0302,CHEMBL372,Homo sapiens,Homo sapiens,9606,pIC50(uM),,UO_0000065,4.52,0
442213,CHEMBL696394,The compound was tested in vitro for its anti-platelet activity against human platelets in presence of ADP,CC(C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)CCCOc1ccc(C(=N)N)cc1)C(=O)N1CCN(C)CC1,,,CHEMBL1153685,Bioorg Med Chem Lett,1997,CHEMBL440177,,CHEMBL440177,6.75,292166,=,1,1,=,,IC50,nM,180.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.18,1
143960,CHEMBL697914,Compound was tested for inhibition of ADP-induced human platelet aggregation,CCCCC[C@H](O)C#C[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCCC(=O)O,,,CHEMBL1130839,Bioorg Med Chem Lett,1998,CHEMBL416229,,CHEMBL416229,8.47,58402,=,1,1,=,,IC50,nM,3.4,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,3.4,0
446489,CHEMBL699333,Inhibition of cellular cholesterol biosynthesis using human fibroblasts in tissue culture,Nc1ccc(SC[C@H]2CO[C@@](CCc3ccc(Cl)cc3)(Cn3ccnc3)O2)cc1,,,CHEMBL1127068,J Med Chem,1993,CHEMBL305220,,CHEMBL305220,8.1,127177,=,1,1,=,,IC50,nM,8.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,8.0,0
376748,CHEMBL841401,Inhibitory activity against LPS-stimulated IL-1 beta release from human monocytes,COc1cc2c(c(C)c1OC)C=CC1=C(C)C(=O)CCC12C,,,CHEMBL1130726,Bioorg Med Chem Lett,1998,CHEMBL121164,,CHEMBL121164,10.0,230949,=,1,1,=,,IC50,nM,0.1,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,0.1,0
475050,CHEMBL811523,Immunosuppressive activity was evaluated by the inhibition of human T-lymphocyte proliferation,C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C,,,CHEMBL1131397,Bioorg Med Chem Lett,1998,CHEMBL160,CYCLOSPORINE,CHEMBL160,7.22,57136,=,1,1,=,,IC50,nM,60.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,60.0,1
59411,CHEMBL763979,Inhibition of human platelet aggregation induced by ADP after 3 min incubation with platelet rich plasma,Cl.Cl.O=S(=O)(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)N1CCN(Cc2ccc(Cl)cc2)CC1,,,CHEMBL1126868,J Med Chem,1993,CHEMBL2447997,,CHEMBL111386,9.28,208572,=,1,1,=,,IC50,nM,0.53,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,0.53,0
46798,CHEMBL763979,Inhibition of human platelet aggregation induced by ADP after 3 min incubation with platelet rich plasma,CCC(CC)CN1CCC(S(=O)(=O)CCCOc2ccc3[nH]c4nc(O)nc-4cc3c2)CC1.Cl,,,CHEMBL1126868,J Med Chem,1993,CHEMBL1203086,,CHEMBL323728,10.41,208567,=,1,1,=,,IC50,nM,0.039,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,0.039,0
235883,CHEMBL699168,Inhibition of 10 uM ADP induced aggregation in human gel filtered platelets in the presence fibrinogen and aspirin.,N=C(N)c1ccc(-c2ccc(N3CCN(CC(=O)O)CC3)nc2)cc1,,,CHEMBL1127402,J Med Chem,1994,CHEMBL126256,,CHEMBL126256,7.85,242182,=,1,1,=,,IC50,nM,14.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,14.0,0
634427,CHEMBL767676,Test inhibition of LTB4 production in human peripheral blood polymorphonuclear leukocytes (HPMN),O=C1OCc2c1cc1cc(OCc3cccc(C4(O)CCOCC4)c3)ccc1c2-c1ccccc1Cl,,,CHEMBL1129067,J Med Chem,1996,CHEMBL340333,,CHEMBL340333,7.96,245881,=,1,1,=,,IC50,nM,11.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,11.0,0
505665,CHEMBL734165,Antitumor activity against moser human colon carcinoma cell line,CNC(=O)OCc1c2c(n(C)c1COC(=O)NC)C(=O)C(C)=C(OC)C2=O,,,CHEMBL1124560,J Med Chem,1989,CHEMBL54787,,CHEMBL54787,,93256,<,1,1,<,,IC50,ug.mL-1,0.03,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,ug ml-1,UO_0000274,0.03,0
185523,CHEMBL842872,Compound was tested for its in vitro activity in the inhibition of platelet aggregation using human platelet rich plasma,Cc1noc(C)c1S(=O)(=O)N[C@@H](CNC(=O)C[C@@H]1C[C@H](c2ccc(C(=N)N)cc2)N(C)O1)C(=O)O.Cl,,,CHEMBL1131698,Bioorg Med Chem Lett,1999,CHEMBL542989,,CHEMBL1191837,7.08,302045,=,1,1,=,,IC50,nM,84.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.084,1
78000,CHEMBL700456,Inhibition of human platelet (isolated from PRP) aggregation,CC1(c2ccc(NC(=N)N)cc2)NC(=O)N(CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)O)c2ccccc2)C1=O,,,CHEMBL1134795,J Med Chem,2001,CHEMBL17569,,CHEMBL17569,6.82,20049,=,1,1,=,,IC50,nM,150.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.15,1
107709,CHEMBL733698,Inhibition of LPS-stimulated TNF-alpha production in monocyte cells,O=C1NCc2c(-c3ccccc3Cl)cc(C3CCNCC3)cc2N1c1c(Cl)cccc1Cl,,,CHEMBL1136271,Bioorg Med Chem Lett,2003,CHEMBL96763,,CHEMBL96763,8.7,174933,=,1,1,=,,IC50,nM,2.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,2.0,0
369732,CHEMBL841401,Inhibitory activity against LPS-stimulated IL-1 beta release from human monocytes,CC(=O)Oc1cc2c(c(C)c1OC(C)=O)CC=C1C(C)(C)C(=O)CCC12C,,,CHEMBL1130726,Bioorg Med Chem Lett,1998,CHEMBL439971,,CHEMBL439971,6.7,230960,=,1,1,=,,IC50,nM,200.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,200.0,1
33537,CHEMBL763979,Inhibition of human platelet aggregation induced by ADP after 3 min incubation with platelet rich plasma,Cl.O=S(=O)(CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCN(Cc2ccc(F)cc2)CC1,,,CHEMBL1126868,J Med Chem,1993,CHEMBL1203030,,CHEMBL320999,10.17,208542,=,1,1,=,,IC50,nM,0.067,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,0.067,0
40754,CHEMBL763979,Inhibition of human platelet aggregation induced by ADP after 3 min incubation with platelet rich plasma,Cl.O=C(NCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)N1CCNCC1,,,CHEMBL1126868,J Med Chem,1993,CHEMBL1203064,,CHEMBL325144,8.09,208522,=,1,1,=,,IC50,nM,8.15,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,8.15,0
280087,CHEMBL698532,PGI-2 agonistic activity by measuring inhibition of 4 uM ADP-induced human platelet aggregation,O=C(O)COc1cccc2c1CCCC2CCC(=O)NN(c1ccccc1)c1ccccc1,,,CHEMBL1150504,Bioorg Med Chem Lett,1995,CHEMBL11211,,CHEMBL11211,7.24,10068,=,1,1,=,,IC50,nM,57.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.057,1
386791,CHEMBL841401,Inhibitory activity against LPS-stimulated IL-1 beta release from human monocytes,CC(=O)Oc1cc2c(c(C)c1OC(C)=O)CC=C1C(C)(C)[C@H](OC(C)=O)CC[C@]12C,,,CHEMBL1130726,Bioorg Med Chem Lett,1998,CHEMBL332596,,CHEMBL332596,7.0,230956,=,1,1,=,,IC50,nM,100.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,100.0,1
38475,CHEMBL764816,Inhibitory activity of Ca-ionophore-A23187-induced Leukotriene B4 (LTB4) release in human polymorphonuclear leukocytes,CCOC(=O)C(Cc1ccc(Br)cc1)Nc1nc2ccccc2s1,,,CHEMBL1127687,J Med Chem,1994,CHEMBL172044,,CHEMBL172044,6.82,341247,=,1,1,=,,IC50,nM,150.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.15,1
234337,CHEMBL873083,Inhibitory concentration against U 46619 induced aggregation of human washed platelets(WP),O=C(O)CCCCCCc1cnccc1CCNS(=O)(=O)c1ccc(Cl)cc1,,,CHEMBL1150530,Bioorg Med Chem Lett,1992,CHEMBL42480,,CHEMBL42480,7.03,68647,=,1,1,=,,IC50,nM,94.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.094,1
221451,CHEMBL842872,Compound was tested for its in vitro activity in the inhibition of platelet aggregation using human platelet rich plasma,Cc1cccc(S(=O)(=O)N[C@@H](CNC(=O)C[C@@H]2C[C@H](c3ccc(C(=N)N)cc3)N(C(C)C)O2)C(=O)O)c1.Cl,,,CHEMBL1131698,Bioorg Med Chem Lett,1999,CHEMBL555326,,CHEMBL1195778,6.85,302043,=,1,1,=,,IC50,nM,140.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.14,1
365262,CHEMBL761638,In vitro inhibition of collagen-induced platelet aggregation in human platelet-rich plasma (PRP),COc1ccc(-c2nnsc2-c2cccs2)cc1,,,CHEMBL1122973,J Med Chem,1985,CHEMBL422626,,CHEMBL422626,,267947,=,1,1,=,,IC50,ug.mL-1,1.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,ug ml-1,UO_0000274,1.0,0
129655,CHEMBL698041,Compound was tested in vitro for inhibitory activity in LTB4 induced Ca mobilization,COc1ccc(CCCCCCCCOc2ccc(CSCc3cccc(C(=O)O)c3)nc2/C=C/C(=O)O)cc1,,,CHEMBL1129361,J Med Chem,1996,CHEMBL422598,,CHEMBL422598,6.88,162527,=,1,1,=,,IC50,nM,131.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,131.0,1
53352,CHEMBL764816,Inhibitory activity of Ca-ionophore-A23187-induced Leukotriene B4 (LTB4) release in human polymorphonuclear leukocytes,Fc1ccc(CC(Nc2nc3cc(C(F)(F)F)ccc3o2)c2ccccn2)cc1,,,CHEMBL1127687,J Med Chem,1994,CHEMBL367911,,CHEMBL367911,8.1,341203,=,1,1,=,,IC50,nM,8.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.008,0
583924,CHEMBL878710,Tested for Concentration required for the inhibition of ADP-induced aggregation of human platelets,O=C(O)COc1cccc2c1CC[C@H](Cn1nc(C(c3ccccc3)c3ccccc3)ccc1=O)C2,,,CHEMBL1132727,Bioorg Med Chem Lett,2000,CHEMBL94751,,CHEMBL94751,7.09,174247,=,1,1,=,,IC50,nM,81.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.081,1
571858,CHEMBL759885,"Inhibitory activity against platelet aggregation, induced by arachidonic acid in human platelet rich plasma",CC(C)(C)CCCCNC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1,,,CHEMBL1126688,J Med Chem,1993,CHEMBL30972,,CHEMBL30972,8.1,47522,=,1,1,=,,IC50,nM,8.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,I50,nM,UO_0000065,8.0,0
119288,CHEMBL733698,Inhibition of LPS-stimulated TNF-alpha production in monocyte cells,O=C1NCc2c(-c3ccccc3Cl)cc(CN3CCNCC3)cc2N1c1c(Cl)cccc1Cl,,,CHEMBL1136271,Bioorg Med Chem Lett,2003,CHEMBL97227,,CHEMBL97227,8.85,174904,=,1,1,=,,IC50,nM,1.4,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,1.4,0
402407,CHEMBL699491,In vitro inhibition of collagen-induced platelet aggregation in human platelet rich plasma,FC(F)(F)c1nc(-c2ccc(Cl)cc2)c(-c2ccc(Cl)cc2)s1,,,CHEMBL1121768,J Med Chem,1981,CHEMBL35880,,CHEMBL35880,,58389,=,1,1,=,,IC50,ug.mL-1,0.032,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,ng ml-1,UO_0000274,32.0,0
494878,CHEMBL734165,Antitumor activity against moser human colon carcinoma cell line,CNC(=O)OCc1c2c(n(C)c1COC(C)=O)C(=O)C(C)=C(OC)C2=O,,,CHEMBL1124560,J Med Chem,1989,CHEMBL58984,,CHEMBL58984,,93247,=,1,1,=,,IC50,ug.mL-1,0.09,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,ug ml-1,UO_0000274,0.09,0
509331,CHEMBL734165,Antitumor activity against moser human colon carcinoma cell line,CNC(=O)OCc1c2c(n(C)c1COC(C)=O)C(=O)C(C)=C(N1CC1)C2=O,,,CHEMBL1124560,J Med Chem,1989,CHEMBL54611,,CHEMBL54611,,93248,=,1,1,=,,IC50,ug.mL-1,0.035,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,ug ml-1,UO_0000274,0.035,0
269953,CHEMBL881157,"Inhibitory activity against U-46,619-induced aggregation of washed human platelets.",Cl.O=C(O)CCCCCC(CNS(=O)(=O)c1ccc([N+](=O)[O-])cc1)c1cccnc1,,,CHEMBL1126260,J Med Chem,1992,CHEMBL543915,,CHEMBL1192640,7.16,263738,=,1,1,=,,IC50,nM,70.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.07,1
378107,CHEMBL841401,Inhibitory activity against LPS-stimulated IL-1 beta release from human monocytes,COc1cc2c(c(C)c1OC)CCC(=O)C2C,,,CHEMBL1130726,Bioorg Med Chem Lett,1998,CHEMBL121430,,CHEMBL121430,9.72,230950,=,1,1,=,,IC50,nM,0.19,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,0.19,0
246564,CHEMBL695988,Antiproliferative activity was evaluated by the 72 hr MTT cell viability assay using human colon carcinoma cells (GC3).,COc1ccc(C[C@H]2NC(=O)/C=C/C[C@@H]([C@H](C)[C@H]3O[C@@H]3c3ccccc3)OC(=O)[C@H](CC(C)C)OC(=O)[C@@H]3CCCCC3NC2=O)cc1Cl,,,CHEMBL1131700,Bioorg Med Chem Lett,1999,CHEMBL423091,,CHEMBL423091,8.89,320863,=,1,1,=,,IC50,nM,1.3,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,1.3,0
488586,CHEMBL699609,Tested for the ability to inhibit Leukotriene B4 (LTB4) induced chemotaxis. (Test compound added to upper and lower wells.),CCCc1c(OCCCOc2ccc(-c3cscn3)c(OC)c2CC2CC2)ccc2c1OC(C(=O)O)CC2,,,CHEMBL1128264,J Med Chem,1995,CHEMBL99099,,CHEMBL99099,7.17,335056,=,1,1,=,,IC50,nM,67.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,67.0,1
64840,CHEMBL764816,Inhibitory activity of Ca-ionophore-A23187-induced Leukotriene B4 (LTB4) release in human polymorphonuclear leukocytes,CCCCc1ccc2nc(NC(Cc3ccc(Cl)cc3)C(=O)OCC)sc2c1,,,CHEMBL1127687,J Med Chem,1994,CHEMBL170711,,CHEMBL170711,6.75,341175,=,1,1,=,,IC50,nM,180.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.18,1
573134,CHEMBL759885,"Inhibitory activity against platelet aggregation, induced by arachidonic acid in human platelet rich plasma",CCCCCNC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1,,,CHEMBL1126688,J Med Chem,1993,CHEMBL283100,BMS-180291,CHEMBL283100,8.15,47559,=,1,1,=,,IC50,nM,7.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,I50,nM,UO_0000065,7.0,0
239291,CHEMBL763984,Inhibitory concentration of compound in human platelet rich plasma against 2 umol of ADP-induced aggregation,CCCCC[C@H](O)/C=C/[C@@H]1[C@H]2C/C(=C/CCCC(=O)[O-])O[C@H]2C[C@H]1O.[Na+],,,CHEMBL1121996,J Med Chem,1982,CHEMBL962,EPOPROSTENOL SODIUM,CHEMBL1139,,6552,=,1,1,=,,IC50,ug.mL-1,0.001,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,ng ml-1,UO_0000274,1.0,0
37198,CHEMBL763559,Concentration required for maximal in vitro inhibition of aggregation of human platelet rich plasma (hPRP),CCNC(=N)c1ccc(C2=NO[C@@H](CC(=O)NC[C@H](NS(=O)(=O)c3cccc(C)c3)C(=O)O)C2)cc1,,,CHEMBL1133917,Bioorg Med Chem Lett,2001,CHEMBL304394,,CHEMBL304394,7.29,123894,=,1,1,=,,IC50,nM,51.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.051,1
309409,CHEMBL764818,Inhibitory activity against production of leukotriene B4 in isolated human polymorphonuclear leukocytes,CC(=O)c1ccc(/C=C/Cc2cc3c(cc2O)CCO3)cc1,,,CHEMBL1124721,J Med Chem,1990,CHEMBL170953,,CHEMBL170953,7.22,340571,=,1,1,=,,IC50,nM,60.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,60.0,1
80312,CHEMBL700456,Inhibition of human platelet (isolated from PRP) aggregation,N=C(N)Nc1ccc(C2NC(=O)N(CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)O)c3ccccc3)C2=O)cc1,,,CHEMBL1134795,J Med Chem,2001,CHEMBL17675,,CHEMBL17675,6.7,20077,=,1,1,=,,IC50,nM,200.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.2,1
619278,CHEMBL702325,In vitro inhibition of TNF-alpha production was determined by using LPS-stimulated human whole blood assay (WBA),CCN1CCC[C@H](C(=O)NO)[C@H]1C(=O)Nc1ccc(OCc2cc(C)nc3ccccc23)cc1,,,CHEMBL1144985,Bioorg Med Chem Lett,2003,CHEMBL337849,,CHEMBL337849,7.0,261484,=,1,1,=,,IC50,nM,100.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.1,1
66133,CHEMBL701320,Inhibition of LPS-stimulated TNF-alpha production in human whole blood,COc1ccc([C@H](Cc2ccncc2)c2ccc(NS(=O)(=O)c3c(F)c(F)c(F)c(F)c3F)cc2)cc1OC1CCCC1,,,CHEMBL1135122,Bioorg Med Chem Lett,2002,CHEMBL286421,,CHEMBL286421,6.85,52319,=,1,1,=,,IC50,nM,140.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.14,1
636683,CHEMBL767676,Test inhibition of LTB4 production in human peripheral blood polymorphonuclear leukocytes (HPMN),COC(=O)c1cc(Cc2ccccc2)c2ccc(OCc3cccc(C4(O)CCOCC4)c3)cc2c1,,,CHEMBL1129067,J Med Chem,1996,CHEMBL129111,,CHEMBL129111,,245861,>,1,1,>,,IC50,nM,70.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,70.0,1
63460,CHEMBL763979,Inhibition of human platelet aggregation induced by ADP after 3 min incubation with platelet rich plasma,CCCC(CCC)CN1CCN(C(=O)NCCCOc2ccc3[nH]c4nc(O)nc-4cc3c2)CC1.Cl,,,CHEMBL1126868,J Med Chem,1993,CHEMBL1203071,,CHEMBL320776,9.89,208587,=,1,1,=,,IC50,nM,0.13,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,0.13,0
260406,CHEMBL697067,Inhibitory potential of hdm2-binding peptides in a Human wild type p53/hdm2 (GST-hdm2 1-188) competition assay,CSCC[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(C)=O)C(=O)NC(C)(C)C(=O)N[C@@H](Cc1ccc(CP(=O)(O)O)cc1)C(=O)N[C@@H](Cc1c[nH]c2cc(C)ccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)NC1(C(=O)N[C@@H](CC(C)C)C(N)=O)CC1,,,CHEMBL1133623,J Med Chem,2000,CHEMBL2370440,,CHEMBL2370440,8.0,205001,=,1,1,=,,IC50,nM,10.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,10.0,0
371803,CHEMBL873457,Inhibition of ADP-induced human platelet rich plasma aggregation,CC(=O)Oc1ccccc1C(=O)OCCCOc1no[n+]([O-])c1S(=O)(=O)c1ccccc1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1145772,J Med Chem,2003,CHEMBL351742,,CHEMBL351742,,322560,=,1,1,=,,IC50,nM,0.001122,CHEMBL372,Homo sapiens,Homo sapiens,9606,pIC50(uM),,UO_0000065,5.95,0
182789,CHEMBL694769,Tested in vitro for the inhibition of ADP-induced aggregation of human blood platelets,N=C(N)c1ccc(CC(=O)NCCC[C@@H](CC(=O)O)NC(=O)CC23C[C@H]4C[C@@H](C2)C[C@@H](C3)C4)cc1,,,CHEMBL1129882,Bioorg Med Chem Lett,1997,CHEMBL350279,,CHEMBL350279,7.17,319857,=,1,1,=,,IC50,nM,67.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,67.0,1
349647,CHEMBL761638,In vitro inhibition of collagen-induced platelet aggregation in human platelet-rich plasma (PRP),c1ccc(-c2nnsc2-c2ccc3c(c2)OCO3)cc1,,,CHEMBL1122973,J Med Chem,1985,CHEMBL138571,,CHEMBL138571,,267948,=,1,1,=,,IC50,ug.mL-1,3.2,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,ug ml-1,UO_0000274,3.2,0
553810,CHEMBL759885,"Inhibitory activity against platelet aggregation, induced by arachidonic acid in human platelet rich plasma",CS(=O)(=O)NC(=O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCC2CCCCC2)co1,,,CHEMBL1126688,J Med Chem,1993,CHEMBL30398,,CHEMBL30398,8.7,47541,=,1,1,=,,IC50,nM,2.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,I50,nM,UO_0000065,2.0,0
68593,CHEMBL763979,Inhibition of human platelet aggregation induced by ADP after 3 min incubation with platelet rich plasma,Cl.O=S(=O)(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)N1CCN(Cc2ccccc2)CC1,,,CHEMBL1126868,J Med Chem,1993,CHEMBL1203092,,CHEMBL113608,9.89,208573,=,1,1,=,,IC50,nM,0.13,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,0.13,0
574253,CHEMBL759885,"Inhibitory activity against platelet aggregation, induced by arachidonic acid in human platelet rich plasma",O=C(O)Cc1cccc(CC2C3CCC(O3)C2c2nc(C(=O)NCCCCC3CCCCC3)co2)c1,,,CHEMBL1126688,J Med Chem,1993,CHEMBL285596,,CHEMBL285596,7.92,47551,=,1,1,=,,IC50,nM,12.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,I50,nM,UO_0000065,12.0,0
71158,CHEMBL763979,Inhibition of human platelet aggregation induced by ADP after 3 min incubation with platelet rich plasma,Cl.Oc1nc2cc3cc(OCCCCc4nnnn4C4CCN(Cc5ccccc5)CC4)ccc3[nH]c-2n1,,,CHEMBL1126868,J Med Chem,1993,CHEMBL1203036,,CHEMBL325807,10.51,208552,=,1,1,=,,IC50,nM,0.031,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,0.031,0
501995,CHEMBL734165,Antitumor activity against moser human colon carcinoma cell line,CNC(=O)OCc1c2c(n(C)c1COC(=O)NC)C(=O)C(C)=C(N1CC1)C2=O,,,CHEMBL1124560,J Med Chem,1989,CHEMBL417922,,CHEMBL417922,,93253,=,1,1,=,,IC50,ug.mL-1,0.13,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,ug ml-1,UO_0000274,0.13,0
442218,CHEMBL696394,The compound was tested in vitro for its anti-platelet activity against human platelets in presence of ADP,CC(C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)CCCOc1ccc(C(=N)N)cc1)C(=O)O,,,CHEMBL1153685,Bioorg Med Chem Lett,1997,CHEMBL34901,,CHEMBL34901,7.0,292163,=,1,1,=,,IC50,nM,100.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.1,1
470313,CHEMBL697158,In vitro inhibitory potency against human gel filtered platelet (GFP) aggregation,O=C(O)C[C@@H](NC(=O)[C@@H]1CCCN(C(=O)CCC2CCNCC2)C1)c1cccs1,,,CHEMBL1132284,J Med Chem,1999,CHEMBL358487,,CHEMBL358487,7.05,292271,=,1,1,=,,IC50,nM,90.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.09,1
510989,CHEMBL700865,Compound was tested for Leukotriene B4-mediated Up-regulation of human neutrophil CD11b/CD18,CCc1cc(-c2ccc(F)cc2)c(O)cc1OCCCOc1cccc(Oc2ccc(C(=O)O)cc2)c1CCC(=O)O,,,CHEMBL1150505,Bioorg Med Chem Lett,1994,CHEMBL262231,,CHEMBL262231,8.59,112602,=,1,1,=,,IC50,nM,2.6,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,2.6,0
48028,CHEMBL763979,Inhibition of human platelet aggregation induced by ADP after 3 min incubation with platelet rich plasma,Cl.O=S(=O)(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)N1CCN(Cc2ccc(F)cc2)CC1,,,CHEMBL1126868,J Med Chem,1993,CHEMBL1203091,,CHEMBL110938,9.55,208571,=,1,1,=,,IC50,nM,0.28,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,0.28,0
398853,CHEMBL768073,Inhibition of 10 uM ADP induced platelet aggregation in human platelet rich citreated plasma (PRP),COc1ccc(C[C@H]2NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H]3CCCN3C(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(C)=O)C3(CCCCC3)SSC[C@@H](C(N)=O)NC(=O)[C@H](CCCN=C(N)N)NC2=O)cc1,,,CHEMBL1127482,J Med Chem,1994,CHEMBL2371523,,CHEMBL2371523,6.82,327415,=,1,1,=,,IC50,nM,150.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.15,1
38476,CHEMBL764816,Inhibitory activity of Ca-ionophore-A23187-induced Leukotriene B4 (LTB4) release in human polymorphonuclear leukocytes,COC(=O)[C@H](CC1CCCCC1)Nc1nc2ccccc2o1,,,CHEMBL1127687,J Med Chem,1994,CHEMBL2110250,,CHEMBL2110250,8.3,341177,=,1,1,=,,IC50,nM,5.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.005,0
34776,CHEMBL763979,Inhibition of human platelet aggregation induced by ADP after 3 min incubation with platelet rich plasma,CCOC(=O)N1CCC(n2nnnc2CCCOc2ccc3[nH]c4nc(O)nc-4cc3c2)CC1,,,CHEMBL1126868,J Med Chem,1993,CHEMBL113499,,CHEMBL113499,9.38,208564,=,1,1,=,,IC50,nM,0.42,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,0.42,0
36029,CHEMBL764816,Inhibitory activity of Ca-ionophore-A23187-induced Leukotriene B4 (LTB4) release in human polymorphonuclear leukocytes,CCCOCC(Cc1ccc(F)cc1)Nc1nc2cc(C(C)C)ccc2o1,,,CHEMBL1127687,J Med Chem,1994,CHEMBL355706,,CHEMBL355706,6.77,341195,=,1,1,=,,IC50,nM,170.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.17,1
553960,CHEMBL763989,The compound was tested for their ability to inhibit ADP-stimulated platelet aggregation in human platelet rich plasma,CS(=O)(=O)O.Cc1noc(C)c1S(=O)(=O)N[C@H](CNC(=O)C[C@@H]1CC(c2ccc(C(=N)N)cc2)=NO1)C(=O)O,,,CHEMBL1132701,J Med Chem,1999,CHEMBL276358,,CHEMBL1183022,6.92,21821,=,1,1,=,,IC50,nM,120.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.12,1
250545,CHEMBL695988,Antiproliferative activity was evaluated by the 72 hr MTT cell viability assay using human colon carcinoma cells (GC3).,COc1ccc(C[C@H]2NC(=O)/C=C/C[C@@H]([C@H](C)[C@H]3O[C@@H]3c3ccccc3)OC(=O)[C@H](CC(C)C)OC(=O)C[C@@H](c3ccccc3)NC2=O)cc1Cl,,,CHEMBL1131700,Bioorg Med Chem Lett,1999,CHEMBL351974,,CHEMBL351974,9.03,320868,=,1,1,=,,IC50,nM,0.94,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,0.94,0
129356,CHEMBL733698,Inhibition of LPS-stimulated TNF-alpha production in monocyte cells,O=C1NCc2c(-c3ccc(F)cc3F)cc(C3CCNCC3)cc2N1c1c(Cl)cccc1Cl,,,CHEMBL1136271,Bioorg Med Chem Lett,2003,CHEMBL319556,,CHEMBL319556,8.89,174932,=,1,1,=,,IC50,nM,1.3,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,1.3,0
246629,CHEMBL873227,Inhibitory concentration of compound was determined against SFLLRN (3 uM) induced platelet aggregation,CC(C)=CCC[C@@H](C)[C@H]1CC[C@@]2(C(=O)O)C3=C(CC[C@]12C)[C@@]1(C)CC[C@H](O[C@@H]2OC[C@H](O)[C@H](O)[C@H]2O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)C(C)(C)[C@@H]1CC3,,,CHEMBL1133319,Bioorg Med Chem Lett,2000,CHEMBL374281,ERYLOSIDE F,CHEMBL374281,,312011,=,1,1,=,,IC50,ug.mL-1,0.3,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,ug ml-1,UO_0000274,0.3,0
253453,CHEMBL696685,In vitro inhibition of ADP-induced platelet aggregation using human platelet rich plasma,O=C([O-])COc1cccc(C[C@@H]2CCCC=C2c2nc(-c3ccccc3)c(-c3ccccc3)o2)c1.[Na+],,,CHEMBL1136467,Bioorg Med Chem Lett,2003,CHEMBL132589,,CHEMBL1205677,7.22,260104,=,1,1,=,,IC50,nM,60.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,60.0,1
456724,CHEMBL696537,The compound was tested for inhibition of blood platelet aggregation induced by ADP,CC#CCC(C)[C@H](O)/C=C/[C@H]1[C@H](O)C[C@]2(C#CCCCO)C/C(=C/CCCC(=O)O)C[C@H]12,,,CHEMBL1126418,Bioorg Med Chem Lett,1992,CHEMBL336895,,CHEMBL336895,6.7,267010,=,1,1,=,,IC50,nM,200.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,M,UO_0000065,2e-07,1
555263,CHEMBL763989,The compound was tested for their ability to inhibit ADP-stimulated platelet aggregation in human platelet rich plasma,Cc1ccc(S(=O)(=O)N[C@@H](CNC(=O)CC2CC(c3ccc(C(=N)N)cc3)=NO2)C(=O)O)o1.O=C(O)C(F)(F)F,,,CHEMBL1132701,J Med Chem,1999,CHEMBL17858,,CHEMBL1178255,6.8,21826,=,1,1,=,,IC50,nM,160.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.16,1
529424,CHEMBL761741,In vitro inhibitory activity on platelet aggregation induced by arachidonic acid (AA),CCOc1cc(-c2ccccc2)nc2cccc(CC)c12,,,CHEMBL1134765,Bioorg Med Chem Lett,2001,CHEMBL96056,,CHEMBL96056,6.85,176495,=,1,1,=,,IC50,nM,140.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.14,1
72248,CHEMBL699531,Concentration required for 50% inhibition of platelet aggregation of human gel-filtered platelets(GFP) in platelet aggregation assay,CCCCS(=O)(=O)N[C@@H](CNC(=O)c1cc2n(n1)CCN(CCC1CCNCC1)C2=O)C(=O)O,,,CHEMBL1130456,Bioorg Med Chem Lett,1997,CHEMBL40502,,CHEMBL40502,8.05,60923,=,1,1,=,,IC50,nM,9.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,9.0,0
49474,CHEMBL764816,Inhibitory activity of Ca-ionophore-A23187-induced Leukotriene B4 (LTB4) release in human polymorphonuclear leukocytes,CC(C)c1ccc2oc(NC(CC3CCCCC3)c3ccccc3)nc2c1,,,CHEMBL1127687,J Med Chem,1994,CHEMBL173611,,CHEMBL173611,8.22,341245,=,1,1,=,,IC50,nM,6.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.006,0
568304,CHEMBL763989,The compound was tested for their ability to inhibit ADP-stimulated platelet aggregation in human platelet rich plasma,N=C(N)c1ccc(C2=NOC(CC(=O)NC[C@H](NS(=O)(=O)NCCc3ccccc3)C(=O)O)C2)cc1.O=C(O)C(F)(F)F,,,CHEMBL1132701,J Med Chem,1999,CHEMBL279598,,CHEMBL1183097,7.16,21810,=,1,1,=,,IC50,nM,70.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.07,1
583971,CHEMBL759885,"Inhibitory activity against platelet aggregation, induced by arachidonic acid in human platelet rich plasma",CC(C)(CCCCNC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1)C(=O)O,,,CHEMBL1126688,J Med Chem,1993,CHEMBL282124,,CHEMBL282124,7.19,47555,=,1,1,=,,IC50,nM,64.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,I50,nM,UO_0000065,64.0,1
104500,CHEMBL700456,Inhibition of human platelet (isolated from PRP) aggregation,CC1(c2ccc(CN)cc2)NC(=O)N(CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)O)c2ccccc2)C1=O,,,CHEMBL1134795,J Med Chem,2001,CHEMBL277734,,CHEMBL277734,6.82,20058,=,1,1,=,,IC50,nM,150.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.15,1
487255,CHEMBL696990,In vitro ability to inhibit the aggregation of ADP-stimulated human platelets,Cc1ccc(S(=O)(=O)N[C@@H](CNC(=O)C2CCC3(CC2)CCN(c2ccncc2)CC3)C(=O)O)cc1,,,CHEMBL1134062,Bioorg Med Chem Lett,2001,CHEMBL285835,,CHEMBL285835,6.75,33901,=,1,1,=,,IC50,nM,177.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.177,1
592637,CHEMBL761738,In vitro for its inhibitory activity against platelet aggregation induced by ADP,N=C(N)Nc1ccc(C(=O)NCCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](Cc2c[nH]c3ccccc23)C(=O)O)cc1,,,CHEMBL1151085,Bioorg Med Chem Lett,1995,CHEMBL293983,,CHEMBL293983,7.16,100705,=,1,1,=,,IC50,nM,70.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.07,1
276902,CHEMBL698689,In vitro inhibition of histamine release from human basophils,c1cc(Nc2nccc(-c3ccco3)n2)cc(OCCn2ccnc2)c1,,,CHEMBL1126800,J Med Chem,1993,CHEMBL91140,,CHEMBL91140,6.7,168427,=,1,1,=,,IC50,nM,200.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.2,1
563462,CHEMBL763989,The compound was tested for their ability to inhibit ADP-stimulated platelet aggregation in human platelet rich plasma,N=C(N)c1ccc(C2=NOC(CC(=O)NC[C@H](NS(=O)(=O)c3ccccc3-c3ccccc3)C(=O)O)C2)cc1.O=C(O)C(F)(F)F,,,CHEMBL1132701,J Med Chem,1999,CHEMBL18011,,CHEMBL1178262,7.1,21832,=,1,1,=,,IC50,nM,80.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.08,1
148636,CHEMBL811521,Concentration required to reduce the proliferation of PHA stimulated human peripheral blood T lymphocytes,C=Cc1cn(CCC(CO)CO)c(=O)[nH]c1=O,,,CHEMBL1133838,Bioorg Med Chem Lett,2001,CHEMBL317723,,CHEMBL317723,,184065,>,1,1,>,,IC50,ug.mL-1,50.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,ug ml-1,UO_0000274,50.0,1
465786,CHEMBL841414,In vitro inhibition of ADP induced human platelet aggregation in platelet rich plasma(PRP) and presence of Tris buffer.,N=C(N)NCCC[C@H](NC(=O)[C@H](CO)NC(=O)c1ccc(NC(=N)N)cc1)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)c1ccc(NC(=N)N)cc1)C(N)=O,,,CHEMBL1151504,Bioorg Med Chem Lett,1994,CHEMBL274425,,CHEMBL274425,7.06,82054,=,1,1,=,,IC50,nM,87.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.087,1
501310,CHEMBL700876,The compound was tested for the inhibition of platelet aggregation,O=C(NC[C@H](NS(=O)(=O)c1ccc(Cl)cc1)C(=O)O)c1cc2cc(CCC3CCNCC3)sc2s1,,,CHEMBL1151496,Bioorg Med Chem Lett,1997,CHEMBL80432,,CHEMBL80432,7.96,335395,=,1,1,=,,IC50,nM,11.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,11.0,0
604159,CHEMBL842220,Inhibition of TNF-alpha synthesis in human monocytes,COc1ccc2c(Cc3c(Cl)cncc3Cl)nnc(-n3cncn3)c2c1,,,CHEMBL1134046,Bioorg Med Chem Lett,2001,CHEMBL81364,,CHEMBL81364,7.14,232417,=,1,1,=,,IC50,nM,72.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,72.0,1
377996,CHEMBL761638,In vitro inhibition of collagen-induced platelet aggregation in human platelet-rich plasma (PRP),COc1ccc(-c2nnsc2-c2ccccc2)cc1,,,CHEMBL1122973,J Med Chem,1985,CHEMBL139214,,CHEMBL139214,,267960,=,1,1,=,,IC50,ug.mL-1,0.01,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,ng ml-1,UO_0000274,10.0,0
37217,CHEMBL763979,Inhibition of human platelet aggregation induced by ADP after 3 min incubation with platelet rich plasma,Cl.O=C(NCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)N1CCN(c2ncccn2)CC1,,,CHEMBL1126868,J Med Chem,1993,CHEMBL1203056,,CHEMBL323187,9.49,208523,=,1,1,=,,IC50,nM,0.32,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,0.32,0
393559,CHEMBL699801,Inhibitory concentration by calcium flux assay,Sc1nc(-c2ccccc2Cl)nn1Cc1cccc(Cl)c1,,,CHEMBL1136144,Bioorg Med Chem Lett,2003,CHEMBL309253,,CHEMBL309253,,152028,<,1,1,<,,IC50,nM,48.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.048,1
228507,CHEMBL697067,Inhibitory potential of hdm2-binding peptides in a Human wild type p53/hdm2 (GST-hdm2 1-188) competition assay,CSCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(C)=O)C(=O)NC(C)(C)C(=O)N[C@@H](Cc1ccc(CP(=O)(O)O)cc1)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)NC1(C(=O)N[C@@H](CC(C)C)C(N)=O)CC1,,,CHEMBL1133623,J Med Chem,2000,CHEMBL2028897,,CHEMBL2028897,6.86,205003,=,1,1,=,,IC50,nM,138.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,138.0,1
641802,CHEMBL767676,Test inhibition of LTB4 production in human peripheral blood polymorphonuclear leukocytes (HPMN),CCc1cc(-c2ccccc2)c2ccc(OCc3cccc(C4(O)CCOCC4)c3)cc2c1,,,CHEMBL1129067,J Med Chem,1996,CHEMBL128716,,CHEMBL128716,8.0,245891,=,1,1,=,,IC50,nM,10.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,10.0,0
470322,CHEMBL697158,In vitro inhibitory potency against human gel filtered platelet (GFP) aggregation,O=C(O)C[C@H](NC(=O)[C@@H]1CCCN(C(=O)/C=C/C2CCNCC2)C1)c1cccnc1,,,CHEMBL1132284,J Med Chem,1999,CHEMBL151213,,CHEMBL151213,6.8,292256,=,1,1,=,,IC50,nM,160.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.16,1
127012,CHEMBL701928,Inhibition of LPS-stimulated TNF-alpha production in human whole blood,CC(C)N1CCC(c2cc(-c3ccc(F)cc3Cl)c3c(c2)N(c2c(Cl)cccc2Cl)C(=O)NC3)CC1,,,CHEMBL1136271,Bioorg Med Chem Lett,2003,CHEMBL328242,,CHEMBL328242,8.25,174917,=,1,1,=,,IC50,nM,5.6,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,5.6,0
402785,CHEMBL768073,Inhibition of 10 uM ADP induced platelet aggregation in human platelet rich citreated plasma (PRP),CC[C@H](C)[C@H]1NC(=O)[C@H](NC(C)=O)CSSC[C@H](C(N)=O)NC(=O)[C@@H](CCCN=C(N)N)NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)[C@@H](CC(=O)O)NC(=O)CNC(=O)[C@@H](CCCN=C(N)N)NC(=O)[C@@H]2CCCN2C1=O,,,CHEMBL1127482,J Med Chem,1994,CHEMBL429529,,CHEMBL429529,6.77,327433,=,1,1,=,,IC50,nM,170.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.17,1
497528,CHEMBL700865,Compound was tested for Leukotriene B4-mediated Up-regulation of human neutrophil CD11b/CD18,CCc1cc(-c2ccc(F)cc2)c(O)cc1OCCCOc1ccc(C#CCCC(=O)O)cc1CCC(=O)O,,,CHEMBL1150505,Bioorg Med Chem Lett,1994,CHEMBL62265,,CHEMBL62265,8.33,112601,=,1,1,=,,IC50,nM,4.7,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,4.7,0
609716,CHEMBL702141,Inhibition of human vascular smooth muscle proliferation was determined,CC(C)COC(=O)N[C@@H](CCC(=O)N1CCN(c2cccc(NC3=NCCCN3)c2)CC1)C(=O)O,,,CHEMBL1146737,Bioorg Med Chem Lett,2004,CHEMBL84683,,CHEMBL84683,9.04,155717,=,1,1,=,,IC50,nM,0.91,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,0.91,0
91563,CHEMBL700456,Inhibition of human platelet (isolated from PRP) aggregation,N=C(N)c1ccc(/C=C2/NC(=O)N(CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)O)c3ccccc3)C2=O)cc1,,,CHEMBL1134795,J Med Chem,2001,CHEMBL16823,,CHEMBL16823,6.82,20056,=,1,1,=,,IC50,nM,150.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.15,1
435607,CHEMBL702719,Compound was tested for inhibition of ADP induced platelet aggregation by using human platelet rich plasma(PRP) assay,CCCCOC(=O)N[C@@H](CNC(=O)c1cc(OCc2ccc(C(=N)N)cc2)no1)C(=O)OC.O=C(O)C(F)(F)F,,,CHEMBL1130705,Bioorg Med Chem Lett,1998,CHEMBL117580,,CHEMBL1180227,7.3,222447,=,1,1,=,,IC50,nM,50.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,50.0,1
382440,CHEMBL841401,Inhibitory activity against LPS-stimulated IL-1 beta release from human monocytes,CC(=O)Oc1cc2c(c(C)c1OC(C)=O)CC=C1[C@@]3(C)CCC(=O)C(C)=C3CC[C@]12C,,,CHEMBL1130726,Bioorg Med Chem Lett,1998,CHEMBL120991,,CHEMBL120991,7.1,230957,=,1,1,=,,IC50,nM,80.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,80.0,1
60841,CHEMBL764816,Inhibitory activity of Ca-ionophore-A23187-induced Leukotriene B4 (LTB4) release in human polymorphonuclear leukocytes,Fc1ccc(C(CC2CCCCC2)Nc2nc3ccccc3o2)cc1,,,CHEMBL1127687,J Med Chem,1994,CHEMBL172341,,CHEMBL172341,6.77,341185,=,1,1,=,,IC50,nM,170.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.17,1
570609,CHEMBL759885,"Inhibitory activity against platelet aggregation, induced by arachidonic acid in human platelet rich plasma",O=C(O)Cc1cccc(CCC2C3CCC(O3)C2c2nc(C(=O)NCCCCC3CCCCC3)co2)c1,,,CHEMBL1126688,J Med Chem,1993,CHEMBL280786,,CHEMBL280786,6.84,47552,=,1,1,=,,IC50,nM,146.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,I50,nM,UO_0000065,146.0,1
606729,CHEMBL760710,Antiaggregatory activity against human platelet-rich plasma induced by ADP,CN1C(=O)c2ccccc2SSc2ccccc2NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN=C(N)N,,,CHEMBL1128348,J Med Chem,1995,CHEMBL18734,SKF-107260,CHEMBL18734,7.05,22975,=,1,1,=,,IC50,nM,90.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.09,1
644177,CHEMBL767676,Test inhibition of LTB4 production in human peripheral blood polymorphonuclear leukocytes (HPMN),OCc1cc(-c2ccccc2)c2ccc(OCc3cccc(C4(O)CCOCC4)c3)cc2c1,,,CHEMBL1129067,J Med Chem,1996,CHEMBL128666,,CHEMBL128666,8.05,245890,=,1,1,=,,IC50,nM,9.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,9.0,0
579932,CHEMBL697935,In vitro inhibitory activity was evaluated against human squalence epoxidase,CCN(C/C=C/C#CC(C)(C)C)Cc1cccc(OCC(C)(C)OCc2ccsc2)c1.Cl,,,CHEMBL1148267,Bioorg Med Chem Lett,2004,CHEMBL537176,,CHEMBL347699,8.01,309145,=,1,1,=,,IC50,nM,9.8,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,9.8,0
50821,CHEMBL763979,Inhibition of human platelet aggregation induced by ADP after 3 min incubation with platelet rich plasma,Cl.O=S(=O)(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCNCC1,,,CHEMBL1126868,J Med Chem,1993,CHEMBL1203067,,CHEMBL324453,,208578,>,1,1,>,,IC50,nM,66.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,66.0,1
545359,CHEMBL702585,In vitro inhibitory activity against superoxide production from human neutrophils stimulated with f-MLP,CCOc1ccc(-c2nc(-c3ccc(C(=O)O)cc3)cs2)cc1OCC,,,CHEMBL1128742,J Med Chem,1995,CHEMBL119994,,CHEMBL119994,6.7,226492,=,1,1,=,,IC50,nM,200.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.2,1
62154,CHEMBL763559,Concentration required for maximal in vitro inhibition of aggregation of human platelet rich plasma (hPRP),Cc1ccccc1S(=O)(=O)N[C@@H](CNC(=O)C[C@H]1CC(c2ccc(C(=N)N)cc2)=NO1)C(=O)O,,,CHEMBL1133917,Bioorg Med Chem Lett,2001,CHEMBL71016,,CHEMBL71016,7.27,123895,=,1,1,=,,IC50,nM,54.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.054,1
45509,CHEMBL764816,Inhibitory activity of Ca-ionophore-A23187-induced Leukotriene B4 (LTB4) release in human polymorphonuclear leukocytes,CSCC(Cc1ccccc1)Nc1nc2cc(C(C)C)ccc2o1,,,CHEMBL1127687,J Med Chem,1994,CHEMBL170031,,CHEMBL170031,7.89,341194,=,1,1,=,,IC50,nM,13.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.013,0
488560,CHEMBL699611,Tested for the ability to inhibit Leukotriene B4 (LTB4) induced chemotaxis. Test compound added to upper and lower wells.,CCCc1c(OCCCOc2ccc(-c3c[nH]nn3)c(OC)c2CCC)ccc2c1OC(C(=O)O)CC2,,,CHEMBL1128264,J Med Chem,1995,CHEMBL354553,,CHEMBL354553,7.06,335046,=,1,1,=,,IC50,nM,88.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,88.0,1
563921,CHEMBL697935,In vitro inhibitory activity was evaluated against human squalence epoxidase,CN(C/C=C/C#CC(C)(C)C)Cc1cccc(OCC(C)(C)OCc2ccsc2)c1,,,CHEMBL1148267,Bioorg Med Chem Lett,2004,CHEMBL346067,,CHEMBL346067,7.96,309142,=,1,1,=,,IC50,nM,11.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,11.0,0
602383,CHEMBL729970,Inhibition of VEGF-stimulated migration of human microvascular endothelial cells,CC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(=O)O)C(=O)O,,,CHEMBL1146719,Bioorg Med Chem Lett,2004,CHEMBL422381,,CHEMBL422381,8.92,346350,=,1,1,=,,IC50,nM,1.2,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,1.2,0
566546,CHEMBL698304,Tested for inhibition of platelet aggregation induced by arachidonic acid (AAIPA) in human platelet rich plasma,O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCC2CCCCC2)co1,,,CHEMBL1152043,Bioorg Med Chem Lett,1992,CHEMBL31765,,CHEMBL31765,8.7,343136,=,1,1,=,,IC50,nM,2.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,I50,uM,UO_0000065,0.002,0
584266,CHEMBL763989,The compound was tested for their ability to inhibit ADP-stimulated platelet aggregation in human platelet rich plasma,Cn1cnc(S(=O)(=O)N[C@@H](CNC(=O)CC2CC(c3ccc(C(=N)N)cc3)=NO2)C(=O)O)c1.O=C(O)C(F)(F)F,,,CHEMBL1132701,J Med Chem,1999,CHEMBL17985,,CHEMBL1178261,6.96,21800,=,1,1,=,,IC50,nM,110.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.11,1
237132,CHEMBL699168,Inhibition of 10 uM ADP induced aggregation in human gel filtered platelets in the presence fibrinogen and aspirin.,N=C(N)c1ccc(-c2ccc([C@]3(O)CC[C@@](O)(CC(=O)O)CC3)cn2)cc1,,,CHEMBL1127402,J Med Chem,1994,CHEMBL339336,,CHEMBL339336,6.85,242180,=,1,1,=,,IC50,nM,140.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,140.0,1
589095,CHEMBL759885,"Inhibitory activity against platelet aggregation, induced by arachidonic acid in human platelet rich plasma",CC(C)(C)CCNC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1,,,CHEMBL1126688,J Med Chem,1993,CHEMBL31850,,CHEMBL31850,8.1,47523,=,1,1,=,,IC50,nM,8.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,I50,nM,UO_0000065,8.0,0
407912,CHEMBL761736,Evaluated for human platelet aggregation.,CCCCCCCCS(=O)(=O)N[C@@H](CCC(=O)N1CCC(CCCC2CCNCC2)CC1)C(=O)O,,,CHEMBL1129099,Bioorg Med Chem Lett,1996,CHEMBL31589,,CHEMBL31589,6.89,46521,=,1,1,=,,IC50,nM,130.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.13,1
225658,CHEMBL699168,Inhibition of 10 uM ADP induced aggregation in human gel filtered platelets in the presence fibrinogen and aspirin.,N=C(N)c1ccc(-c2ccc([C@H]3CC[C@](O)(CC(=O)O)CC3)cc2)cc1,,,CHEMBL1127402,J Med Chem,1994,CHEMBL126386,,CHEMBL126386,7.89,242187,=,1,1,=,,IC50,nM,13.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,13.0,0
273575,CHEMBL881157,"Inhibitory activity against U-46,619-induced aggregation of washed human platelets.",Cl.O=C(O)CCCCCC(CNS(=O)(=O)c1ccc(-c2ccc3ccccc3c2)cc1)c1cccnc1,,,CHEMBL1126260,J Med Chem,1992,CHEMBL541097,,CHEMBL1190553,8.4,263749,=,1,1,=,,IC50,nM,4.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.004,0
469991,CHEMBL841662,Inhibition of TNF alpha synthesis in human monocytes,COc1ccc2c(Cc3c(Cl)cncc3Cl)nncc2c1/C=C/CCCc1ccccc1,,,CHEMBL1132750,Bioorg Med Chem Lett,2000,CHEMBL309341,,CHEMBL309341,7.28,127279,=,1,1,=,,IC50,nM,52.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,52.0,1
296220,CHEMBL698689,In vitro inhibition of histamine release from human basophils,CCN(CC)CCOc1ccc(Nc2nccc(-c3ccncc3)n2)cc1,,,CHEMBL1126800,J Med Chem,1993,CHEMBL92149,,CHEMBL92149,6.7,168353,=,1,1,=,,IC50,nM,200.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.2,1
379392,CHEMBL761638,In vitro inhibition of collagen-induced platelet aggregation in human platelet-rich plasma (PRP),COc1ccc(-c2snnc2-c2ccc(SC)cc2)cc1,,,CHEMBL1122973,J Med Chem,1985,CHEMBL344846,,CHEMBL344846,,267959,=,1,1,=,,IC50,ug.mL-1,0.032,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,ng ml-1,UO_0000274,32.0,0
351221,CHEMBL841402,Compound was tested for inhibitory activity against LPS-stimulated IL-1 beta release from human monocytes; 80-700,CC1=C(O)C(=O)C=C2C1=CC=C1C(C)(C)C(=O)CCC21C,,,CHEMBL1130726,Bioorg Med Chem Lett,1998,CHEMBL121525,,CHEMBL121525,7.1,230959,=,1,1,=,,IC50,nM,80.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,80.0,1
460791,CHEMBL701319,Inhibition of leukotriene B4 production in human whole blood,c1ccc(Cc2ccc(OCCN3CCCC3)cc2)cc1,,,CHEMBL1134981,Bioorg Med Chem Lett,2002,CHEMBL14608,,CHEMBL14608,6.92,215612,=,1,1,=,,IC50,nM,120.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.12,1
250965,CHEMBL697067,Inhibitory potential of hdm2-binding peptides in a Human wild type p53/hdm2 (GST-hdm2 1-188) competition assay,CSCC[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(C)=O)C(=O)NC(C)(C)C(=O)N[C@@H](Cc1ccc(CP(=O)(O)O)cc1)C(=O)N[C@@H](Cc1c[nH]c2cc(F)ccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)NC1(C(=O)N[C@@H](CC(C)C)C(N)=O)CC1,,,CHEMBL1133623,J Med Chem,2000,CHEMBL2370439,,CHEMBL2370439,7.85,205005,=,1,1,=,,IC50,nM,14.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,14.0,0
451832,CHEMBL697158,In vitro inhibitory potency against human gel filtered platelet (GFP) aggregation,CC(C)(C)C#C[C@@H](CC(=O)O)NC(=O)[C@@H]1CCCN(C(=O)CCC2CCNCC2)C1,,,CHEMBL1132284,J Med Chem,1999,CHEMBL147389,,CHEMBL147389,7.1,292276,=,1,1,=,,IC50,nM,80.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.08,1
37221,CHEMBL763979,Inhibition of human platelet aggregation induced by ADP after 3 min incubation with platelet rich plasma,Cl.Oc1nc2cc3cc(OCCCCc4nnnn4C4CCN(CC5CCCCC5)CC4)ccc3[nH]c-2n1,,,CHEMBL1126868,J Med Chem,1993,CHEMBL1203055,,CHEMBL109599,10.7,208547,=,1,1,=,,IC50,nM,0.02,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,0.02,0
71172,CHEMBL764816,Inhibitory activity of Ca-ionophore-A23187-induced Leukotriene B4 (LTB4) release in human polymorphonuclear leukocytes,CCOCC(Cc1ccc(F)cc1)Nc1nc2cc(C(C)C)ccc2o1,,,CHEMBL1127687,J Med Chem,1994,CHEMBL170511,,CHEMBL170511,7.39,341196,=,1,1,=,,IC50,nM,41.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.041,1
49445,CHEMBL763979,Inhibition of human platelet aggregation induced by ADP after 3 min incubation with platelet rich plasma,Cl.O=S(=O)(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCN(Cc2ccccc2)CC1,,,CHEMBL1126868,J Med Chem,1993,CHEMBL1203032,,CHEMBL324216,10.6,208543,=,1,1,=,,IC50,nM,0.025,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,0.025,0
46817,CHEMBL764816,Inhibitory activity of Ca-ionophore-A23187-induced Leukotriene B4 (LTB4) release in human polymorphonuclear leukocytes,CCOC(=O)C(Cc1ccc(Cl)cc1)Nc1nc2ccccc2s1,,,CHEMBL1127687,J Med Chem,1994,CHEMBL171408,,CHEMBL171408,6.7,341173,=,1,1,=,,IC50,nM,200.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.2,1
633242,CHEMBL767676,Test inhibition of LTB4 production in human peripheral blood polymorphonuclear leukocytes (HPMN),Cn1nnc(-c2cc(-c3ccoc3)c3ccc(OCc4cccc(C5(O)CCOCC5)c4)cc3c2)n1,,,CHEMBL1129067,J Med Chem,1996,CHEMBL338132,,CHEMBL338132,8.7,245841,=,1,1,=,,IC50,nM,2.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,2.0,0
51932,CHEMBL764816,Inhibitory activity of Ca-ionophore-A23187-induced Leukotriene B4 (LTB4) release in human polymorphonuclear leukocytes,CNC(=O)C(CC1CCCCC1)Nc1nc2cc(C)ccc2o1,,,CHEMBL1127687,J Med Chem,1994,CHEMBL171570,,CHEMBL171570,7.14,341199,=,1,1,=,,IC50,nM,72.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.072,1
633344,CHEMBL767676,Test inhibition of LTB4 production in human peripheral blood polymorphonuclear leukocytes (HPMN),O=C(c1ccccc1)c1cc(-c2ccoc2)c2ccc(OCc3cccc(C4(O)CCOCC4)c3)cc2c1,,,CHEMBL1129067,J Med Chem,1996,CHEMBL338461,,CHEMBL338461,9.0,245866,=,1,1,=,,IC50,nM,1.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,1.0,0
174082,CHEMBL811522,Concentration required to reduce the proliferation of PHA stimulated human peripheral blood T lymphocytes to 50% of untreated PHA Stimulated control,Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1,,,CHEMBL1133838,Bioorg Med Chem Lett,2001,CHEMBL141,LAMIVUDINE,CHEMBL141,,184060,>,1,1,>,,IC50,ug.mL-1,50.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,ug ml-1,UO_0000274,50.0,1
381673,CHEMBL873457,Inhibition of ADP-induced human platelet rich plasma aggregation,CC(=O)Oc1ccccc1C(=O)OCc1no[n+]([O-])c1C#N,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1145772,J Med Chem,2003,CHEMBL165969,,CHEMBL165969,,322558,=,1,1,=,,IC50,nM,6.166e-05,CHEMBL372,Homo sapiens,Homo sapiens,9606,pIC50(uM),,UO_0000065,7.21,0
609712,CHEMBL702141,Inhibition of human vascular smooth muscle proliferation was determined,O=C(N[C@@H](CCC(=O)N1CCN(c2cccc(NC3=NCCCCN3)c2)CC1)C(=O)O)OCc1ccccc1,,,CHEMBL1146737,Bioorg Med Chem Lett,2004,CHEMBL314636,,CHEMBL314636,8.77,155720,=,1,1,=,,IC50,nM,1.7,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,1.7,0
613810,CHEMBL842220,Inhibition of TNF-alpha synthesis in human monocytes,COc1ccc2c(Cc3c(Cl)cncc3Cl)nnc(N3CCOCC3)c2c1,,,CHEMBL1134046,Bioorg Med Chem Lett,2001,CHEMBL421151,,CHEMBL421151,7.21,232425,=,1,1,=,,IC50,nM,62.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,62.0,1
136016,CHEMBL699805,Compound was tested in vitro inhibitory activity against human neutrophil CD11b/CD18. ,CCc1cc(-c2ccc(F)cc2)c(O)cc1OCCCOc1ccc2c(=O)c3cc(C(=O)O)ccc3oc2c1CCC(=O)O,,,CHEMBL1129361,J Med Chem,1996,CHEMBL292782,,CHEMBL292782,8.92,162544,=,1,1,=,,IC50,nM,1.2,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,1.2,0
328565,CHEMBL768604,In vitro inhibition of U 46619 induced aggregation of washed platelets,O=C(O)CSC(CCCCNS(=O)(=O)c1ccc(Cl)cc1)CCCc1cccnc1,,,CHEMBL1126283,J Med Chem,1992,CHEMBL341686,,CHEMBL341686,8.22,264756,=,1,1,=,,IC50,nM,6.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.006,0
101935,CHEMBL699503,Inhibitory activity against PAF-induced aggregation of human platelets suspended in plasma,CCCOc1c(OC)cc([C@@H]2CC[C@@H](c3cc(OC)c(OC)c(OC)c3)O2)cc1S(=O)(=O)C[C@H](C)CCCO,,,CHEMBL1126126,J Med Chem,1992,CHEMBL116072,,CHEMBL116072,7.88,221181,=,1,1,=,,IC50,nM,13.2,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,13.2,0
329076,CHEMBL702335,Ability to block the release of TNF-alpha in human whole blood,COc1ccc(-c2ccc(C(N)=O)nc2)cc1O[C@H]1CC2CCC1C2,,,CHEMBL1151544,Bioorg Med Chem Lett,1997,CHEMBL166320,,CHEMBL166320,6.85,321474,=,1,1,=,,IC50,nM,140.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.14,1
63428,CHEMBL841606,The compound was evaluated for reduction of ADP-induced human platelet aggregation response by 50% using PRP assay,N=C(N)c1ccc(C(=O)Nc2ccc3c(c2)CCC(CC(=O)O)O3)cc1,,,CHEMBL1133397,Bioorg Med Chem Lett,2000,CHEMBL323720,,CHEMBL323720,6.72,242483,=,1,1,=,,IC50,nM,190.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.19,1
69963,CHEMBL763979,Inhibition of human platelet aggregation induced by ADP after 3 min incubation with platelet rich plasma,Cl.O=S(=O)(CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCN(Cc2ccccc2)CC1,,,CHEMBL1126868,J Med Chem,1993,CHEMBL1203085,,CHEMBL109740,10.38,208530,=,1,1,=,,IC50,nM,0.042,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,0.042,0
546788,CHEMBL702585,In vitro inhibitory activity against superoxide production from human neutrophils stimulated with f-MLP,CCCOc1cc(-c2nc(-c3ccc4c(c3)CCC(=O)N4)cs2)ccc1OC,,,CHEMBL1128742,J Med Chem,1995,CHEMBL117161,,CHEMBL117161,7.05,226495,=,1,1,=,,IC50,nM,90.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.09,1
141560,CHEMBL733698,Inhibition of LPS-stimulated TNF-alpha production in monocyte cells,O=C1NCc2c(-c3ccccc3Cl)cc(N3CCNCC3)cc2N1c1c(Cl)cccc1Cl,,,CHEMBL1136271,Bioorg Med Chem Lett,2003,CHEMBL96487,,CHEMBL96487,8.54,174930,=,1,1,=,,IC50,nM,2.9,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,2.9,0
495594,CHEMBL699613,Tested for the ability to inhibit Leukotriene B4 (LTB4) induced degranulation.,CCCc1c(OCCCOc2ccc(-c3cscn3)c(OC)c2CCC)ccc2c1OC(CCC(=O)O)CC2,,,CHEMBL1128264,J Med Chem,1995,CHEMBL436047,,CHEMBL436047,7.16,335060,=,1,1,=,,IC50,nM,70.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,70.0,1
453109,CHEMBL697158,In vitro inhibitory potency against human gel filtered platelet (GFP) aggregation,O=C(O)C[C@H](NC(=O)[C@@H]1CCN(C(=O)/C=C/C2CCNCC2)C1)c1cccnc1,,,CHEMBL1132284,J Med Chem,1999,CHEMBL147239,,CHEMBL147239,6.85,292230,=,1,1,=,,IC50,nM,140.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.14,1
450411,CHEMBL701319,Inhibition of leukotriene B4 production in human whole blood,OC1CCN(CCOc2ccc(Cc3ccccc3)cc2)C1,,,CHEMBL1134981,Bioorg Med Chem Lett,2002,CHEMBL115105,,CHEMBL115105,6.72,215616,=,1,1,=,,IC50,nM,190.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.19,1
570591,CHEMBL759885,"Inhibitory activity against platelet aggregation, induced by arachidonic acid in human platelet rich plasma",CCCNC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1,,,CHEMBL1126688,J Med Chem,1993,CHEMBL433435,,CHEMBL433435,8.1,47564,=,1,1,=,,IC50,nM,8.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,I50,nM,UO_0000065,8.0,0
570596,CHEMBL759885,"Inhibitory activity against platelet aggregation, induced by arachidonic acid in human platelet rich plasma",O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCC(F)(F)F)co1,,,CHEMBL1126688,J Med Chem,1993,CHEMBL281293,,CHEMBL281293,7.92,47561,=,1,1,=,,IC50,nM,12.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,I50,nM,UO_0000065,12.0,0
44316,CHEMBL763559,Concentration required for maximal in vitro inhibition of aggregation of human platelet rich plasma (hPRP),CCNC(=N)c1ccc(C2=NOC(CC(=O)NCCC(=O)O)C2)cc1,,,CHEMBL1133917,Bioorg Med Chem Lett,2001,CHEMBL70963,,CHEMBL70963,7.05,123885,=,1,1,=,,IC50,nM,89.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.089,1
470319,CHEMBL697158,In vitro inhibitory potency against human gel filtered platelet (GFP) aggregation,O=C(O)C[C@H](NC(=O)[C@@H]1CCCN(C(=O)CCC2CCNCC2)C1)c1cncc(-c2ccccc2)c1,,,CHEMBL1132284,J Med Chem,1999,CHEMBL346632,,CHEMBL346632,7.16,292263,=,1,1,=,,IC50,nM,70.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.07,1
565762,CHEMBL763989,The compound was tested for their ability to inhibit ADP-stimulated platelet aggregation in human platelet rich plasma,CN(Cc1ccccc1)S(=O)(=O)N[C@@H](CNC(=O)CC1CC(c2ccc(C(=N)N)cc2)=NO1)C(=O)O.O=C(O)C(F)(F)F,,,CHEMBL1132701,J Med Chem,1999,CHEMBL18035,,CHEMBL1178263,7.07,21811,=,1,1,=,,IC50,nM,86.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.086,1
375210,CHEMBL761638,In vitro inhibition of collagen-induced platelet aggregation in human platelet-rich plasma (PRP),COc1ccc(-c2snnc2-c2ccc(OC)cc2OC)cc1,,,CHEMBL1122973,J Med Chem,1985,CHEMBL135085,,CHEMBL135085,,267946,=,1,1,=,,IC50,ug.mL-1,0.032,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,ng ml-1,UO_0000274,32.0,0
607670,CHEMBL761738,In vitro for its inhibitory activity against platelet aggregation induced by ADP,N=C(N)c1ccc(C(=O)NCCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](Cc2ccc3ccccc3c2)C(=O)O)cc1,,,CHEMBL1151085,Bioorg Med Chem Lett,1995,CHEMBL300378,,CHEMBL300378,7.36,100703,=,1,1,=,,IC50,nM,44.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.044,1
561427,CHEMBL697935,In vitro inhibitory activity was evaluated against human squalence epoxidase,CCN(C/C=C/C#CC(C)(C)C)Cc1cccc(OCC(C)(C)OCc2ccsc2)c1,,,CHEMBL1148267,Bioorg Med Chem Lett,2004,CHEMBL347699,,CHEMBL347699,8.27,309152,=,1,1,=,,IC50,nM,5.4,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,5.4,0
579160,CHEMBL759885,"Inhibitory activity against platelet aggregation, induced by arachidonic acid in human platelet rich plasma",O=C(O)Cc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCC2CCCCC2)co1,,,CHEMBL1126688,J Med Chem,1993,CHEMBL31043,,CHEMBL31043,7.85,47547,=,1,1,=,,IC50,nM,14.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,I50,nM,UO_0000065,14.0,0
510309,CHEMBL696978,Concentration required to reduce ADP-induced platelet aggregation in platelet rich plasma by 50%.,N=C(N)c1ccc(C(=O)Nc2ccc3c(c2)CCC(CC(=O)O)C3)cc1,,,CHEMBL1132483,J Med Chem,1999,CHEMBL147258,,CHEMBL147258,6.72,282406,=,1,1,=,,IC50,nM,190.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.19,1
141912,CHEMBL765890,Concentration of peptide resulting in 50% inhibition of C5a (100 nM) causing the release of MPO from polymorphonuclear leukocytes,CN[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@H](CC1CCCCC1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CCCN=C(N)N)C(=O)O,,,CHEMBL1132227,J Med Chem,1999,CHEMBL3350739,,CHEMBL3350739,6.97,103069,=,1,1,=,,IC50,nM,107.15,CHEMBL372,Homo sapiens,Homo sapiens,9606,-Log IC50,,UO_0000065,6.97,1
553899,CHEMBL878080,"Inhibitory activity against HIV-1, in peripheral blood lymphocytes",Nc1ncnc2c1ncn2OCCOCP(=O)(O)O,,,CHEMBL1128300,J Med Chem,1995,CHEMBL285316,,CHEMBL285316,6.7,43320,=,1,1,=,,IC50,nM,200.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.2,1
69953,CHEMBL763979,Inhibition of human platelet aggregation induced by ADP after 3 min incubation with platelet rich plasma,CCOC(=O)N1CCC(n2nnnc2CCCCOc2ccc3[nH]c4nc(O)nc-4cc3c2)CC1,,,CHEMBL1126868,J Med Chem,1993,CHEMBL109445,,CHEMBL109445,10.0,208563,=,1,1,=,,IC50,nM,0.1,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,0.1,0
646505,CHEMBL767676,Test inhibition of LTB4 production in human peripheral blood polymorphonuclear leukocytes (HPMN),O=C1OCc2c1cc1cc(OCc3cccc(C4(O)CCOCC4)c3)ccc1c2-c1ccoc1,,,CHEMBL1129067,J Med Chem,1996,CHEMBL129018,,CHEMBL129018,8.7,245877,=,1,1,=,,IC50,nM,2.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,2.0,0
614801,CHEMBL702141,Inhibition of human vascular smooth muscle proliferation was determined,O=C(N[C@@H](CCC(=O)N1CCN(c2cccc(NC3=NCCCN3)c2)CC1)C(=O)O)OCc1ccccc1,,,CHEMBL1146737,Bioorg Med Chem Lett,2004,CHEMBL312929,,CHEMBL312929,8.96,155718,=,1,1,=,,IC50,nM,1.1,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,1.1,0
44398,CHEMBL764816,Inhibitory activity of Ca-ionophore-A23187-induced Leukotriene B4 (LTB4) release in human polymorphonuclear leukocytes,CCOC(=O)C(Cc1ccccc1)Nc1nc2cc(C(C)C)ccc2o1,,,CHEMBL1127687,J Med Chem,1994,CHEMBL171091,,CHEMBL171091,9.3,341180,=,1,1,=,,IC50,nM,0.5,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.0005,0
159766,CHEMBL872816,Inhibition of growth of human mammary carcinoma (MCF-7) cell line.,COc1ccc(NS(=O)(=O)c2c(F)c(F)c(F)c(F)c2F)cc1NC(=O)[C@H](CO)NC(C)=O,,,CHEMBL1134655,J Med Chem,2001,CHEMBL122187,,CHEMBL122187,8.21,227926,=,1,1,=,,IC50,nM,6.2,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,6.2,0
48051,CHEMBL764816,Inhibitory activity of Ca-ionophore-A23187-induced Leukotriene B4 (LTB4) release in human polymorphonuclear leukocytes,CC(C)c1ccc2oc(N[C@@H](CN3CCCCC3)c3ccccc3)nc2c1,,,CHEMBL1127687,J Med Chem,1994,CHEMBL2110343,,CHEMBL2110343,7.0,341214,=,1,1,=,,IC50,nM,100.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.1,1
219033,CHEMBL700643,Inhibitory concentration required for scavenging of superoxide anion generated by stimulated human neutrophils,COc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)cc1OC,,,CHEMBL1131525,Bioorg Med Chem Lett,1998,CHEMBL277300,,CHEMBL277300,7.0,19841,=,1,1,=,,IC50,nM,100.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.1,1
249301,CHEMBL841666,Inhibition of alpha-CD3 mAb induced IL-2 production in human whole blood,COc1cc(-c2nn([C@H]3CC[C@H](N4CCN(C)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)c1cc2ccccc2o1,,,CHEMBL1135159,Bioorg Med Chem Lett,2002,CHEMBL43773,,CHEMBL43773,8.22,75953,=,1,1,=,,IC50,nM,6.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.006,0
302538,CHEMBL698689,In vitro inhibition of histamine release from human basophils,c1cc(Nc2nccc(-c3cccnc3)n2)cc(OCCn2ccnc2)c1,,,CHEMBL1126800,J Med Chem,1993,CHEMBL58436,,CHEMBL58436,7.0,168403,=,1,1,=,,IC50,nM,100.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.1,1
175169,CHEMBL694769,Tested in vitro for the inhibition of ADP-induced aggregation of human blood platelets,N=C(N)c1ccc(CC(=O)NCCC[C@@H](CC(=O)O)NC(=O)CCC23C[C@H]4C[C@@H](C2)C[C@@H](C3)C4)cc1,,,CHEMBL1129882,Bioorg Med Chem Lett,1997,CHEMBL164528,,CHEMBL164528,7.21,319862,=,1,1,=,,IC50,nM,61.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,61.0,1
401019,CHEMBL699491,In vitro inhibition of collagen-induced platelet aggregation in human platelet rich plasma,COc1ccc(-c2ncsc2-c2ccc(OC)cc2)cc1,,,CHEMBL1121768,J Med Chem,1981,CHEMBL37631,,CHEMBL37631,,58390,=,1,1,=,,IC50,ug.mL-1,0.032,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,ng ml-1,UO_0000274,32.0,0
646460,CHEMBL701912,Concentration required to inhibit the rate of platelet aggregation by 50% was determined with human gel filtered platelets (GFP),O=C(O)CCNC(=O)CN1CCC[C@@H](CCC2CCNCC2)C1=O,,,CHEMBL1128523,J Med Chem,1995,CHEMBL113366,,CHEMBL113366,7.08,213151,=,1,1,=,,IC50,nM,83.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.083,1
125971,CHEMBL765890,Concentration of peptide resulting in 50% inhibition of C5a (100 nM) causing the release of MPO from polymorphonuclear leukocytes,NC(N)=NCC[C@@H]1NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](CC2CCCCC2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](NC(=O)[C@@H](N)Cc2ccccc2)CCNC1=O,,,CHEMBL1132227,J Med Chem,1999,CHEMBL291795,,CHEMBL291795,7.36,103083,=,1,1,=,,IC50,nM,43.65,CHEMBL372,Homo sapiens,Homo sapiens,9606,-Log IC50,,UO_0000065,7.36,1
621120,CHEMBL729970,Inhibition of VEGF-stimulated migration of human microvascular endothelial cells,CC(C)(C)OC(=O)N[C@H](CCCCN)C(=O)Nc1ccc(C(=O)O)c(-c2ccc(O)cc2)c1,,,CHEMBL1146719,Bioorg Med Chem Lett,2004,CHEMBL433611,,CHEMBL433611,10.7,346354,=,1,1,=,,IC50,nM,0.02,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,0.02,0
48043,CHEMBL763979,Inhibition of human platelet aggregation induced by ADP after 3 min incubation with platelet rich plasma,Cl.Oc1nc2cc3cc(OCCCc4nnnn4C4CCN(CC5CCCCO5)CC4)ccc3[nH]c-2n1,,,CHEMBL1126868,J Med Chem,1993,CHEMBL1203082,,CHEMBL111341,10.15,208560,=,1,1,=,,IC50,nM,0.071,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,0.071,0
286974,CHEMBL702047,In vitro inhibition of arachidonic acid induced platelet aggregation of human platelet-rich plasma,CCCC#CCOCC1C2CCC(O2)C1C/C=C\CCCC(=O)O,,,CHEMBL1123449,J Med Chem,1986,CHEMBL74740,,CHEMBL74740,6.7,136704,=,1,1,=,,IC50,nM,200.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,I50,uM,UO_0000065,0.2,1
66152,CHEMBL764816,Inhibitory activity of Ca-ionophore-A23187-induced Leukotriene B4 (LTB4) release in human polymorphonuclear leukocytes,CC(C)c1ccc2oc(NC(Cc3ccc(F)cc3)c3ccccn3)nc2c1,,,CHEMBL1127687,J Med Chem,1994,CHEMBL354312,,CHEMBL354312,7.92,341234,=,1,1,=,,IC50,nM,12.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.012,0
560844,CHEMBL878710,Tested for Concentration required for the inhibition of ADP-induced aggregation of human platelets,O=C(O)COc1cccc2c1CC[C@H](Cn1cc(C(c3ccccc3)c3ccccc3)ccc1=O)C2,,,CHEMBL1132727,Bioorg Med Chem Lett,2000,CHEMBL318294,,CHEMBL318294,6.89,174251,=,1,1,=,,IC50,nM,130.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.13,1
228098,CHEMBL695988,Antiproliferative activity was evaluated by the 72 hr MTT cell viability assay using human colon carcinoma cells (GC3).,COc1ccc(C[C@H]2NC(=O)/C=C/C[C@@H]([C@H](C)[C@H]3O[C@@H]3c3ccccc3)OC(=O)[C@H](CC(C)C)OC(=O)[C@H](C)CNC2=O)cc1Cl,,,CHEMBL1131700,Bioorg Med Chem Lett,1999,CHEMBL441018,CRYPTOPHYCIN A,CHEMBL441018,9.62,320856,=,1,1,=,,IC50,nM,0.24,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,0.24,0
512061,CHEMBL697915,"Compound was tested for inhibition of U-46,619 induced aggregation of human platelets",O=C(O)CCc1cc(Cc2ccccc2)cc2c1CCC(NS(=O)(=O)c1ccc(Cl)cc1)C2,,,CHEMBL1130822,Bioorg Med Chem Lett,1998,CHEMBL27856,,CHEMBL27856,8.22,43498,=,1,1,=,,IC50,nM,6.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.006,0
34779,CHEMBL763979,Inhibition of human platelet aggregation induced by ADP after 3 min incubation with platelet rich plasma,CCC(CC)CN1CCC(n2nnnc2CCCOc2ccc3[nH]c4nc(O)nc-4cc3c2)CC1.Cl,,,CHEMBL1126868,J Med Chem,1993,CHEMBL1203039,,CHEMBL111437,10.92,208557,=,1,1,=,,IC50,nM,0.012,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,0.012,0
125963,CHEMBL765890,Concentration of peptide resulting in 50% inhibition of C5a (100 nM) causing the release of MPO from polymorphonuclear leukocytes,CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN)C(=O)N1CCC[C@H]1C(=O)N[C@H](CC1CCCCC1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CCCN=C(N)N)C(=O)O,,,CHEMBL1132227,J Med Chem,1999,CHEMBL3350743,,CHEMBL3350743,6.72,103075,=,1,1,=,,IC50,nM,190.55,CHEMBL372,Homo sapiens,Homo sapiens,9606,-Log IC50,,UO_0000065,6.72,1
557636,CHEMBL763989,The compound was tested for their ability to inhibit ADP-stimulated platelet aggregation in human platelet rich plasma,N=C(N)c1ccc(C2=NOC(CC(=O)NC[C@H](NS(=O)(=O)c3cccc4ccccc34)C(=O)O)C2)cc1.O=C(O)C(F)(F)F,,,CHEMBL1132701,J Med Chem,1999,CHEMBL18323,,CHEMBL1178271,7.26,21804,=,1,1,=,,IC50,nM,55.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.055,1
568301,CHEMBL763989,The compound was tested for their ability to inhibit ADP-stimulated platelet aggregation in human platelet rich plasma,N=C(N)c1ccc(C2=NOC(CC(=O)NC[C@H](NS(=O)(=O)c3ccc4ccccc4c3)C(=O)O)C2)cc1.O=C(O)C(F)(F)F,,,CHEMBL1132701,J Med Chem,1999,CHEMBL275193,,CHEMBL1182995,6.85,21803,=,1,1,=,,IC50,nM,140.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.14,1
72260,CHEMBL698100,In vitro inhibition of LTB4 production in human blood.,COC1(C(=N)/C=C(\O)OCc2ccc3ccccc3c2)CCOCC1,,,CHEMBL1153693,Bioorg Med Chem Lett,1996,CHEMBL148894,,CHEMBL148894,7.16,290809,=,1,1,=,,IC50,nM,70.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.07,1
39583,CHEMBL763979,Inhibition of human platelet aggregation induced by ADP after 3 min incubation with platelet rich plasma,CC(C)CN1CCC(n2nnnc2CCCCOc2ccc3[nH]c4nc(O)nc-4cc3c2)CC1.Cl,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1126868,J Med Chem,1993,CHEMBL1203042,,CHEMBL111547,,208558,=,1,1,=,,IC50,nM,0.009,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,0.009,0
447819,CHEMBL841662,Inhibition of TNF alpha synthesis in human monocytes,COc1ccc2c(Cc3c(Cl)cncc3Cl)nncc2c1CCCCCc1ccccc1,,,CHEMBL1132750,Bioorg Med Chem Lett,2000,CHEMBL419814,,CHEMBL419814,6.99,127278,=,1,1,=,,IC50,nM,103.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,103.0,1
546317,CHEMBL697915,"Compound was tested for inhibition of U-46,619 induced aggregation of human platelets",O=C(O)CCc1c(Cc2ccccc2)ccc2c1CCC(NS(=O)(=O)c1ccc(Cl)cc1)C2,,,CHEMBL1130822,Bioorg Med Chem Lett,1998,CHEMBL9937,,CHEMBL9937,7.07,43487,=,1,1,=,,IC50,nM,86.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.086,1
431712,CHEMBL696537,The compound was tested for inhibition of blood platelet aggregation induced by ADP,CC#CCC(C)[C@H](O)/C=C/[C@H]1[C@H](O)C[C@]2(C#CCCCI)C/C(=C/CCCC(=O)O)C[C@H]12,,,CHEMBL1126418,Bioorg Med Chem Lett,1992,CHEMBL138317,,CHEMBL138317,6.7,267005,=,1,1,=,,IC50,nM,200.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,M,UO_0000065,2e-07,1
66142,CHEMBL763979,Inhibition of human platelet aggregation induced by ADP after 3 min incubation with platelet rich plasma,Cl.O=S(=O)(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)N1CCN(Cc2cccc(C(F)(F)F)c2)CC1,,,CHEMBL1126868,J Med Chem,1993,CHEMBL1203089,,CHEMBL111603,9.49,208569,=,1,1,=,,IC50,nM,0.32,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,0.32,0
236957,CHEMBL695988,Antiproliferative activity was evaluated by the 72 hr MTT cell viability assay using human colon carcinoma cells (GC3).,COc1ccc(C[C@H]2NC(=O)/C=C/C[C@@H]([C@H](C)[C@H]3O[C@@H]3c3ccccc3)OC(=O)[C@H](CC(C)C)OC(=O)[C@H](C)NC2=O)cc1Cl,,,CHEMBL1131700,Bioorg Med Chem Lett,1999,CHEMBL164673,,CHEMBL164673,7.89,320861,=,1,1,=,,IC50,nM,13.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,13.0,0
375251,CHEMBL700001,Compound is evaluated for inhibitory effect on the generation of Leukotriene B4 (LTB4) from human neutrophils,CCN1CC/C(=C\c2cc(C(C)(C)C)c(O)c(C(C)(C)C)c2)C1=O,,,CHEMBL1123637,J Med Chem,1987,CHEMBL432337,,CHEMBL432337,6.82,104867,=,1,1,=,,IC50,nM,150.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,M,UO_0000065,1.5e-07,1
36030,CHEMBL764816,Inhibitory activity of Ca-ionophore-A23187-induced Leukotriene B4 (LTB4) release in human polymorphonuclear leukocytes,CCOC(=O)c1ccc2oc(NC(CC3CCCCC3)c3ccccc3)nc2c1,,,CHEMBL1127687,J Med Chem,1994,CHEMBL174412,,CHEMBL174412,7.35,341211,=,1,1,=,,IC50,nM,45.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.045,1
563924,CHEMBL697935,In vitro inhibitory activity was evaluated against human squalence epoxidase,CCN(C/C=C/C#CC(C)(C)C)Cc1cccc(OCc2cc(-c3ccsc3)cs2)c1,,,CHEMBL1148267,Bioorg Med Chem Lett,2004,CHEMBL27885,,CHEMBL27885,8.14,309143,=,1,1,=,,IC50,nM,7.2,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,7.2,0
203563,CHEMBL842872,Compound was tested for its in vitro activity in the inhibition of platelet aggregation using human platelet rich plasma,Cc1ccccc1S(=O)(=O)N[C@@H](CNC(=O)C[C@@H]1C[C@H](c2ccc(C(=N)N)cc2)N(C)O1)C(=O)O.Cl,,,CHEMBL1131698,Bioorg Med Chem Lett,1999,CHEMBL538299,,CHEMBL1189233,7.24,302044,=,1,1,=,,IC50,nM,58.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.058,1
315142,CHEMBL699152,In vitro inhibition of ADP-induced human platelet aggregation.,CS(=O)(=O)N[C@@H](CNC(=O)c1ccc2c(c1)C(=O)N(CCC1CCNCC1)C2)C(=O)O,,,CHEMBL1129711,Bioorg Med Chem Lett,1996,CHEMBL82862,,CHEMBL82862,7.85,151584,=,1,1,=,,IC50,nM,14.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,14.0,0
626660,CHEMBL842220,Inhibition of TNF-alpha synthesis in human monocytes,COc1ccc2c(Cc3c(Cl)c[n+]([O-])cc3Cl)nnc(-c3nccs3)c2c1,,,CHEMBL1134046,Bioorg Med Chem Lett,2001,CHEMBL79902,,CHEMBL79902,8.52,232426,=,1,1,=,,IC50,nM,3.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,3.0,0
581503,CHEMBL759885,"Inhibitory activity against platelet aggregation, induced by arachidonic acid in human platelet rich plasma",CCCCCN(C)C(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1,,,CHEMBL1126688,J Med Chem,1993,CHEMBL418583,,CHEMBL418583,8.05,47560,=,1,1,=,,IC50,nM,9.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,I50,nM,UO_0000065,9.0,0
448846,CHEMBL696394,The compound was tested in vitro for its anti-platelet activity against human platelets in presence of ADP,CC(C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)CCCOc1ccc(C(=N)N)cc1)C(=O)N1CCOCC1,,,CHEMBL1153685,Bioorg Med Chem Lett,1997,CHEMBL150351,,CHEMBL150351,7.1,292167,=,1,1,=,,IC50,nM,79.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.079,1
209462,CHEMBL842632,Ability to inhibit bone resorption in human osteoclast obtained from giant cell tumors of bone,CO/C(=C\C=C\c1cc2cc(Cl)c(Cl)cc2[nH]1)C(=O)NC1CC(C)(C)N(C)C(C)(C)C1,,,CHEMBL1130718,Bioorg Med Chem Lett,1998,CHEMBL434032,,CHEMBL434032,7.87,229245,=,1,1,=,,IC50,nM,13.5,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,13.5,0
639280,CHEMBL767676,Test inhibition of LTB4 production in human peripheral blood polymorphonuclear leukocytes (HPMN),O=C1OCc2c1cc1cc(OCc3cccc(C4(O)CC5COC(C4)O5)c3)ccc1c2-c1ccoc1,,,CHEMBL1129067,J Med Chem,1996,CHEMBL128238,,CHEMBL128238,8.15,245875,=,1,1,=,,IC50,nM,7.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,7.0,0
591904,CHEMBL763989,The compound was tested for their ability to inhibit ADP-stimulated platelet aggregation in human platelet rich plasma,N=C(N)c1ccc(C2=NOC(CC(=O)NC[C@H](NS(=O)(=O)c3cccc4nsnc34)C(=O)O)C2)cc1.O=C(O)C(F)(F)F,,,CHEMBL1132701,J Med Chem,1999,CHEMBL18821,,CHEMBL1178285,7.04,21815,=,1,1,=,,IC50,nM,91.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.091,1
417796,CHEMBL768073,Inhibition of 10 uM ADP induced platelet aggregation in human platelet rich citreated plasma (PRP),CCCCOc1ccc(C[C@H]2NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H]3CCCN3C(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(C)=O)CSSC[C@@H](C(N)=O)NC(=O)[C@H](CCCN=C(N)N)NC2=O)cc1,,,CHEMBL1127482,J Med Chem,1994,CHEMBL2371530,,CHEMBL2371530,7.0,327440,=,1,1,=,,IC50,nM,100.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.1,1
486660,CHEMBL768070,In vitro inhibition of human Platelet-rich plasma (PRP) aggregation induced by 5 uM ADP,N=C(c1ccc(C(=O)Nc2ccc3c(c2)CC(CC(=O)O)CC3)cc1)N1CCOCC1,,,CHEMBL1131137,J Med Chem,1998,CHEMBL130878,,CHEMBL130878,7.1,250105,=,1,1,=,,IC50,nM,80.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,80.0,1
446762,CHEMBL697158,In vitro inhibitory potency against human gel filtered platelet (GFP) aggregation,COc1ncc([C@H](CC(=O)O)NC(=O)[C@@H]2CCCN(C(=O)CCC3CCNCC3)C2)cc1Cl,,,CHEMBL1132284,J Med Chem,1999,CHEMBL357098,,CHEMBL357098,7.05,292240,=,1,1,=,,IC50,nM,90.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.09,1
85629,CHEMBL700456,Inhibition of human platelet (isolated from PRP) aggregation,COC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)CN1C(=O)NC(C)(c2ccc(C(=N)N)cc2)C1=O)c1ccccc1,,,CHEMBL1134795,J Med Chem,2001,CHEMBL16812,,CHEMBL16812,7.16,20053,=,1,1,=,,IC50,nM,70.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.07,1
576980,CHEMBL763989,The compound was tested for their ability to inhibit ADP-stimulated platelet aggregation in human platelet rich plasma,CC(C)CNS(=O)(=O)N[C@@H](CNC(=O)CC1CC(c2ccc(C(=N)N)cc2)=NO1)C(=O)O.O=C(O)C(F)(F)F,,,CHEMBL1132701,J Med Chem,1999,CHEMBL18322,,CHEMBL1178270,7.28,21812,=,1,1,=,,IC50,nM,52.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.052,1
44295,CHEMBL702324,Compound tested for the in vitro inhibition of TNF-alpha production was determined by using LPS-stimulated human whole blood assay (WBA),O=C1NCCCC[C@@H](C(=O)NCC(=O)N2CCOCC2)NC(=O)[C@H](Cc2ccc(-c3ccccc3C(F)(F)F)cc2)[C@@H](C(=O)NO)CCCO1,,,CHEMBL1136470,Bioorg Med Chem Lett,2003,CHEMBL325163,,CHEMBL325163,,261098,>,1,1,>,,IC50,nM,70.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,70.0,1
572515,CHEMBL697935,In vitro inhibitory activity was evaluated against human squalence epoxidase,CCN(C/C=C/C#CC(C)(C)C)Cc1cccc(OCC(CC)(CC)OCc2ccsc2)c1,,,CHEMBL1148267,Bioorg Med Chem Lett,2004,CHEMBL160746,,CHEMBL160746,6.92,309150,=,1,1,=,,IC50,nM,120.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,120.0,1
535900,CHEMBL696393,The compound was tested for inhibition of human platelet aggregation induced by ADP,CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O,,,CHEMBL1127169,Bioorg Med Chem Lett,1993,CHEMBL495,ALPROSTADIL,CHEMBL495,,176961,=,1,1,=,,IC50,ug.mL-1,0.0136,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,ng ml-1,UO_0000274,13.6,0
597434,CHEMBL702141,Inhibition of human vascular smooth muscle proliferation was determined,CC(C)COC(=O)N[C@@H](CCC(=O)N1CCN(c2cccc(NC3=NCC(O)CN3)c2)CC1)C(=O)O,,,CHEMBL1146737,Bioorg Med Chem Lett,2004,CHEMBL407984,,CHEMBL407984,8.7,155716,=,1,1,=,,IC50,nM,2.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,2.0,0
295929,CHEMBL696392,Inhibition of ADP-induced platelet aggregation in human gel-filtered platelets,Nc1cc(COc2ccc3[nH]c(C(=O)NC[C@H](NS(=O)(=O)c4ccccc4)C(=O)O)cc3c2)ccn1,,,CHEMBL1151560,Bioorg Med Chem Lett,1997,CHEMBL96788,,CHEMBL96788,7.35,174762,=,1,1,=,,IC50,nM,45.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,45.0,1
49442,CHEMBL763979,Inhibition of human platelet aggregation induced by ADP after 3 min incubation with platelet rich plasma,Cl.O=S(=O)(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)N1CCN(CCc2ccccc2)CC1,,,CHEMBL1126868,J Med Chem,1993,CHEMBL1203035,,CHEMBL107501,8.98,208544,=,1,1,=,,IC50,nM,1.04,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,1.04,0
276604,CHEMBL696392,Inhibition of ADP-induced platelet aggregation in human gel-filtered platelets,O=C(NC[C@H](NS(=O)(=O)c1ccccc1)C(=O)O)c1cc2cc(OCCN3CCNCC3)ccc2[nH]1,,,CHEMBL1151560,Bioorg Med Chem Lett,1997,CHEMBL96174,,CHEMBL96174,7.92,174754,=,1,1,=,,IC50,nM,12.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,12.0,0
363155,CHEMBL763288,Inhibition of collagen-induced human platelet rich plasma aggregation,CC(=O)Oc1ccccc1C(=O)OCCCOc1no[n+]([O-])c1-c1ccccc1,,,CHEMBL1145772,J Med Chem,2003,CHEMBL351637,,CHEMBL351637,10.68,322561,=,1,1,=,,IC50,nM,0.02089,CHEMBL372,Homo sapiens,Homo sapiens,9606,pIC50(uM),,UO_0000065,4.68,0
342543,CHEMBL764818,Inhibitory activity against production of leukotriene B4 in isolated human polymorphonuclear leukocytes,OCc1ccccc1/C=C/Cc1cc2c(cc1O)CCO2,,,CHEMBL1124721,J Med Chem,1990,CHEMBL172049,,CHEMBL172049,6.89,340557,=,1,1,=,,IC50,nM,130.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,130.0,1
257618,CHEMBL763982,Inhibitory activity against aggregation of human platelets,CC1(c2ccc(C(=N)N)cc2)NC(=O)N(CC(=O)NC(CC(=O)O)c2ccc3c(c2)OCO3)C1=O,,,CHEMBL1129321,J Med Chem,1996,CHEMBL302242,,CHEMBL302242,7.1,116226,=,1,1,=,,IC50,nM,80.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.08,1
644179,CHEMBL767676,Test inhibition of LTB4 production in human peripheral blood polymorphonuclear leukocytes (HPMN),N#Cc1cc(-c2ccoc2)c2ccc(OCc3cccc(C4(O)CCOCC4)c3)cc2c1,,,CHEMBL1129067,J Med Chem,1996,CHEMBL99469,,CHEMBL99469,8.7,245870,=,1,1,=,,IC50,nM,2.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,2.0,0
641805,CHEMBL767676,Test inhibition of LTB4 production in human peripheral blood polymorphonuclear leukocytes (HPMN),OC1(c2cccc(COc3ccc4c(-c5ccoc5)cc(Cc5nccs5)cc4c3)c2)CCOCC1,,,CHEMBL1129067,J Med Chem,1996,CHEMBL339970,,CHEMBL339970,9.0,245863,=,1,1,=,,IC50,nM,1.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,1.0,0
492646,CHEMBL768070,In vitro inhibition of human Platelet-rich plasma (PRP) aggregation induced by 5 uM ADP,C#CC/N=C(\N)c1ccc(C(=O)Nc2ccc3c(c2)CC(CC(=O)O)CC3)cc1,,,CHEMBL1131137,J Med Chem,1998,CHEMBL130892,,CHEMBL130892,7.0,250107,=,1,1,=,,IC50,nM,100.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,100.0,1
173286,CHEMBL820341,Inhibition of growth of human mammary carcinoma (MCF-7) cell line.,COc1ccc(NS(=O)(=O)c2c(F)c(F)c(F)c(F)c2F)cc1F,,,CHEMBL1134655,J Med Chem,2001,CHEMBL79280,BATABULIN,CHEMBL79280,7.34,227925,=,1,1,=,,IC50,nM,46.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,46.0,1
36018,CHEMBL763979,Inhibition of human platelet aggregation induced by ADP after 3 min incubation with platelet rich plasma,CCCC(CCC)CN1CCC(n2nnnc2CCCOc2ccc3[nH]c4nc(O)nc-4cc3c2)CC1.Cl,,,CHEMBL1126868,J Med Chem,1993,CHEMBL1203041,,CHEMBL111445,10.09,208555,=,1,1,=,,IC50,nM,0.082,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,0.082,0
407766,CHEMBL699491,In vitro inhibition of collagen-induced platelet aggregation in human platelet rich plasma,COc1ccc(-c2nc(CC(=O)[O-])sc2-c2ccc(OC)cc2)cc1.[Li+],,,CHEMBL1121768,J Med Chem,1981,CHEMBL35585,,CHEMBL1204442,,58383,=,1,1,=,,IC50,ug.mL-1,0.032,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,ng ml-1,UO_0000274,32.0,0
280382,CHEMBL698689,In vitro inhibition of histamine release from human basophils,Cc1cc(C)cc(Nc2nccc(-c3ccccn3)n2)c1,,,CHEMBL1126800,J Med Chem,1993,CHEMBL93508,,CHEMBL93508,7.0,168300,=,1,1,=,,IC50,nM,100.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.1,1
133531,CHEMBL702417,Compound was tested in vitro for inhibitory activity against human neutrophil aggregation.,COc1ccc(/C=C/CCCCOc2ccc(C(=O)c3cccc(C(=O)O)c3)cc2CCC(=O)O)cc1,,,CHEMBL1129361,J Med Chem,1996,CHEMBL49302,,CHEMBL49302,7.0,162532,=,1,1,=,,IC50,nM,100.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,100.0,1
470025,CHEMBL701319,Inhibition of leukotriene B4 production in human whole blood,CC(=O)NC1CCN(CCOc2ccc(Cc3ccccc3)cc2)CC1,,,CHEMBL1134981,Bioorg Med Chem Lett,2002,CHEMBL114563,,CHEMBL114563,6.75,215622,=,1,1,=,,IC50,nM,180.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.18,1
558608,CHEMBL759885,"Inhibitory activity against platelet aggregation, induced by arachidonic acid in human platelet rich plasma",O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(/C(S)=N/CCCCC2CCCCC2)co1,,,CHEMBL1126688,J Med Chem,1993,CHEMBL416395,,CHEMBL416395,8.7,47539,=,1,1,=,,IC50,nM,2.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,I50,nM,UO_0000065,2.0,0
51933,CHEMBL764816,Inhibitory activity of Ca-ionophore-A23187-induced Leukotriene B4 (LTB4) release in human polymorphonuclear leukocytes,CC(=O)Nc1ccc2oc(NC(CC3CCCCC3)c3ccccc3)nc2c1,,,CHEMBL1127687,J Med Chem,1994,CHEMBL170523,,CHEMBL170523,7.11,341205,=,1,1,=,,IC50,nM,78.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.078,1
32400,CHEMBL764816,Inhibitory activity of Ca-ionophore-A23187-induced Leukotriene B4 (LTB4) release in human polymorphonuclear leukocytes,CC(C)c1ccc2oc(NC(Cc3cccc(Cl)c3)c3ccccn3)nc2c1,,,CHEMBL1127687,J Med Chem,1994,CHEMBL265475,,CHEMBL265475,8.3,341217,=,1,1,=,,IC50,nM,5.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.005,0
71154,CHEMBL763979,Inhibition of human platelet aggregation induced by ADP after 3 min incubation with platelet rich plasma,CC(C)CN1CCN(C(=O)NCCCOc2ccc3[nH]c4nc(O)nc-4cc3c2)CC1.Cl,,,CHEMBL1126868,J Med Chem,1993,CHEMBL1203074,,CHEMBL113160,9.74,208588,=,1,1,=,,IC50,nM,0.18,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,0.18,0
564613,CHEMBL763989,The compound was tested for their ability to inhibit ADP-stimulated platelet aggregation in human platelet rich plasma,CCCCS(=O)(=O)N[C@@H](CNC(=O)CC1CC(c2ccc(C(=N)N)cc2)=NO1)C(=O)O.O=C(O)C(F)(F)F,,,CHEMBL1132701,J Med Chem,1999,CHEMBL276296,,CHEMBL1183019,7.38,21796,=,1,1,=,,IC50,nM,42.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.042,1
71112,CHEMBL841606,The compound was evaluated for reduction of ADP-induced human platelet aggregation response by 50% using PRP assay,N=C(N)c1ccc(C(=O)Nc2ccc3c(c2)CCC(CC(=O)O)C3=O)c(F)c1,,,CHEMBL1133397,Bioorg Med Chem Lett,2000,CHEMBL126411,,CHEMBL126411,7.0,242484,=,1,1,=,,IC50,nM,100.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.1,1
60736,CHEMBL763559,Concentration required for maximal in vitro inhibition of aggregation of human platelet rich plasma (hPRP),CCCNC(=N)c1ccc(C2=NOC(CC(=O)NCCC(=O)O)C2)cc1,,,CHEMBL1133917,Bioorg Med Chem Lett,2001,CHEMBL71507,,CHEMBL71507,6.92,123881,=,1,1,=,,IC50,nM,120.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.12,1
370898,CHEMBL700001,Compound is evaluated for inhibitory effect on the generation of Leukotriene B4 (LTB4) from human neutrophils,CN1CC/C(=C\c2cc(C(C)(C)C)c(O)c(C(C)(C)C)c2)C1=O,,,CHEMBL1123637,J Med Chem,1987,CHEMBL60987,,CHEMBL60987,6.82,104874,=,1,1,=,,IC50,nM,150.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,M,UO_0000065,1.5e-07,1
125511,CHEMBL733698,Inhibition of LPS-stimulated TNF-alpha production in monocyte cells,O=C(c1cc(-c2ccc(F)cc2Cl)c2c(c1)N(c1c(Cl)cccc1Cl)C(=O)NC2)N1CCNCC1,,,CHEMBL1136271,Bioorg Med Chem Lett,2003,CHEMBL96225,,CHEMBL96225,8.42,174920,=,1,1,=,,IC50,nM,3.8,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,3.8,0
416224,CHEMBL699491,In vitro inhibition of collagen-induced platelet aggregation in human platelet rich plasma,COC(=O)Cc1nc(-c2ccc(OC)cc2)c(-c2ccc(OC)cc2)s1,,,CHEMBL1121768,J Med Chem,1981,CHEMBL37380,,CHEMBL37380,,58392,=,1,1,=,,IC50,ug.mL-1,0.0001,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,ng ml-1,UO_0000274,0.1,0
34774,CHEMBL763979,Inhibition of human platelet aggregation induced by ADP after 3 min incubation with platelet rich plasma,Cl.O=C(NCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)N1CCC(N2CCCCC2)CC1,,,CHEMBL1126868,J Med Chem,1993,CHEMBL1203072,,CHEMBL111528,8.01,208586,=,1,1,=,,IC50,nM,9.86,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,9.86,0
631329,CHEMBL702141,Inhibition of human vascular smooth muscle proliferation was determined,O=C(N[C@@H](CCC(=O)N1CCN(c2cccc(NC3=NCCN3)c2)CC1)C(=O)O)OCc1ccccc1,,,CHEMBL1146737,Bioorg Med Chem Lett,2004,CHEMBL87130,,CHEMBL87130,8.52,155708,=,1,1,=,,IC50,nM,3.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,3.0,0
341921,CHEMBL699152,In vitro inhibition of ADP-induced human platelet aggregation.,CC(C)CS(=O)(=O)N[C@@H](CNC(=O)c1ccc2c(c1)C(=O)N(CCC1CCNCC1)C2)C(=O)O,,,CHEMBL1129711,Bioorg Med Chem Lett,1996,CHEMBL311734,,CHEMBL311734,8.05,151583,=,1,1,=,,IC50,nM,9.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,9.0,0
503292,CHEMBL734165,Antitumor activity against moser human colon carcinoma cell line,CNC(=O)OCc1c2c(n(C)c1COC(=O)NC)C(O)=C(C)C(=N)C2=O,,,CHEMBL1124560,J Med Chem,1989,CHEMBL300031,,CHEMBL300031,,93258,=,1,1,=,,IC50,ug.mL-1,3.1,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,ug ml-1,UO_0000274,3.1,0
631333,CHEMBL702141,Inhibition of human vascular smooth muscle proliferation was determined,CCNC(=O)N[C@@H](CCC(=O)N1CCN(c2cccc(NC3=NCCCN3)c2)CC1)C(=O)O,,,CHEMBL1146737,Bioorg Med Chem Lett,2004,CHEMBL313045,,CHEMBL313045,,155711,>,1,1,>,,IC50,nM,10.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,10.0,0
293565,CHEMBL698689,In vitro inhibition of histamine release from human basophils,c1cncc(-c2ccnc(Nc3cccc(-n4ccnc4)c3)n2)c1,,,CHEMBL1126800,J Med Chem,1993,CHEMBL291963,,CHEMBL291963,6.7,168406,=,1,1,=,,IC50,nM,200.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.2,1
373292,CHEMBL700565,Compound was evaluated for GROalpha-mediated calcium mobilization in human polymorphonuclear neutrophils(PMNs),N#Cc1ccc(NC(=O)Nc2ccccc2Br)c(O)c1Br,,,CHEMBL1149089,J Med Chem,2004,CHEMBL28009,,CHEMBL28009,9.1,36907,=,1,1,=,,IC50,nM,0.79,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,0.79,0
462029,CHEMBL841662,Inhibition of TNF alpha synthesis in human monocytes,COc1ccc2c(Cc3c(Cl)cncc3Cl)nncc2c1OCCCCCc1ccccc1,,,CHEMBL1132750,Bioorg Med Chem Lett,2000,CHEMBL74631,,CHEMBL74631,7.08,127276,=,1,1,=,,IC50,nM,83.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,83.0,1
55709,CHEMBL763559,Concentration required for maximal in vitro inhibition of aggregation of human platelet rich plasma (hPRP),CCNC(=N)c1ccc(C2=NO[C@@H](CC(=O)NC[C@H](NS(=O)(=O)c3ccccc3C)C(=O)O)C2)cc1,,,CHEMBL1133917,Bioorg Med Chem Lett,2001,CHEMBL67643,,CHEMBL67643,7.37,123896,=,1,1,=,,IC50,nM,43.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.043,1
476838,CHEMBL734165,Antitumor activity against moser human colon carcinoma cell line,CNC(=O)OCc1c2c(n(C)c1COC(C)=O)C(O)=C(C)C(=N)C2=O,,,CHEMBL1124560,J Med Chem,1989,CHEMBL55013,,CHEMBL55013,,93257,=,1,1,=,,IC50,ug.mL-1,12.8,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,ug ml-1,UO_0000274,12.8,0
264069,CHEMBL695988,Antiproliferative activity was evaluated by the 72 hr MTT cell viability assay using human colon carcinoma cells (GC3).,COc1ccc(C[C@H]2NC(=O)/C=C/C[C@@H]([C@H](C)[C@H]3O[C@@H]3c3ccccc3)OC(=O)[C@H](CC(C)C)OC(=O)C[C@@H](Cc3ccccc3)NC2=O)cc1Cl,,,CHEMBL1131700,Bioorg Med Chem Lett,1999,CHEMBL349357,,CHEMBL349357,8.28,320867,=,1,1,=,,IC50,nM,5.2,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,5.2,0
69958,CHEMBL763979,Inhibition of human platelet aggregation induced by ADP after 3 min incubation with platelet rich plasma,Cl.Oc1nc2cc3cc(OCCCc4nnnn4C4CCN(CC5CCCCC5)CC4)ccc3[nH]c-2n1,,,CHEMBL1126868,J Med Chem,1993,CHEMBL1203053,,CHEMBL109958,10.8,208548,=,1,1,=,,IC50,nM,0.016,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,0.016,0
71156,CHEMBL763979,Inhibition of human platelet aggregation induced by ADP after 3 min incubation with platelet rich plasma,CCC(CC)CN1CCC(S(=O)(=O)CCCCOc2ccc3[nH]c4nc(O)nc-4cc3c2)CC1.Cl,,,CHEMBL1126868,J Med Chem,1993,CHEMBL1203050,,CHEMBL111022,10.68,208566,=,1,1,=,,IC50,nM,0.021,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,0.021,0
516077,CHEMBL697915,"Compound was tested for inhibition of U-46,619 induced aggregation of human platelets",Cc1ccccc1Cc1cc(CCC(=O)O)c2c(c1)CC(NS(=O)(=O)c1ccc(Cl)cc1)CC2,,,CHEMBL1130822,Bioorg Med Chem Lett,1998,CHEMBL281036,,CHEMBL281036,8.1,43497,=,1,1,=,,IC50,nM,8.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.008,0
558827,CHEMBL763989,The compound was tested for their ability to inhibit ADP-stimulated platelet aggregation in human platelet rich plasma,Cc1ccc(NS(=O)(=O)N[C@@H](CNC(=O)CC2CC(c3ccc(C(=N)N)cc3)=NO2)C(=O)O)cc1.O=C(O)C(F)(F)F,,,CHEMBL1132701,J Med Chem,1999,CHEMBL277137,,CHEMBL1183045,7.14,21809,=,1,1,=,,IC50,nM,72.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.072,1
223174,CHEMBL697067,Inhibitory potential of hdm2-binding peptides in a Human wild type p53/hdm2 (GST-hdm2 1-188) competition assay,CSCC[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(C)=O)C(=O)NC(C)(C)C(=O)N[C@@H](Cc1ccc(CP(=O)(O)O)cc1)C(=O)N[C@@H](Cc1c[nH]c2cc(Cl)ccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)NC1(C(=O)N[C@@H](CC(C)C)C(N)=O)CC1,,,CHEMBL1133623,J Med Chem,2000,CHEMBL2370438,,CHEMBL2370438,8.3,205004,=,1,1,=,,IC50,nM,5.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,5.0,0
330191,CHEMBL699152,In vitro inhibition of ADP-induced human platelet aggregation.,O=C(O)c1ccc(S(=O)(=O)N[C@@H](CNC(=O)c2ccc3c(c2)C(=O)N(CCC2CCNCC2)C3)C(=O)O)cc1,,,CHEMBL1129711,Bioorg Med Chem Lett,1996,CHEMBL84259,,CHEMBL84259,8.15,151570,=,1,1,=,,IC50,nM,7.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,7.0,0
242453,CHEMBL841666,Inhibition of alpha-CD3 mAb induced IL-2 production in human whole blood,CN1CCN([C@H]2CC[C@H](n3nc(-c4ccc(Nc5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1,,,CHEMBL1135159,Bioorg Med Chem Lett,2002,CHEMBL46785,,CHEMBL46785,6.87,75945,=,1,1,=,,IC50,nM,135.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.135,1
485902,CHEMBL700876,The compound was tested for the inhibition of platelet aggregation,O=C(NC[C@H](NS(=O)(=O)c1cccnc1)C(=O)O)c1cc2cc(CCC3CCNCC3)sc2s1,,,CHEMBL1151496,Bioorg Med Chem Lett,1997,CHEMBL78760,,CHEMBL78760,8.1,335390,=,1,1,=,,IC50,nM,8.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,8.0,0
49456,CHEMBL764816,Inhibitory activity of Ca-ionophore-A23187-induced Leukotriene B4 (LTB4) release in human polymorphonuclear leukocytes,COc1ccc2oc(NC(Cc3ccc(F)cc3)c3ccccn3)nc2c1,,,CHEMBL1127687,J Med Chem,1994,CHEMBL354336,,CHEMBL354336,7.96,341235,=,1,1,=,,IC50,nM,11.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.011,0
32387,CHEMBL763979,Inhibition of human platelet aggregation induced by ADP after 3 min incubation with platelet rich plasma,Cl.Oc1nc2cc3cc(OCCCCc4nnnn4C4CCNCC4)ccc3[nH]c-2n1,,,CHEMBL1126868,J Med Chem,1993,CHEMBL1203045,,CHEMBL110157,8.27,208561,=,1,1,=,,IC50,nM,5.33,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,5.33,0
34772,CHEMBL763979,Inhibition of human platelet aggregation induced by ADP after 3 min incubation with platelet rich plasma,Cl.O=C(NCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)N1CCN(CC2CCCCO2)CC1,,,CHEMBL1126868,J Med Chem,1993,CHEMBL1203058,,CHEMBL113267,9.8,208520,=,1,1,=,,IC50,nM,0.16,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,0.16,0
53343,CHEMBL763979,Inhibition of human platelet aggregation induced by ADP after 3 min incubation with platelet rich plasma,Cl.Oc1nc2cc3cc(OCCCc4nnnn4C4CCN(Cc5ccc(F)cc5)CC4)ccc3[nH]c-2n1,,,CHEMBL1126868,J Med Chem,1993,CHEMBL1203034,,CHEMBL111162,10.49,208551,=,1,1,=,,IC50,nM,0.032,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,0.032,0
46820,CHEMBL764816,Inhibitory activity of Ca-ionophore-A23187-induced Leukotriene B4 (LTB4) release in human polymorphonuclear leukocytes,CN(C)S(=O)(=O)c1ccc2oc(NC(Cc3ccc(F)cc3)c3ccccn3)nc2c1,,,CHEMBL1127687,J Med Chem,1994,CHEMBL171128,,CHEMBL171128,7.3,341219,=,1,1,=,,IC50,nM,50.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.05,1
579120,CHEMBL759883,"Inhibitory activity against platelet aggregation, induced by arachidonic acid in human platelet rich plasma",CCCCCCCNC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1,,,CHEMBL1126688,J Med Chem,1993,CHEMBL30743,,CHEMBL30743,8.7,47513,=,1,1,=,,IC50,nM,2.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,I 50,nM,UO_0000065,2.0,0
590358,CHEMBL759885,"Inhibitory activity against platelet aggregation, induced by arachidonic acid in human platelet rich plasma",O=C(NCCCCC1CCCCC1)c1coc(C2C3CCC(O3)C2Cc2ccccc2C(=O)O)n1,,,CHEMBL1126688,J Med Chem,1993,CHEMBL30845,,CHEMBL30845,7.28,47548,=,1,1,=,,IC50,nM,52.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,I50,nM,UO_0000065,52.0,1
48041,CHEMBL763979,Inhibition of human platelet aggregation induced by ADP after 3 min incubation with platelet rich plasma,Cl.O=S(=O)(CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCN(CC2CCCCC2)CC1,,,CHEMBL1126868,J Med Chem,1993,CHEMBL1203018,,CHEMBL109984,10.52,208538,=,1,1,=,,IC50,nM,0.03,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,0.03,0
629179,CHEMBL761738,In vitro for its inhibitory activity against platelet aggregation induced by ADP,N=C(N)c1ccc(C(=O)NCCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](Cc2ccc(F)cc2)C(=O)O)cc1,,,CHEMBL1151085,Bioorg Med Chem Lett,1995,CHEMBL294640,,CHEMBL294640,7.33,100714,=,1,1,=,,IC50,nM,47.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.047,1
453265,CHEMBL771475,Antiviral activity against human respiratory syncytial virus (RSV),NC(=O)CCN(CCC(N)=O)S(=O)(=O)c1cccc(Nc2nc(Nc3cccc(S(=O)(=O)N(CCC(N)=O)CCC(N)=O)c3)nc(Nc3ccc(-c4ccc(Nc5nc(Nc6cccc(S(=O)(=O)N(CCC(N)=O)CCC(N)=O)c6)nc(Nc6cccc(S(=O)(=O)N(CCC(N)=O)CCC(N)=O)c6)n5)cc4S(=O)(=O)O)c(S(=O)(=O)O)c3)n2)c1,,,CHEMBL1149193,J Med Chem,2004,CHEMBL414291,,CHEMBL414291,7.3,35810,=,1,1,=,,IC50,nM,50.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.05,1
483670,CHEMBL811523,Immunosuppressive activity was evaluated by the inhibition of human T-lymphocyte proliferation,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,,,CHEMBL1131397,Bioorg Med Chem Lett,1998,CHEMBL413,SIROLIMUS,CHEMBL413,9.3,57137,=,1,1,=,,IC50,nM,0.5,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,0.5,0
557633,CHEMBL763989,The compound was tested for their ability to inhibit ADP-stimulated platelet aggregation in human platelet rich plasma,CCCc1ccc(S(=O)(=O)N[C@@H](CNC(=O)CC2CC(c3ccc(C(=N)N)cc3)=NO2)C(=O)O)cc1.O=C(O)C(F)(F)F,,,CHEMBL1132701,J Med Chem,1999,CHEMBL18361,,CHEMBL1178272,6.89,21806,=,1,1,=,,IC50,nM,130.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.13,1
617848,CHEMBL701316,Tested for the inhibition of leukotriene biosynthesis in human whole blood,NC(=O)N(O)C/C=C/c1cccc(Oc2ccccc2)c1,,,CHEMBL1152010,Bioorg Med Chem Lett,1993,CHEMBL105855,,CHEMBL105855,7.05,195304,=,1,1,=,,IC50,nM,90.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.09,1
118524,CHEMBL765890,Concentration of peptide resulting in 50% inhibition of C5a (100 nM) causing the release of MPO from polymorphonuclear leukocytes,CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H]1CCCCNC(=O)[C@@H](CCN=C(N)N)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](CC2CCCCC2)NC(=O)[C@@H]2CCCN2C1=O,,,CHEMBL1132227,J Med Chem,1999,CHEMBL291589,,CHEMBL291589,7.07,103079,=,1,1,=,,IC50,nM,85.11,CHEMBL372,Homo sapiens,Homo sapiens,9606,-Log IC50,,UO_0000065,7.07,1
266522,CHEMBL696392,Inhibition of ADP-induced platelet aggregation in human gel-filtered platelets,Cc1ccc(S(=O)(=O)N[C@@H](CNC(=O)c2cc3cc(OCC4CCNCC4)ccc3[nH]2)C(=O)O)cc1,,,CHEMBL1151560,Bioorg Med Chem Lett,1997,CHEMBL327216,,CHEMBL327216,8.22,174756,=,1,1,=,,IC50,nM,6.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,6.0,0
141567,CHEMBL701928,Inhibition of LPS-stimulated TNF-alpha production in human whole blood,CC(C1CC1)N1CCC(c2cc(-c3ccc(F)cc3Cl)c3c(c2)N(c2c(Cl)cccc2Cl)C(=O)NC3)CC1,,,CHEMBL1136271,Bioorg Med Chem Lett,2003,CHEMBL318934,,CHEMBL318934,8.15,174914,=,1,1,=,,IC50,nM,7.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,7.0,0
631334,CHEMBL729970,Inhibition of VEGF-stimulated migration of human microvascular endothelial cells,CC(C)(C)OC(=O)N[C@H](CCCN)C(=O)Nc1ccc(C(=O)O)c(-c2ccc(O)cc2)c1,,,CHEMBL1146719,Bioorg Med Chem Lett,2004,CHEMBL368362,,CHEMBL368362,8.96,346351,=,1,1,=,,IC50,nM,1.1,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,1.1,0
292054,CHEMBL696392,Inhibition of ADP-induced platelet aggregation in human gel-filtered platelets,O=C(NC[C@H](NS(=O)(=O)c1ccccc1)C(=O)O)c1cc2cc(OCCCc3c[nH]cn3)ccc2[nH]1,,,CHEMBL1151560,Bioorg Med Chem Lett,1997,CHEMBL441810,,CHEMBL441810,7.0,174760,=,1,1,=,,IC50,nM,100.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,100.0,1
533423,CHEMBL760777,Potent antiplatelet activity was evaluated,CCc1cccc2nc(-c3ccccc3)cc(O)c12,,,CHEMBL1134765,Bioorg Med Chem Lett,2001,CHEMBL318774,,CHEMBL318774,6.82,176503,=,1,1,=,,IC50,nM,150.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.15,1
210684,CHEMBL842872,Compound was tested for its in vitro activity in the inhibition of platelet aggregation using human platelet rich plasma,Cc1cccc(S(=O)(=O)N[C@@H](CNC(=O)C[C@@H]2C[C@H](c3ccc(C(=N)N)cc3)N(Cc3ccccc3)O2)C(=O)O)c1.Cl,,,CHEMBL1131698,Bioorg Med Chem Lett,1999,CHEMBL554766,,CHEMBL1195519,6.72,302046,=,1,1,=,,IC50,nM,190.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.19,1
49421,CHEMBL763559,Concentration required for maximal in vitro inhibition of aggregation of human platelet rich plasma (hPRP),CCCCNC(=N)c1ccc(C2=NO[C@@H](CC(=O)NC[C@H](NC(=O)OCCCC)C(=O)O)C2)cc1,,,CHEMBL1133917,Bioorg Med Chem Lett,2001,CHEMBL73664,,CHEMBL73664,7.21,123900,=,1,1,=,,IC50,nM,62.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.062,1
574897,CHEMBL697935,In vitro inhibitory activity was evaluated against human squalence epoxidase,C=CCC(CC=C)(COc1cccc(CN(CC)C/C=C/C#CC(C)(C)C)c1)OCc1ccsc1,,,CHEMBL1148267,Bioorg Med Chem Lett,2004,CHEMBL155969,,CHEMBL155969,6.8,309144,=,1,1,=,,IC50,nM,160.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,160.0,1
456830,CHEMBL701319,Inhibition of leukotriene B4 production in human whole blood,CNC(=O)C1CCN(CCOc2ccc(Cc3ccccc3)cc2)CC1,,,CHEMBL1134981,Bioorg Med Chem Lett,2002,CHEMBL114615,,CHEMBL114615,6.89,215626,=,1,1,=,,IC50,nM,130.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.13,1
460627,CHEMBL696538,The compound was tested for inhibition of blood platelet aggregation induced by ADP; 0.5-2.5*10e-9,CC#CCC(C)[C@H](O)/C=C/[C@H]1[C@H](O)C[C@]2(C#CCCCBr)C/C(=C\CCCC(=O)O)C[C@H]12,,,CHEMBL1126418,Bioorg Med Chem Lett,1992,CHEMBL138153,,CHEMBL138153,9.3,267004,=,1,1,=,,IC50,nM,0.5,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,M,UO_0000065,5e-10,0
62165,CHEMBL763979,Inhibition of human platelet aggregation induced by ADP after 3 min incubation with platelet rich plasma,Cl.O=S(=O)(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)N1CCN(CCC2CCCCC2)CC1,,,CHEMBL1126868,J Med Chem,1993,CHEMBL1203065,,CHEMBL326019,8.69,208584,=,1,1,=,,IC50,nM,2.04,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,2.04,0
177865,CHEMBL811521,Concentration required to reduce the proliferation of PHA stimulated human peripheral blood T lymphocytes,C=Cc1cn(COC(CO)CO)c(=O)[nH]c1=O,,,CHEMBL1133838,Bioorg Med Chem Lett,2001,CHEMBL99533,,CHEMBL99533,,184062,>,1,1,>,,IC50,ug.mL-1,50.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,ug ml-1,UO_0000274,50.0,1
69972,CHEMBL764816,Inhibitory activity of Ca-ionophore-A23187-induced Leukotriene B4 (LTB4) release in human polymorphonuclear leukocytes,COC(=O)[C@@H](CC1CCCCC1)Nc1nc2ccccc2o1,,,CHEMBL1127687,J Med Chem,1994,CHEMBL2110344,,CHEMBL2110344,7.0,341176,=,1,1,=,,IC50,nM,100.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.1,1
519900,CHEMBL697915,"Compound was tested for inhibition of U-46,619 induced aggregation of human platelets",O=C(O)CCc1cc(Cc2ccc(-c3ccccc3)cc2)cc2c1CCC(NS(=O)(=O)c1ccc(Cl)cc1)C2,,,CHEMBL1130822,Bioorg Med Chem Lett,1998,CHEMBL418394,,CHEMBL418394,7.31,43490,=,1,1,=,,IC50,nM,49.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.049,1
143110,CHEMBL767836,Compound were tested for in vitro inhibition against human PMNL.,CC(C)(C)Sc1c(CC(C)(C)C(=O)[O-])n(Cc2ccc(Cl)cc2)c2ccc(OCc3ccc4ccccc4n3)cc12.[Na+],,,CHEMBL1129361,J Med Chem,1996,CHEMBL313489,QUIFLAPON SODIUM,CHEMBL16596,8.52,162510,=,1,1,=,,IC50,nM,3.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,3.0,0
536279,CHEMBL702585,In vitro inhibitory activity against superoxide production from human neutrophils stimulated with f-MLP,CCOc1ccc(-c2nc(-c3cc(OC(C)=O)cc(OC(C)=O)c3)cs2)cc1OCC,,,CHEMBL1128742,J Med Chem,1995,CHEMBL339653,,CHEMBL339653,9.0,226479,=,1,1,=,,IC50,nM,1.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.001,0
312612,CHEMBL699152,In vitro inhibition of ADP-induced human platelet aggregation.,CCCCCS(=O)(=O)N[C@@H](CNC(=O)c1ccc2c(c1)C(=O)N(CCC1CCNCC1)C2)C(=O)O,,,CHEMBL1129711,Bioorg Med Chem Lett,1996,CHEMBL310294,,CHEMBL310294,8.05,151579,=,1,1,=,,IC50,nM,9.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,9.0,0
307221,CHEMBL699152,In vitro inhibition of ADP-induced human platelet aggregation.,CCCCS(=O)(=O)N[C@@H](Cc1ccc(OCCCCC2CCNCC2)cc1)C(=O)O,,,CHEMBL1129711,Bioorg Med Chem Lett,1996,CHEMBL916,TIROFIBAN,CHEMBL916,7.96,151567,=,1,1,=,,IC50,nM,11.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,11.0,0
487030,CHEMBL700876,The compound was tested for the inhibition of platelet aggregation,O=C(NC[C@H](NS(=O)(=O)c1cccs1)C(=O)O)c1cc2cc(CCC3CCNCC3)sc2s1,,,CHEMBL1151496,Bioorg Med Chem Lett,1997,CHEMBL78503,,CHEMBL78503,8.05,335387,=,1,1,=,,IC50,nM,9.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,9.0,0
279259,CHEMBL698828,Compound was evaluated for the inhibition of CRF-stimulated cyclic adenosine monophosphate production,CCCN(CC1CC1)c1nc(C)nc(Nc2c(Cl)cc(Cl)cc2Cl)c1Cl,,,CHEMBL1129375,J Med Chem,1996,CHEMBL45281,,CHEMBL45281,7.0,263504,=,1,1,=,,IC50,nM,100.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,100.0,1
479414,CHEMBL768070,In vitro inhibition of human Platelet-rich plasma (PRP) aggregation induced by 5 uM ADP,N=C(c1ccc(C(=O)Nc2ccc3c(c2)CC(CC(=O)O)CO3)cc1)N1CCOCC1,,,CHEMBL1131137,J Med Chem,1998,CHEMBL129877,,CHEMBL129877,7.18,250122,=,1,1,=,,IC50,nM,66.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,66.0,1
71160,CHEMBL763979,Inhibition of human platelet aggregation induced by ADP after 3 min incubation with platelet rich plasma,Cl.Cl.O=C(NCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)N1CCN(Cc2ccc(Cl)cc2)CC1,,,CHEMBL1126868,J Med Chem,1993,CHEMBL2447996,,CHEMBL321001,9.54,208527,=,1,1,=,,IC50,nM,0.29,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,0.29,0
125513,CHEMBL733698,Inhibition of LPS-stimulated TNF-alpha production in monocyte cells,CN1CCC(c2cc(-c3ccc(F)cc3Cl)c3c(c2)N(c2c(Cl)cccc2Cl)C(=O)NC3)CC1,,,CHEMBL1136271,Bioorg Med Chem Lett,2003,CHEMBL96653,,CHEMBL96653,8.89,174919,=,1,1,=,,IC50,nM,1.3,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,1.3,0
575462,CHEMBL759885,"Inhibitory activity against platelet aggregation, induced by arachidonic acid in human platelet rich plasma",O=C(O)CCc1ccccc1CCC1C2CCC(O2)C1c1nc(C(=O)NCCCCC2CCCCC2)co1,,,CHEMBL1126688,J Med Chem,1993,CHEMBL287525,,CHEMBL287525,7.2,47549,=,1,1,=,,IC50,nM,63.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,I50,nM,UO_0000065,63.0,1
68606,CHEMBL763979,Inhibition of human platelet aggregation induced by ADP after 3 min incubation with platelet rich plasma,Cl.Oc1nc2cc3cc(OCCCCc4nnnn4C4CCN(Cc5ccc(F)cc5)CC4)ccc3[nH]c-2n1,,,CHEMBL1126868,J Med Chem,1993,CHEMBL1203040,,CHEMBL323005,10.29,208550,=,1,1,=,,IC50,nM,0.051,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,0.051,0
587763,CHEMBL759885,"Inhibitory activity against platelet aggregation, induced by arachidonic acid in human platelet rich plasma",CC(C)(C)NC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1,,,CHEMBL1126688,J Med Chem,1993,CHEMBL287421,,CHEMBL287421,7.92,47524,=,1,1,=,,IC50,nM,12.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,I50,nM,UO_0000065,12.0,0
485534,CHEMBL768070,In vitro inhibition of human Platelet-rich plasma (PRP) aggregation induced by 5 uM ADP,C#CC/N=C(\N)c1ccc(C(=O)Nc2ccc3c(c2)CC(CC(=O)O)CO3)cc1,,,CHEMBL1131137,J Med Chem,1998,CHEMBL130437,,CHEMBL130437,7.11,250104,=,1,1,=,,IC50,nM,78.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,78.0,1
183328,CHEMBL872816,Inhibition of growth of human mammary carcinoma (MCF-7) cell line.,COc1ccc(NS(=O)(=O)c2c(F)c(F)c(F)c(F)c2F)cc1NC(=O)[C@@H](N)CO,,,CHEMBL1134655,J Med Chem,2001,CHEMBL120121,,CHEMBL120121,7.36,227924,=,1,1,=,,IC50,nM,44.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,44.0,1
138083,CHEMBL701928,Inhibition of LPS-stimulated TNF-alpha production in human whole blood,CCN1CCC(c2cc(-c3ccc(F)cc3Cl)c3c(c2)N(c2c(Cl)cccc2Cl)C(=O)NC3)CC1,,,CHEMBL1136271,Bioorg Med Chem Lett,2003,CHEMBL96345,,CHEMBL96345,8.4,174918,=,1,1,=,,IC50,nM,4.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,4.0,0
300735,CHEMBL881157,"Inhibitory activity against U-46,619-induced aggregation of washed human platelets.",Cl.O=C(O)CCCCC(CNS(=O)(=O)c1ccc(Cl)cc1)c1cccnc1,,,CHEMBL1126260,J Med Chem,1992,CHEMBL542490,,CHEMBL1191398,7.1,263747,=,1,1,=,,IC50,nM,80.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.08,1
53304,CHEMBL763559,Concentration required for maximal in vitro inhibition of aggregation of human platelet rich plasma (hPRP),COc1ccccc1CNC(=N)c1ccc(C2=NO[C@@H](CC(=O)NC[C@H](NS(=O)(=O)c3c(C)noc3C)C(=O)O)C2)cc1,,,CHEMBL1133917,Bioorg Med Chem Lett,2001,CHEMBL304948,,CHEMBL304948,7.26,123892,=,1,1,=,,IC50,nM,55.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.055,1
589250,CHEMBL763989,The compound was tested for their ability to inhibit ADP-stimulated platelet aggregation in human platelet rich plasma,Cc1ccccc1S(=O)(=O)N[C@@H](CNC(=O)CC1CC(c2ccc(C(=N)N)cc2)=NO1)C(=O)O.O=C(O)C(F)(F)F,,,CHEMBL1132701,J Med Chem,1999,CHEMBL435942,,CHEMBL1185839,7.39,21798,=,1,1,=,,IC50,nM,41.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.041,1
58212,CHEMBL763979,Inhibition of human platelet aggregation induced by ADP after 3 min incubation with platelet rich plasma,O=CN1CCN(S(=O)(=O)CCCOc2ccc3[nH]c4nc(O)nc-4cc3c2)CC1,,,CHEMBL1126868,J Med Chem,1993,CHEMBL322340,,CHEMBL322340,7.88,208575,=,1,1,=,,IC50,nM,13.05,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,13.05,0
327034,CHEMBL768604,In vitro inhibition of U 46619 induced aggregation of washed platelets,O=C(O)CCC(CCCCNS(=O)(=O)c1ccc(Cl)cc1)CCOc1cccnc1,,,CHEMBL1126283,J Med Chem,1992,CHEMBL63904,,CHEMBL63904,7.89,264753,=,1,1,=,,IC50,nM,13.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.013,0
343603,CHEMBL701315,Inhibition of interleukin-2 (IL-2) synthesis in human whole blood stimulated by PMA/ionomycin.,O=C(Nc1ccc(-n2nc(C(F)(F)F)cc2Cl)cc1)c1ccncc1F,,,CHEMBL1133605,J Med Chem,2000,CHEMBL318855,,CHEMBL318855,6.8,188111,=,1,1,=,,IC50,nM,158.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,158.0,1
45508,CHEMBL764816,Inhibitory activity of Ca-ionophore-A23187-induced Leukotriene B4 (LTB4) release in human polymorphonuclear leukocytes,COc1ccc2oc(NC(Cc3ccccc3)c3ccccc3)nc2c1,,,CHEMBL1127687,J Med Chem,1994,CHEMBL170232,,CHEMBL170232,8.05,341187,=,1,1,=,,IC50,nM,9.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.009,0
493509,CHEMBL701913,Concentration required to reduce ADP-induced platelet aggregation in platelet rich plasma by 50%,N=C(N)c1ccc(C(=O)Nc2ccc3c(c2)CCN(CC(=O)O)C3)cc1,,,CHEMBL1132483,J Med Chem,1999,CHEMBL148205,,CHEMBL148205,6.77,282408,=,1,1,=,,IC50,nM,170.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.17,1
64839,CHEMBL763979,Inhibition of human platelet aggregation induced by ADP after 3 min incubation with platelet rich plasma,Cl.O=C(NCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)N1CCN(CCc2ccccc2)CC1,,,CHEMBL1126868,J Med Chem,1993,CHEMBL1203060,,CHEMBL431444,9.52,208554,=,1,1,=,,IC50,nM,0.3,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,0.3,0
625091,CHEMBL701819,Compound was tested in vitro for inhibition of human mixed lymphocyte proliferation (HuMLR),C=CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC,,,CHEMBL1130792,Bioorg Med Chem Lett,1998,CHEMBL269732,TACROLIMUS ANHYDROUS,CHEMBL269732,9.43,342760,=,1,1,=,,IC50,nM,0.37,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,0.37,0
627442,CHEMBL702141,Inhibition of human vascular smooth muscle proliferation was determined,CC(C)COC(=O)N[C@@H](CCC(=O)N1CCN(c2cccc(NC3=NCC(F)CN3)c2)CC1)C(=O)O,,,CHEMBL1146737,Bioorg Med Chem Lett,2004,CHEMBL87372,,CHEMBL87372,9.74,155709,=,1,1,=,,IC50,nM,0.18,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,0.18,0
624826,CHEMBL729970,Inhibition of VEGF-stimulated migration of human microvascular endothelial cells,CCCC[C@@H](NC(=O)OC(C)(C)C)C(=O)Nc1ccc(C(=O)O)c(-c2ccc(O)cc2)c1,,,CHEMBL1146719,Bioorg Med Chem Lett,2004,CHEMBL368395,,CHEMBL368395,,346355,>,1,1,>,,IC50,nM,100.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,100.0,1
555255,CHEMBL763989,The compound was tested for their ability to inhibit ADP-stimulated platelet aggregation in human platelet rich plasma,Cc1ccccc1S(=O)(=O)N[C@@H](CNC(=O)C[C@H]1CC(c2ccc(C(=N)N)cc2)=NO1)C(=O)O.O=C(O)C(F)(F)F,,,CHEMBL1132701,J Med Chem,1999,CHEMBL18024,,CHEMBL71016,6.89,21836,=,1,1,=,,IC50,nM,130.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.13,1
339370,CHEMBL699152,In vitro inhibition of ADP-induced human platelet aggregation.,O=C(NC[C@H](NS(=O)(=O)c1cccs1)C(=O)O)c1ccc2c(c1)C(=O)N(CCC1CCNCC1)C2,,,CHEMBL1129711,Bioorg Med Chem Lett,1996,CHEMBL314622,,CHEMBL314622,8.15,151573,=,1,1,=,,IC50,nM,7.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,7.0,0
134414,CHEMBL733698,Inhibition of LPS-stimulated TNF-alpha production in monocyte cells,O=C1NCc2c(-c3ccccc3Cl)cc(OC3CCNCC3)cc2N1c1c(Cl)cccc1Cl,,,CHEMBL1136271,Bioorg Med Chem Lett,2003,CHEMBL94825,,CHEMBL94825,8.8,174908,=,1,1,=,,IC50,nM,1.6,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,1.6,0
329071,CHEMBL702335,Ability to block the release of TNF-alpha in human whole blood,COc1ccc(-c2ccc(C(N)=O)nc2)cc1OC1CCCC1,,,CHEMBL1151544,Bioorg Med Chem Lett,1997,CHEMBL352153,,CHEMBL352153,6.75,321475,=,1,1,=,,IC50,nM,180.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.18,1
587773,CHEMBL759885,"Inhibitory activity against platelet aggregation, induced by arachidonic acid in human platelet rich plasma",O=C(O)COc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCC2CCCCC2)co1,,,CHEMBL1126688,J Med Chem,1993,CHEMBL30832,,CHEMBL30832,8.15,47546,=,1,1,=,,IC50,nM,7.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,I50,nM,UO_0000065,7.0,0
525479,CHEMBL702585,In vitro inhibitory activity against superoxide production from human neutrophils stimulated with f-MLP,CCOc1ccc(-c2nc(-c3ccc(C(=O)O)s3)cs2)cc1OCC,,,CHEMBL1128742,J Med Chem,1995,CHEMBL122304,,CHEMBL122304,7.1,226488,=,1,1,=,,IC50,nM,80.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.08,1
636851,CHEMBL699196,Concentration inhibiting 50% of the copper induced lipid peroxidation determined using the thiobarbituric acid reactive substance and expressed as an MDA equivalent,CCCCN(C(=O)C1=COc2cc(O)c(C(C)(C)C)cc2O1)c1ccccc1,,,CHEMBL1134682,J Med Chem,2001,CHEMBL339617,,CHEMBL339617,6.7,243427,=,1,1,=,,IC50,nM,200.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,M,UO_0000065,2e-07,1
234038,CHEMBL763984,Inhibitory concentration of compound in human platelet rich plasma against 2 umol of ADP-induced aggregation,CCCCC[C@H](O)/C=C/[C@@H]1[C@H]2C(=O)/C(=C/CCCC(=O)[O-])O[C@H]2C[C@H]1O.[Na+],,,CHEMBL1121996,J Med Chem,1982,CHEMBL268952,,CHEMBL1206391,,6551,=,1,1,=,,IC50,ug.mL-1,0.015,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,ng ml-1,UO_0000274,15.0,0
596630,CHEMBL842220,Inhibition of TNF-alpha synthesis in human monocytes,COc1ccc2c(Cc3c(Cl)cncc3Cl)nnc(N3CCCC3)c2c1,,,CHEMBL1134046,Bioorg Med Chem Lett,2001,CHEMBL79535,,CHEMBL79535,8.05,232433,=,1,1,=,,IC50,nM,9.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,9.0,0
347803,CHEMBL700565,Compound was evaluated for GROalpha-mediated calcium mobilization in human polymorphonuclear neutrophils(PMNs),N#Cc1ccc(NC(=O)Nc2ccccc2)c(O)c1,,,CHEMBL1149089,J Med Chem,2004,CHEMBL25573,,CHEMBL25573,6.92,36906,=,1,1,=,,IC50,nM,120.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,120.0,1
507428,CHEMBL696990,In vitro ability to inhibit the aggregation of ADP-stimulated human platelets,O=C(O)CN1CCC2(CCC(C(=O)N3CCN(c4ccncc4)CC3)CC2)CC1,,,CHEMBL1134062,Bioorg Med Chem Lett,2001,CHEMBL280622,,CHEMBL280622,6.93,33885,=,1,1,=,,IC50,nM,117.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.117,1
170475,CHEMBL694769,Tested in vitro for the inhibition of ADP-induced aggregation of human blood platelets,COc1ccc(CCS(=O)(=O)N[C@H](CCCCNC(=O)c2ccc(C(=N)N)cc2)CC(=O)O)cc1,,,CHEMBL1129882,Bioorg Med Chem Lett,1997,CHEMBL162379,,CHEMBL162379,7.1,319860,=,1,1,=,,IC50,nM,79.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,79.0,1
358254,CHEMBL761638,In vitro inhibition of collagen-induced platelet aggregation in human platelet-rich plasma (PRP),COc1ccc(-c2snnc2-c2ccco2)cc1,,,CHEMBL1122973,J Med Chem,1985,CHEMBL139248,,CHEMBL139248,,267958,=,1,1,=,,IC50,ug.mL-1,0.032,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,ng ml-1,UO_0000274,32.0,0
36008,CHEMBL763979,Inhibition of human platelet aggregation induced by ADP after 3 min incubation with platelet rich plasma,Cl.O=S(=O)(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)N1CCN(c2nc3ccccc3s2)CC1,,,CHEMBL1126868,J Med Chem,1993,CHEMBL1203075,,CHEMBL111842,8.31,208581,=,1,1,=,,IC50,nM,4.88,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,nM,UO_0000065,4.88,0
537228,CHEMBL696393,The compound was tested for inhibition of human platelet aggregation induced by ADP,CCCC[C@H](C)C[C@H](O)/C=C/[C@@H]1[C@H]2C[C@H](CCOCC(=O)O)C[C@H]2C[C@H]1O,,,CHEMBL1127169,Bioorg Med Chem Lett,1993,CHEMBL439954,,CHEMBL439954,,176958,=,1,1,=,,IC50,ug.mL-1,0.0125,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,ng ml-1,UO_0000274,12.5,0
401252,CHEMBL761736,Evaluated for human platelet aggregation.,O=C(O)[C@H](CCC(=O)N1CCC(CCCC2CCNCC2)CC1)NS(=O)(=O)c1cccc2ccccc12,,,CHEMBL1129099,Bioorg Med Chem Lett,1996,CHEMBL32626,,CHEMBL32626,8.0,46519,=,1,1,=,,IC50,nM,10.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.01,0
125536,CHEMBL701920,Inhibition of LPS-induced TNF-alpha production in human whole blood.,CC(C)(Nc1ccc(C(Cc2cc[n+]([O-])cc2)c2ccc(OC(F)F)c(OC(F)F)c2)cn1)c1ccccc1,,,CHEMBL1136601,Bioorg Med Chem Lett,2003,CHEMBL351187,,CHEMBL351187,7.0,321488,=,1,1,=,,IC50,nM,100.0,CHEMBL372,Homo sapiens,Homo sapiens,9606,IC50,uM,UO_0000065,0.1,1
